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Effect of dietary β-glucan supplementation on growth, intestinal 
functionality and disease progression in selected cyprinids 
(Cyprinus carpio and Danio rerio) 
Abstract 
 
Three experiments were conducted to investigate the effects of dietary supplementation 
of a ß-(1,3)(1,6)-D-glucan derived from the yeast Saccharomyces cerevisiae, on growth 
performance parameters and intestinal functionality in mirror carp (Cyprinus carpio L.) 
and on progression of a chronic, pre-existing mycobacteriosis in zebrafish (Danio rerio).  
The 1st experiment revealed that mirror carp fed diets containing 1% and 2% ß-glucan 
showed significant improvements in growth performance compared to fish fed both the 
control and the 0.1% ß-glucan containing diet. Equally, fish fed diets supplemented with 
1% and 2% ß-glucan displayed significantly higher infiltration of leukocytes into the 
epithelial layer of in the anterior intestine. This effect was not observed in the posterior 
intestine. There were no significant differences in the intestinal absorptive surface area 
and number of goblet cells in either intestinal region. Compared to control fed fish, the 
haematocrit value was significantly elevated in fish fed the 2% ß-glucan diet. The blood 
monocyte fraction was significantly higher in fish fed the 1% and 2% ß-glucan diets. No 
significant changes were observed in the other blood parameters assessed. 
In the 2nd experiment, culture-dependent microbiology unveiled that aerobic 
heterotrophic bacterial levels in mirror carp intestinal microbiota were unaffected by 
dietary β-glucan after two and four weeks. No effects were observed on the 
allochthonous lactic acid bacteria (LAB) populations at either time point, however, 
reduced autochthonous LAB populations were observed at week four. PCR-DGGE 
confirmed these findings through a reduction of the abundance of autochthonous LAB 
operational taxonomical units (OTUs) in β-glucan fed fish compared to the control fed 
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fish. DGGE analyses also revealed that dietary β-glucan reduced the number of OTUs 
and the species richness of the allochthonous microbiota after two weeks, but not after 
four weeks. In contrast, dietary β-glucan reduced the number of OTUs, the species 
richness and diversity of the autochthonous microbiota after two weeks, and those 
parameters remained reduced after four weeks. Intestinal microvilli length and density 
were significantly increased after four weeks in fish fed diets supplemented with 1%           
β-glucan. 
The 3rd experiment comprised of two individual trials where dead or moribund fish 
displayed the classical clinical signs of mycobacteriosis. In experiment I (200 days), 
zebrafish were fed diets supplemented with 0% (control, C) or 0.1% ß-glucan (B). In 
experiment II (63 days), zebrafish were fed diet C or diet B continuously or both diets 
intermittently (CB) in weekly intervals. Dietary ß-glucan failed to improve survival 
rates in both experiments. In experiment II, histopathological analysis revealed absent 
(normal appearance), moderate and severe manifestations of granulomas. Ecological 
microbial community analysis of intestinal samples collected at day 63 showed 
significantly higher number of OTUs, species richness and diversity in treatments B and 
CB compared to the control treatment.  
In conclusion, high dietary ß-glucan supplementation levels enhanced growth 
performance, leukocyte infiltration in the anterior intestine and the ultrastructure of the 
enterocytes in mirror carp without detrimental effects on intestinal morphology or the 
haemato-immunological parameters assessed. In addition, intestinal microbial 
communities were altered in healthy mirror carp and diseased zebrafish. It was also 
demonstrated that dietary ß-glucan failed to impact the progression of a pre-existing 
mycobacteriosis in zebrafish. Future research is required to investigate the underlying 
reasons for the observed effects by applying advanced molecular techniques, and 
whether these effects occur under commercial husbandry, or in different fish species. 
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1.1. The importance of aquaculture and the position of cyprinids 
The world population is expected to increase from nearly 7 billion in 2011 to 
approximately 8 billion by 2025 and to over 9.5 billion by 2050 (UN, 2011). The 
dietary supply of food and specifically protein for this rising population is a major task 
for future generations and aquaculture plays an important role in this demand. The 
global annual food fish supply per capita increased from 9.9 kg in the 1960s to 18.1 kg 
in 2009; further estimates predict a supply of 18.8 kg in 2011 (FAO, 2012) and this 
requirement is likely to rise even more. This increase however is covered at a 
progressive rate by harvests from aquaculture production since the harvests from 
capture fisheries have been stagnating since the late 1980s; recent data from 2006 until 
2011 (estimated) indicate annual capture yields fluctuating around 90 million tonnes 
(Figure 1.1). In contrast, aquaculture production faced a tremendous and persistent 
boom since the 1980s with mean annual growth rates of approximately 8.8%; the data 
for the recent years reflect this fact with the global production rising from 47.3 million 
tonnes in 2006 up to 63.6 million tonnes in 2011 (inland and marine, without aquatic 
plants), equivalent to an increment of over 34%. 
Figure 1.1: World capture fisheries and aquaculture production (from FAO, 2012) 
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Within aquaculture, the freshwater based production is prominent and accounted for 
nearly 62% of the total aquaculture production in 2010 (increasing from approximately 
50% in 1980) whereas marine water based production supplies approximately 30% 
(declining from 40% in the same period). Within freshwater aquaculture the production 
of cyprinids plays a dominant role. In 2010 total worldwide cyprinid production 
accounted for 71.9% or 24.2 million tonnes of all freshwater aquaculture production. 
Cyprinid species produced (with descending share of production) include silver carp 
(Hypophthalmichthys molitrix) and bighead carp (Hypophthalmichthys nobilis), Indian 
major carps [catla (Catla catla), rohu (Labeo rohita) and mrigal (Cirrhinus cirrhosus)], 
grass carp (Ctenopharyngodon idella), common carp (Cyprinus carpio), goldfish 
(Carassius auratus auratus) and crucian carp (Carassius carassius) and other cyprinids 
(Figure 1.2). 
Figure 1.2: Aquaculture production of freshwater species/species group in 2010 (from 
FAO, 2012) 
 
  
Another increasingly
ornamental fish industry, even though it does obviousl
supply for human nutrition. According to
total value of the industry has risen dramatically since the late 1980s. In 2009 the value 
(imports plus exports) accounted for nearly 70
approximately 100 million US$ during the early 1980s (Figure 1.3). Many of the traded 
species belong to cyprinids as the recent study by
authors identified 172 ornamental cyprinid species with 91 species having been 
previously unrepresented in reference libraries. The most prominent representant of 
ornamental cyprinids is the Koi carp (
prices; unconfirmed reports mention a record price of 2.2 million US$ for one single koi 
carp. 
Figure 1.3: Annual total value (in US$) of the global ornamental fish industry (imports 
plus exports) from 1976 until 2009 
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A third sector where a cyprinid species plays an integral part is the research sector. The 
zebrafish (Danio rerio) has gained considerably more attention over the past decades as 
an ideal research model organism in a variety of scientific fields, e.g. infection studies, 
cancer research, developmental biology, environmental toxicology, drug screening, 
evolution and aquaculture. The zebrafish information network (ZFIN, http://zfin.org/) 
reports global data from 1998 until 2012 about the annual number of publications 
released, the number of researchers within the field, the number of laboratories and the 
number of companies related to zebrafish research (Figure 1.4). It highlights the rapid 
boom of the field over the last decade. Recent ambitions have strived for standardization 
of nutritionally balanced zebrafish diets in order to minimize unwanted nutritional 
effects affecting the outcomes of experiments and in order to increase the confidence in 
the comparison of different experiments (Penglase et al., 2012). 
 
Figure 1.4: Registered number of publications, researchers, laboratories and companies 
with zebrafish information network (http://zfin.org/) in the years from 1998 until 2012 
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1.2. Aquaculture production, disease and prophylaxis  
The continuously rising expansion and intensification of aquaculture production 
described in the previous paragraph also implicates a continuously rising burden of 
disease; this is elucidated by several major disease epidemics over the last two decades 
(Peeler and Feist, 2011). The most prominent large scale disease outbreak in all main 
salmon producing countries with severe economical and animal welfare consequences 
was the recent epidemic of infectious salmon anaemia (ISA). First reported in 1984 
(Thorud and Djupvik, 1988) it caused massive production losses in the Faroe Islands 
(Lyngoy, 2003) and in the years 2007-2009 in Chile (Mardones et al., 2009). Delayed 
total losses of 2 billion US$ and 26,000 jobs have been predicted for the Chilean crisis 
for 2009-2011 (Asche et al., 2009). Another major disease with significant financial 
implications is the white spot syndrome virus (WSSV) in crustaceans; since its first 
emergence (presumably in China) in 1993 the disease spread rapidly and globally to all 
known production zones having caused total financial losses of at least 10 billion 
US$ to date (Stentiford, 2011). The most prominent severe disease concerning cyprinids 
in recent years was caused by the koi herpes virus (KHV). It was first described in 
Europe in 1996, the first major outbreak however was reported in Israel in 1998 in 
farms producing common carp and koi carp (Haenen et al., 2004); the disease spread to 
90% of the carp farms in Israel until the end of 2000 with estimated financial losses of  
3 million US$ per year. The disease further spread through international transport of  
carp and ornamental koi carp (Gilad et al., 2003) and is now present in Europe, US, 
Israel, South Africa, Japan and South-East Asia (Haenen et al., 2004). It is estimated 
that diseases in aquaculture overall account for global financial losses of several billion 
US$ per year (Defoirdt et al., 2011). 
 
  
The most important objective in aquaculture production therefore is the maintenance of 
the fish’s freedom of disease in order to sustain high growth rates and survival which in 
turn leads to a greater profitability
by a pathogen generally occurs when several factors coincide (Figure 1.5
pathogen is present in the first place in order to manifest its virulence in the host; 
pathogenic organisms that cause disease in fish include bacteria, viruses, fungi and 
parasites. Secondly, the host fish is susceptible to this pathogen; en
e.g. age or the genetic constitution of a fish 
1993; Arkush et al., 2002
the fish. Thirdly, the conditions in the fish’s environment are 
present which can impair normal physiological processes and cause disease. Stressors 
include adverse water conditions (e.g. oxygen satiation, pH, ammonia, nitrite, carbon 
dioxide, temperature, salinity and turbidity), high stock
interactions among fish, handling (harvesting, grading, transport, therapeutic 
treatments), frequent disturbances, inadequate nutrition (nutrient deficiencies, feeding 
regime, toxins in the diet) and a general lack of sanitati
III, 2002). 
 
 
 
 
 
 
Figure 1.5: Only the simultaneous 
and adverse environmental conditions lead to
Svobodova et al., 1993)
7 
 (Gatlin III, 2002). The outbreak of a disease caused 
(Houghton et al., 1991
; Grimholt et al., 2003) can have an effect on susceptibility of 
adverse, i.e. stressors are 
ing densities (overcrowding), 
on (Schaperclaus, 1991
coincidence of a virulent pathoge
 the onset of a disease
  
Chapter 1 
). A virulent 
dogenous factors, 
; Wiegertjes et al., 
; Gatlin 
n, a susceptible host 
 (adapted from 
Chapter 1 
 
8 
 
Depending on the persistence of the stressor exposure and the intensity, the 
physiological stress response by the organism can be acute or chronic. Acute stress has 
been shown to be beneficial by enhancing the immune reaction, e.g. in rats (Dhabhar 
and McEwen, 1997) and rainbow trout (Peters and Schwarzer, 1985; Möck and Peters, 
1990; Demers and Bayne, 1997). Chronic stress response however is generally believed 
to suppress or dysregulate immune function and make the organism more susceptible to 
pathogens with the eventual risk of causing diseases ( Gatlin III, 2002; Dhabhar, 2009). 
The famous phrase “prevention is better than cure” was coined by Erasmus of 
Rotterdam (1466-1536) already half a millennium ago. This philosophy takes on much 
more significance in today’s animal husbandry in such a way that research and industry 
constantly try to optimize the production conditions. Some of the stressors in 
aquaculture mentioned above can be avoided or, at least, minimized by good 
management and foresighted planning. Some stressors however will always be present 
to some degree in intensive aquaculture production, e.g. inadequate stocking densities, 
suboptimal or poor water quality, handling and transport. Therefore one popular means 
of trying to prevent disease outbreaks and mortalities is the dietary administration of 
immunostimulants in order to boost the fish’s immune system. A lot of concerted 
research efforts have been put forward over the last two to three decades to find new 
and further characterize known immunostimulants. In recent years, research efforts have 
been additionally accelerated since the European Union has ratified a ban on the non-
medical use of antibiotics in animal nutrition in the Regulation (EC) No 1831/2003 
(EU, 2003), effective from 2006 onwards. 
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1.3. Defining the term immunostimulants 
A possible definition of a substance, which acts as an immunostimulant, is the 
classification in groups of origin by Sakai (1999), even though that is independent on 
their mode of action. In this context, those studied in fish and shellfish trials can be 
generally divided into synthetic products (e.g. levamisole), bacterial/fungal substances 
(e.g. lipopolysaccharides, ß-glucans), animal and plant components (e.g. glycyrrhizin), 
diet components (e.g. vitamin C and E), hormones, cytokines and others. The use of 
immunostimulants in aquaculture strives for an enhanced disease resistance through 
increased immunological competence. A similar classification is mentioned by Galeotti 
(1998). This implicates that immunostimulants can be of either natural or synthetic 
origin. Raa (2000) defined immunostimulants as substances, which activate leukocytes 
and therefore may provide higher resistance against viral, bacterial, fungal and parasitic 
infections. In recent years it has been clarified, that foreign substances entering the body 
are recognized by pattern recognition receptors (PRRs) by means of the so-called 
pathogen-associated molecular patterns (PAMPs), highly conserved molecular motifs 
(Janeway, 1992, Medzhitov and Janeway, 2000, Didierlaurent et al., 2005). Against this 
background Bricknell and Dalmo (2005) redefined a former definition as different 
leukocytes may express different PRRs as follows: ’An immunostimulant is a naturally 
occurring compound that modulates the immune system by increasing the host’s 
resistance against diseases that in most circumstances are caused by pathogens‛. 
Thereby they limit them to naturally occurring substances. 
A great range of immunostimulants have received attention in aquaculture over the last 
two to three decades. The immunostimulants however with probably the best scientific 
track record and most established on an industrial scale in the aquaculture industry are 
β-glucans. 
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1.4. What are β-glucans? 
1.4.1. Sources of β-glucans 
β-glucans are widely distributed in nature and can be found in the cell walls of yeasts, 
cereal grains, algae, bacteria and fungi (Zekovic et al., 2005). The most common 
sources for natural β-glucans with highly immunostimulating properties are yeasts and 
fungi. The fungus derived forms, lentinan (obtained from Lentinus edodes), 
scleroglucan (from genus Sclerotium) and schizophyllan (from Schizophyllum 
commune), are β-(1,3)(1,6)-D-glucans and have been extensively studied in human as 
well as in animal nutrition. One of the first studies, conducted in 1969 by Chihara et al. 
(1969), showed an inhibiting effect of lentinan on tumour growth in transplanted mice 
tumours after systemic infection. Lentinan and schizophyllan are nowadays used 
clinically in cancer therapy in Japan (Kaneko et al., 1989). An industrial schizophyllan 
product used in aquaculture is VitaStim. The most established yeast derived 
immunostimulating β-(1,3)(1,6)-D-glucans are extracted from the yeast Saccharomyces 
cerevisiae, which is utilized in commercial products such as Leiber® Beta-S or 
Macrogard®, EcoActivaTM (mixed with mannans) and Zymosan (mixed with mannans, 
proteins and nucleic acids). Krestin (also PSK) is a protein-bound β-glucan obtained 
from the fungus Trametes versicolor. But in contrast to the β-glucans mentioned 
previously, krestin has a β-(1,4)-linked backbone with β-(1,3) and β-(1,6) side chains, 
which bind to the protein moieties O- or N-glycosidicly (Tsukagoshi et al., 1984). 
Laminaran provides a water soluble and an insoluble form of β-(1,3)(1,6)-D-glucan and 
is an extract from brown algae (Laminariae spp.) (Peat et al., 1958; Kim et al., 2000). 
An example of a microbial β-(1,3)-glucan is the linear curdlan, which is derived by 
fermentation from Agrobacterium sp. and Alcaligenes sp.. 
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1.4.2. Chemical structure and solubility 
Glucans are polysaccharides consisting of repeating D-glucose monomers. They can be 
branched or unbranched and are linked by O-glycosidic bonds, either α- or β-bonds. 
Examples for α-glucans are starch, dextran or glycogen, but there are no practical 
applications of these polysaccharides as immunostimulants. In this context, the              
β-glucans are highly important because of their properties as biological response 
modifiers. In yeasts they are located in the notably thick cell wall (100-200 nm), which 
consists of three layers. The cell wall is made up of 80-90% polysaccharides, mainly            
β-glucans and mannans. The β-glucans in the intermediate layer give strength and 
rigidity to the cell wall by forming a microfibrillar network. Humbel et al. (2001) 
analysed the cell wall of Schizosaccharomyces pombe and suggested, that this layer was 
comprised mainly of β-(1,6) branched β-(1,3)-glucan. Figure 1.6 shows the structure of 
a yeast cell wall (Sigma-Aldrich). 
 
Figure 1.6: Typical structure of the yeast cell wall (source: www.sigmaaldrich.com) 
Differences between various β-glucans occur regarding their molecular weight, primary 
structure (including linkage), degree of polymerization (DP) and branching (DB) and 
the conformation (triple/single helix or random coil) (Yadomae and Ohno, 1996; Kim et 
al., 2000; Yadomae, 2000). There are linear β-glucans with a mixed β-(1,3)(1,4)-linkage 
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backbone, e.g. from barley (Mantovani et al., 2008), which have shown positive effects 
on disease resistance in rainbow trout (Sealey et al., 2008). More eminent in this respect 
are the β-glucans only consisting of a backbone of β-(1,3)-linked-D-glucopyranosyl 
units. These glucose polymers can be linear or branched with randomly distributed 
single β-(1,6)-linked D-glucopyranosyl side chains, in which case it provides a comb-
like structure (Bohn and BeMiller, 1995). Thereby the main and side chains can vary in 
length; the side chains support complex tertiary structures, stabilized by inter-chain 
hydrogen bonds (Mantovani et al., 2008), which also determines their properties as 
structural polysaccharides. The branched β-(1,3)(1,6)-D-glucans seem to be the most 
active among the immunostimulants (Bohn and BeMiller, 1995). Figure 1.7 shows the 
typical structure of a β-(1,3)(1,6)-D-glucan. 
 
  
Figure 1.7: Typical primary structure of a yeast β-(1,3)(1,6)-D-glucan (source:  
www.beta13dglucan.org) 
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The critical properties for effective biological response modifiers are the molecular 
weight (MW) and the water solubility, which again depends on the degree of branching 
and the chemical modification (Suzuki et al., 1991; Williams et al., 1991; Williams et 
al., 1992). If the degree of polymerization (as a function of the DB) is more than 100, 
the β-glucans are insoluble in water and solubility increases as the DP decreases. The 
solubility in water ranges from insoluble (curdlan at room temperature) and gelling 
(scleroglucan) to completely soluble (laminaran) (Bohn and BeMiller, 1995).                 
A classification in terms of solubility is: alkali-insoluble, acetic acid insoluble             
1,3-β-glucans, alkali-soluble 1,3-β-glucans and highly branched 1,6-β-glucans (Zekovic 
et al., 2005). This passes an insolubility on most β-glucans and thus limits their 
application in in vitro experiments (Mantovani et al., 2008). Bohn & BeMiller (1995) 
mentioned in their review that in terms of clinical use the molecular weight of the most 
effective β-glucans is between 100 and 200 kDa with a degree of branching from 0.2 to 
0.33 and a triple helical structure. Figure 1.8 shows as an example the triple helical 
structure of schizophyllan (Mizuno, 1999).      
             
 
Figure 1.8: Model of the triple helical structure of schizophyllan (from Mizuno, 1999) 
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1.5. Teleost immunity 
1.5.1. Lymphatic organs 
The lymphatic organs of bony fish can be divided in primary and secondary organs. The 
head kidney (pronephros), trunk kidney (mesonephros) and thymus are the primary 
organs. The spleen and the different types of MALT (mucosa-associated lymphoid 
tissue) represent the secondary organs (Zapata et al., 1996); the MALT in fish is 
considered to be well developed and can be found in the intestine (GALT = gut-
associated lymphoid tissue), gills and skin (Van Muiswinkel and Wal, 2006). The 
number of leukocytes in these organs is appreciable (Rombout et al., 1986; Rombout et 
al., 1989). The primary lymphatic organs are responsible for the generation and 
differentiation of lymphocytes (Hansen and Zapata, 1998), whereas the T-cells are 
processed in the thymus and the B-cells in the kidney. The secondary lymphatic organs 
could be regarded as the ’battlefield‛, the infiltrated antigens clash here with the 
maturated, immune competent lymphocytes. The main difference to the mammalian 
immune system is that fish don’t possess bone marrow and lymph nodes (Press and 
Evensen, 1999), and furthermore the fact that the kidney in fish is a lymphatic as well as 
an important haematopoietic organ (Faenge, 1986; Hansen and Zapata, 1998). 
1.5.2. The immune system 
The teleost immune system can be described on the basis of either compartments or 
functions. The classification via compartments takes place in a cellular and a humoral 
immune system. The functional categorization occurs in a nonspecific/innate immunity 
(IIS = innate immune system) and a specific/acquired/adapted immunity (AIS = 
adaptive immune system). The IIS comprises thereby physico-chemical barriers such as 
scales, skin and mucus layer, phagocytic and non-specific cytotoxic activity and non-
  
specific humoral activity like the complement system, lysozyme and C
The IIS is independent of any recognition mechanisms of pathogens (because
phylogenetic highly conserved PAMPs), barely temperature dependent and the response 
is carried out rapidly (minutes to hours) 
An effective innate immune response is particularly importan
stages as the AIS is yet to fully develop 
phylogenetic further development of the IIS. Fish are the first vertebrates with an AIS, 
which appears in the presence of lympho
histocompatibility complex)
response (Nakanishi, 2003
the development of so
pathogens takes weeks to months and the AIS is temperature
balance, the teleost immune system is more simple and less differentiated compared to 
the mammalian immune system 
levels of the teleost immune system. 
Figure 1.9: Structure of the teleost immune 
systemhttp://www.webmed.ch/Aktuell/Immunsystem.htm
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1.6. How are β-glucans recognized in vertebrates? – Receptors 
As mentioned above, invading pathogens exhibit evolutionary conserved PAMPs, 
which are recognized by vertebrate immune cells via specific receptors, the PRRs, upon 
contact. Those receptors for β-glucan are present in all animals, in invertebrates as well 
as in vertebrates (Raa, 2000) and are important for the recognition of fungal pathogens. 
This is the reason why we can see effects both in shrimp and fish. The receptors, which 
are known to date for being involved in binding of β-glucan in vertebrates, are the 
complement receptor 3 (CR 3), Toll-like receptor (TLR) 2 and 6, lactosylceramide 
(LacCer) and dectin-1, which all prompt innate immune responses (Brown and Gordon, 
2003; Chen and Seviour, 2007); but TLR 2 and 6 and dectin-1 take part in adaptive 
responses as well (Dalmo and Bøgwald, 2008). As known so far, these receptors are 
located on cell surfaces; recognizing plasma molecules are unknown to date, even 
though opsonisation takes part in the recognition of particulate glucans (Brown and 
Gordon, 2005). Dennehy and Brown (2007) suggest, that mainly Dectin-1 by itself, but 
also its collaboration with TLRs is most important in responding to infectious agents. 
The receptors can be found both on immune and non-immune cells including 
monocytes/macrophages, neutrophils, Langerhans cells, eosinophils, NK cells, 
endothelial cells, alveolar epithelial cells and fibroblasts (Brown and Gordon, 2003). A 
further potential receptor for β-glucans could be the scavenger receptor (SR); it is 
present on macrophages and dendritic cells as well as on certain endothelial cells (Peiser 
et al., 2002). Several studies implied soluble β-glucans as ligands, but no specific 
scavenger receptors have been identified to date (Rice et al., 2002). In contrast, the 
detection in invertebrates is carried out mainly in the hemolymph; the Drosophila 
scavenger receptor is the solely known cellular β-glucan receptor (Soltanian et al., 
2009).  
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Regarding the current knowledge in fish it has been shown, that in Atlantic halibut 
(Hippoglossus hippoglossus) larvae the intestinal epithelial layer is involved in the 
uptake of laminaran (Strand and Dalmo, 1997). Moreover, a receptor for β-glucan was 
located on salmon macrophages, granulocytes and non-specific cytotoxic cells (Engstad 
and Robertsen, 1993; Engstad, 1994; Engstad and Robertsen, 1994), and the receptor on 
macrophages appear capable of recognizing very short β-(1,3)-linkages (3 linked 
glucose molecules) and not the β-(1,6)-linkages (Engstad and Robertsen, 1994). 
Ainsworth (1994) detected on channel catfish neutrophils a receptor for the β-glucan 
component of zymosan, a cell wall preparation of S. cerevisiae. It has also been 
suggested, that CR3 is present in head kidney leukocytes of carp (Nakao et al., 2003). 
 
1.7. β-glucans in aquaculture 
1.7.1. Effects of β-glucans on growth 
Reports on the influence of β-glucan on growth performance are conflictive. Although it 
is not the main objective of immunostimulant applications, several studies have 
demonstrated enhancing effects on growth performance (Table 1.1). Improved growth 
performance after 56 days dietary administration was reported in koi carp (Cyprinus 
carpio koi) (Lin et al., 2011) and large yellow croaker (Pseudosciaena crocea) (Ai et 
al., 2007) with S. cerevisiae β-glucan as well as rohu (Labeo rohita) fingerlings with a 
barley derived β-glucan (Misra et al., 2006). Also studies with Penaeus species have 
shown enhanced growth parameters 39 days after an initial 3 hour β-glucan bath 
immersion (Sung et al., 1994) or oral administration over 75-84 days (Felix et al., 2008; 
Van Hai and Fotedar, 2009; Zhao et al., 2012). Positive effects on growth rates were 
also seen in sea cucumber (Apostichopus japonicus) over 29 days (Gu et al., 2011; Zhao 
et al., 2011). Many other studies however did not observe such positive effects on 
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growth performance, e.g. in Nile tilapia (Oreochromis niloticus) (Whittington et al., 
2005; Shelby et al., 2009), European sea bass (Dicentrarchus labrax) (Bagni et al., 
2005), channel catfish (Welker et al., 2007) or hybrid striped bass (Morone chrysops x 
Morone saxatilis) (Li et al., 2009). Even negative effects on feed conversion were found 
after 3 (but not after 9) weeks with a medium and high β-glucan barley based diet or a 
wheat based basal diet containing 0.2% S. cerevisiae β-glucan compared to a wheat 
meal based control diet, when fed to rainbow trout (Sealey et al., 2008); also weight 
gain was significantly reduced after week 3 with the high β-glucan barley diet.  
It is impossible up to date to elucidate logically, why growth enhancing effects can be 
seen under certain circumstances in some fish/shellfish species and not in others. Dalmo 
& Bøgwald (2008) suggest that the effects may depend on the concentration of β-glucan 
in the diet and its solubility, the fish species, temperature and length of the feeding 
period; they also mention that the intestine only absorbs soluble β-glucan and there are 
no endogenous enzymes which degrade particulate β-glucan making them available for 
absorption. They also hypothesize, when growth enhancing effects occur, that the β-
glucans induce a localized intestinal immune response that in turn leads to resistance 
against pathogens which otherwise would cause reduced weight gain and possibly 
disease.  
1.7.2. Immunostimulating effects of β-glucans in vitro  
In vitro studies are a useful means to conduct very specific and isolated experiments 
under controlled conditions, it must be noted however that the results may not always 
fully translate into an in vivo system with its complex processes (Kiron, 2012). Several 
studies reported the in vitro effects of β-glucans on fish immune cells, nearly always 
macrophages isolated from the pronephros (Table 1.2). β-glucans enhanced the 
respiratory burst, one of the crucial innate immune responses on the cellular level, in 
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Table 1.1: Reported growth performance enhancing effects of β-glucans in aquaculture 
species 
Species β-glucan type Feeding regime Effects Reference 
Cyprinus 
carpio koi 
S. cerevisiae    
β-glucan 
0.09% inclusion               
fed to apparent satiation 
↑ weight gain 
↑SGR 
Lin et al. 
(2012) 
Labeo rohita Barley derived 
β-glucan 
0.025% and 0.5% inclusion 
fed at 3% of BW day-1 
↑SGR Misra et al. 
(2006) 
Pseudosciaena 
crocea 
S. cerevisiae   
β-glucan 
0.09% inclusion                                       
fed to apparent satiation 
↑SGR Ai et al.  
(2007) 
Penaeus 
monodon 
S. cerevisiae   
β-glucan 
3 h bath immersion at      
0.5, 1, and 2 mg/ml 
↑body length 
↑body weight 
Sung et al. 
(2004) 
Penaeus 
latisulcatus 
β-(1,3)-glucan 0.2% inclusion                 
fed at 3%-5% of BW day-1 
↑SGR        
↑FCR 
Van Hai and 
Fotedar  
(2009) 
Penaeus 
monodon 
S. cerevisiae   
β-glucan 
0.1, 0.7 & 1.3% inclusion, 
fed at 10% of BW day-1 in 
weekly intervals 
↑ weight gain   
↑ SGR  
Felix et al. 
(2008) 
Litopenaeus 
vannamei 
β-(1,3)-glucan 0.025% inclusion ↑ weight gain Zhao et al. 
(2012) 
Apostichopus 
japonicus 
S. cerevisiae   
β-glucan 
0.125% inclusion              
fed at 3% / 2% of BW day-1 
for 3/5 weeks  
↑body weight  
↑SGR 
Zhao et al. 
(2011) 
Apostichopus 
japonicus 
S. cerevisiae   
β-glucan 
0.075 and 0.15% inclusion                          
fed to apparent satiation 
↑SGR Gu et al. 
(2011) 
 
isolated macrophages from Indian major carp catla (Catla catla) (Kamilya et al., 2006a) 
and Atlantic salmon macrophages (Sveinbjornsson and Seljelid, 1994; Dalmo and 
Seljelid, 1995). Three key studies however gave more detailed and contrary insights 
into this topic. Jorgensen and Robertsen (1995) showed that the commercial β-glucan 
MacroGard® raised the respiratory burst activity in Atlantic salmon macrophages at    
0.1 and 1 µg/ml while a concentration of 10 µg/ml had no effects; but 50 µg/ml had 
even inhibitory effects. Castro et al. (1999) investigated the effects of 3 yeast β-glucans 
from S. cerevisiae and a fungus β-glucan from S. commune (0-500 µg/ml) on turbot 
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(Psetta maxima) and gilthead seabream (Sparus aurata) phagocytes. The cell responses 
in both species were similar. Overall, the authors hypothesize that low concentrations 
prepared the cells for a higher production of reactive oxygen species prior to a later 
following activation of the respiratory burst; but high concentration of β-glucans may 
exhaust the phagocytic cells due to a direct induction of the respiratory burst. Kudrenko 
et al. (2009) however reported in a recent study with barramundi (Lates calcarifer) 
macrophages that β-glucans of different sources (curdlan, paramylon, laminaran and 
purified yeast β-glucan) stimulate the respiratory burst at concentrations of 100 and 
1000 µg/ml; but only two other stimulants in this experiment (LPS and Zymosan) were 
able to prime the macrophages at low concentrations (0.1 and 1 µg/ml). The authors 
suggest that the β-glucans activate macrophages in high concentrations, but do not 
prime them through the β-glucan receptor. They also investigated the effect of an acid 
environment on β-glucans after determining the stomach pH of the carnivorous 
barramundi, which was at pH 2 for up to 6h after feeding. The β-glucans, treated with 
HCl to simulate those conditions, lost their ability to activate macrophages. This 
circumstance might underline the relevance of the digestive system of the respective 
species in terms of the efficacy of orally delivered β-glucans. In contrast to stomachless 
herbivorous and omnivorous species, the β-glucans are exposed to a strongly acid 
environment in the stomach of carnivorous species. This might influence their physico-
chemical properties and consequently their biological effects. 
β-glucans also improved another important part of the cellular innate immune response. 
Phagocytic processes were increased in macrophages isolated from catla (Kamilya et 
al., 2006a) and Atlantic salmon (Dalmo and Seljelid, 1995) and enhanced pinocytosis 
was described in Atlantic salmon (Sveinbjornsson and Seljelid, 1994). Also acid 
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phosphatase activity was augmented in Atlantic salmon macrophages (Sveinbjornsson 
and Seljelid, 1994; Dalmo and Seljelid, 1995). 
While the above described improved respiratory burst and phagocytic activity of catla 
macrophages translated into a higher bactericidal activity against Escherichia coli 
(Kamilya et al., 2006a), this effect was not observed in Atlantic salmon macrophages 
against a virulent and an avirulent strain of Aeromonas salmonicida (Jorgensen and 
Robertsen, 1995).  
Another important part of innate immunity was activated, when Paulsen et al. (2001) 
administered a S. cerevisiae β-glucan to Atlantic salmon macrophages. The lysozyme 
production was increased in an almost linear dose-response relation from 1 to 250 µg/ml 
(up to 6-fold higher compared to controls); a concurrent enrichment of the lysozyme 
gene transcript occurred as well. Furthermore, macrophages of fish infected with the 
skin parasite Ichthyobodo necator showed increased lysozyme activity under ß-glucan 
stimulation.  
1.7.3. Immunostimulating effects of β-glucans in vivo 
Several methods have been used to administer β-glucans in in vivo-studies: injection 
intraperitoneal (ip), immersion bathing and oral delivery via feeding.  
1.7.3.1. Injection 
The ip injection – delivery into the body cavity – is a highly effective method with fast 
occurring effects and ensures that the desired dose is administered, but it’s costly and 
labour-intensive, impractical for use in smaller fish and a stressful situation for treated 
fish (Galindo-Villegas and Hosokawa, 2004). In most of the studies the influence of the 
used β-glucans in association with disease challenges was examined (Table 1.3).  
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Table 1.2: Reported in vitro effects of β-glucans in aquaculture species  
Species β-glucan type Effects Reference 
Catla catla P. florida         
β-glucan 
↑ respiratory burst                                          
↑ phagocytic and bactericidal activity 
Kamilya et al. 
(2006) 
Salmo 
salar 
β-(1,3)- 
polyglucose 
from curdlan 
↑ respiratory burst                                           
↑ pinocytic activity                                        
↑ acid phosphatase 
Sveinbjornsson 
and Seljelid   
(1994) 
Salmo 
salar 
Native 
laminaran 
↑ phagocytotic index                                      
↑ intracellular superoxide anion                    
↑ acid phosphatase activity 
Dalmo and 
Seljelid      
(1995) 
sulphated 
laminaran 
↑ intracellular superoxide anion                       
↑ acid phosphatase activity 
Salmo 
salar 
S. cerevisiae     
β-glucan 
↑ respiratory burst at low β-glucan levels 
→bactericidal activity against A.salmonicida 
Jorgensen and 
Robertsen  
(1995) 
Psetta 
maxima 
and Sparus 
aurata 
S. cerevisiae and 
S. commune     
β-glucans 
↑ respiratory burst with high β-glucan levels  
leading to exhaustion; priming effect with 
low β-glucan levels for ↑ respiratory burst  
Castro et al. 
(1999) 
Lates 
calcarifer 
various             
β-glucans 
↑ respiratory burst with high β-glucan levels 
no priming effect with low levels                
→ respiratory burst after 6 h HCl treatment 
of β-glucans 
Kudrenko et al. 
(2009) 
Salmo 
salar 
S. cerevisiae     
β-glucan 
↑ lysozyme activity and gene transcript          
↑ lysozyme production in Ichthyobodo 
necator infected fish 
Paulsen et al. 
(2001) 
 
Administration of β-glucans ip has been reported to significantly increase survival rates 
upon challenges with E. tarda (Yano et al., 1989; 1991) and A. hydrophila (Yano et al., 
1991; Selvaraj et al., 2005; Rodriguez et al., 2009) in cyprinids (carp and zebrafish), 
upon challenges with V. salmonicida, V. anguillarum and Y. ruckeri (Robertsen et al., 
1990) in Atlantic salmon and upon challenges with E. ictaluri (Chen and Ainsworth, 
1992) in channel catfish. In these studies innate immune responses were elevated, likely 
having promoted the higher survival rates observed. For example, higher activities of 
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pronephros phagocytotic cells were detected in channel catfish (Chen and Ainsworth, 
1992), and in carp where it likely lead to the rapid elimination of the challenge bacteria 
from the blood (Yano et al., 1989); another non-challenge study by Brattgjerd et al. 
(1994) reported increased phagocytic activities of Atlantic salmon macrophages against 
V. salmonicida, but interestingly not against R. salmoninarum. Enhanced bactericidal 
activities of phagocytes against the respective pathogens were seen in carp (Selvaraj et 
al., 2005), zebrafish (Rodriguez et al., 2009) and channel catfish (Chen and Ainsworth, 
1992). Furthermore, an augmented activation of the alternative complement pathway 
occurred in carp (Yano et al., 1989; 1991); in Selvaraj et al.’s (2005) study however the 
classical and alternative complement pathway remained unaffected. Higher levels of 
total blood leukocytes, the proportion of monocytes and neutrophils and a decrease of 
eosinophils and basophils as well as an enhancement of the respiratory burst of 
pronephros macrophages were detected in carp (Selvaraj et al., 2005). A higher 
respiratory burst in non-challenged Atlantic salmon macrophages was also observed by 
Brattgjerd et al. (1994). Another important part of the innate immune defence, the 
presence of lysozyme, was increased in the blood of non-challenged Atlantic salmon 
(Brattgjerd et al., 1994; Paulsen et al., 2003). The studies of Selvaraj (2005) and Chen 
and Ainsworth (1992) have also indicated β-glucan effects on the adaptive immune 
response when serum antibody titres against A. hydrophila and E. ictaluri, respectively, 
were increased following vaccination.  
Interestingly, a recent study by Kim et al. (2009) also reported anti-viral effects of        
β-glucans when grass carp displayed increased survival rates upon a challenge with the 
grass carp haemorrhage virus. In addition, the authors showed augmented activities of 
antioxidant enzymes (superoxide dismutase and catalase) in erythrocytes and increased 
expression levels of the Mx gene, an anti-viral response gene. 
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Table 1.3: Reported effects of β-glucans after intraperitoneal injection in aquaculture species 
Species β-glucan type Injection dose Effects Reference 
Cyprinus carpio lentinan          
schizophyllan 
scleroglucan 
2, 5 and 10 mg kg-1 ↑ survival against E. tarda & A. hydrophila                                 
↑ elimination of E. tarda from blood                                            
↑ phagocytic index  of pronephros cells                                       
↑ alternative complement pathway 
Yano et al. (1989) 
Yano et al. (1991) 
Cyprinus carpio S. cerevisiae β-glucan 100, 500 and 1000 µg ↑ survival against A. hydrophila                                                   
↑ total blood leukocytes, neutrophils and monocytes levels           
↑ respiratory burst and bactericidal activity                                 
↑ antibody titres against A. hydrophila                                       
→ classical and alternative complement pathway 
Selvaraj et al.   
(2005) 
Danio rerio S. cerevisiae β-glucan 0.5, 2 and 5 mg ml-1 ↑ survival against A. hydrophila                                                   
↑ bactericidal activity of myelomonocytic kidney cells  
Rodriguez et al. 
(2009) 
Ctenopharyngodon 
idella 
Poria cocos β-glucan 10 mg kg-1 ↑ survival against grass carp haemorrhage virus                          
↑ SOD and catalase activity in erythrocytes                                 
↑ Mx gene expression 
Kim et al.         
(2009) 
Salmo salar S. cerevisiae β-glucan 0.1 – 2.5 mg fish-1 ↑ survival against V. salmonicida, V. anguillarum &Y. ruckeri  Robertsen et al. 
(1990) 
Salmo salar S. cerevisiae β-glucan 14.8 mg fish-1 ↑ serum lysozyme and macrophage respiratory burst                     
↑ phagocytic activity against V. salmonicida                              
→ phagocytic activity against R. salmoninarum 
Brattgjerd et al. 
(1994) 
Salmo salar S. cerevisiae β-glucan 60 mg kg-1 ↑ plasma lysozyme activity and gene transcripts Paulsen et al. 
(2003) 
Ictalurus punctatus S. cerevisiae β-glucan 50 and 750 µg fish-1 ↑ phagocytic index & bactericidal activity of phagocytes              
↑ survival against E. ictaluri                                                         
↑ serum antibody titres against E. ictaluri 
Chen & Ainsworth 
(1992) 
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1.7.3.2. Immersion 
Very few studies have been conducted so far regarding the administration of β-glucans 
via bathing or immersion. Even though this could be a putatively efficient way of 
treating large quantities of fish, the majority of the studies have not shown any positive 
results. Immersion appears to be less successful as fish are probably not capable of 
absorbing particulate β-glucans, which are insoluble in water. 
Selvaraj et al. (2005) conducted immersion studies with carp by bathing them at days 1, 
3 and 5 with S. cerevisiae β-glucans. At day 7 the authors challenged the carp with                
A. hydrophila. No modifying effects occurred regarding the measured parameters, viz. 
survival, total and differential leukocyte counts, respiratory burst and bactericidal 
activity, antibody titres, classical and alternative complement pathway activity. Juvenile 
Chinook salmon (Oncorhynchus tshawytscha) received a vaccine of A. salmonicida 
either alone or in combinations with a commercial β-glucan (from S. commune) both in 
crude or pure form via a 15 min bathing (Nikl et al., 1993). The fish showed no 
enhanced protection to a challenge with virulent A. salmonicida 21 days after the 
vaccination. In contrast, Anderson et al. (1995) proved that glucan immersion led to 
higher but temporary resistance of rainbow trout against A. salmonicida after treatment 
for 3 days. This effect was non-existent after 14 days. A study with juvenile American 
white shrimp (Litopenaeus vannamei) reported a 2-fold increase of the superoxide anion 
generation and a 1.4-fold increase in superoxide dismutase activity in haemocytes and 
muscles after 6 hours immersion in a solution with a S. cerevisiae β-glucans (Campa-
Cordova et al., 2002). The authors conclude that the β-glucans were competent to 
enhance the respiratory burst in haemocytes after a single bath treatment. 
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1.7.3.3. Oral administration 
The oral administration of β-glucans incorporated in feeds would be the most preferable 
way as large quantities of fish could be treated more easily. As already mentioned under 
section 2.9.1 (Injection), administration of β-glucans has the potential to reduce 
mortalities due to pathogenic challenges by strengthening the host’s innate immune 
defences. This phenomenon has also been observed when β-glucans had been delivered 
orally. Yet, the level of information about the mechanisms of action is low because 
most of the previous research has focused on the other ways of administration 
(Soltanian et al., 2009).  
 
1.7.3.3.1. Other fish 
Many studies have shown the protective effects of dietary β-glucans in fish upon 
challenges with various stressors relevant to aquaculture husbandry. β-glucans from      
S. commune and S. cerevisiae have been reported to enhance the survival upon 
challenges with A. salmonicida in chinook salmon (Nikl et al., 1993) and rainbow trout 
(Siwicki et al., 1994). Three commercial β-glucans were administered to gilthead 
seabream (Couso et al., 2003). All glucans and doses led to higher resistance against 
Photobacterium damselae while the effects were more distinct with high 
supplementation. A subsequent study was conducted with the S. cerevisiae β-glucan 
with the same feeding scheme twice in a row and dosages of 0.1, 0.5 and 1%; 
interestingly, the mortality caused by P.damselae was reduced with 0.1%, unaffected 
with 0.5% and even raised with 1% β-glucan compared to control groups. Higher 
survival rates after S. cerevisiae β-glucan administration have been reported in hybrid 
striped bass (Li et al., 2009), large yellow croaker (Ai et al., 2007) and channel catfish 
(Welker et al., 2011) upon challenges with Streptococcus iniae, V. harveyi and E. 
ictaluri, respectively.  
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Anti-viral properties of barley and S. cerevisiae β-glucans have been shown when 
rainbow trout challenged with the infectious haematopoietic necrosis virus (IHNV) 
displayed higher survival rates (Sealey et al., 2008).  
More recently, positive effects of β-glucans were also revealed in parasite challenge 
studies. Rainbow trout infected with Ichthyophthirius multifiliis had lower infection 
rates when they were fed diets supplemented with high levels of paramylon (5%) from 
the algae Euglena gracilis (Jafaar et al., 2011) or yeast β-glucan (Lauridsen and 
Buchmann, 2010). Simultaneously, in both studies an increase in blood lysozyme 
activity occurred, possibly explaining the reduction in infection rates. Furthermore, 
dietary yeast β-glucans had distinctly reducing effects on the formation of Loma 
salmonae xenomas on the gills of rainbow trouts (Guselle et al., 2010) and dactylogyrid 
monogeneans infection rates in spotted rose snapper (Lutjanus guttatus) (Rio-Zaragoza 
et al., 2011). 
β-glucans also revealed their positive effects when studies reproduced stressful 
situations common to aquaculture practise (Jeney et al., 1997; Volpatti et al., 1998). 
Rainbow trout having received β-glucans over four weeks prior to transportation stress 
displayed a minor reduction in innate immune parameters (respiratory burst, phagocytic 
activity, lysozyme) compared to control fed fish.   
Where examined in those studies as well as in other non-challenge studies, enhanced 
activities of important parameters related to innate immunity were detected. β-glucans 
caused higher phagocytic activities of blood leukocytes in rainbow trout (Siwicki et al., 
1994; Jeney et al., 1997; Volpatti et al., 1998) and spleen/pronephros macrophages in 
pike perch (Siwicki et al., 2009) and large yellow croaker (Ai et al., 2007), respectively. 
An increase of respiratory burst activity was observed in spleen phagocytes of gilthead 
seabream (Couso et al., 2003) and pikeperch (Siwicki et al., 2009) and pronephros 
macrophages of large yellow croaker (Ai et al., 2007) and blood leukocytes of rainbow 
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trout (Jeney et al., 1997; Volpatti et al., 1998). A higher neutrophil oxidative radical 
production in whole blood occurred in the studies of Siwicki et al. (1994) and Li et al. 
(2009), although no effects were seen on the respiratory burst activity of pronephros 
macrophages and blood serum lysozyme in Li et al.’s (2009) study. Furthermore, 
bactericidal and myeloperoxidase activity were enhanced in the study of Siwicki et al. 
(1994) in blood leukocytes without changes in haematocrit and total leukocyte levels. 
Also enhancing effects on blood serum lysozyme have been reported (Bagni et al., 
2005; Ai et al., 2007; Siwicki et al., 2009; Welker et al., 2011). Alternative complement 
pathway activity was enhanced after short-term administration in sea bass (Bagni et al., 
2005) but not after long-term administration in sea bass (Bagni et al., 2005) and large 
yellow croaker (Ai et al., 2007). 
Other studies however led to contradictory results in challenge studies. Dalmo et al. 
(1998) reported that orally administered laminaran could not protect Atlantic salmon 
upon challenges with A. salmonicida and V. salmonicida when the diets were fed for 10 
days prior to challenging. A S. cerevisiae β-glucan administered for 5 weeks had also no 
effect on survival rates of turbots challenged with V. anguillarum (deBaulny et al., 
1996). A S. cerevisiae β-glucan supplemented to diets for Nile tilapia and fed for 14 
weeks had no effect on survival rates when the fish were challenged with S. iniae after 
week 12 (Whittington et al., 2005). A series of three experiments included the 
administration of two S. cerevisiae β-glucans to Nile tilapia in varying concentrations, 
stocking densities and durations (2 or 4 weeks) (Shelby et al., 2009). Challenges with   
S. iniae and E. tarda did not reveal any protection. The same products fed for 4 weeks 
followed by 2 weeks of a control diet to channel catfish did not improve survival rates 
in a subsequent challenge with E. ictaluri (Welker et al., 2007).  
Simultaneously, the measured innate immune parameters in those studies were in most 
instances not enhanced through dietary β-glucan supplementation. Total blood 
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leukocyte cell counts remained unaffected in channel catfish after four weeks of feeding 
(Welker et al., 2007) but were increased in turbot at days 8 and 21 after five weeks of 
feeding (deBaulney et al., 1996). No effects were seen on bactericidal and respiratory 
burst activity of blood leukocytes (Welker et al., 2007). Furthermore, lysozyme activity 
did not change in the studies of deBaulny et al. (1996), Shelby et al. (2009) and Welker 
et al. (2007); Whittington et al. (2005) reported the same and, beyond that, even a 
decline in the highest β-glucan group two weeks after the challenge. Complement 
activities were not affected by dietary β-glucans (deBaulny et al., 1996; Welker et al., 
2007; Shelby et al., 2009). 
 
1.7.3.3.2 Cyprinids 
A few studies have investigated the effects of orally administered β-glucans on disease 
resistance and immune response in cyprinids. β-glucans were able to increase survival 
rates of carp (Kwak et al., 2003; Gopalakannan and Arul, 2010) and rohu (Misra et al., 
2006) upon challenges with A. hydrophila and survival rates of rohu (Misra et al., 2006) 
upon a challenge with E. tarda. In these studies a simultaneous enrichment in total 
blood leukocyte counts (Misra et al., 2006; Gopalakannan and Arul, 2010) and 
macrophages/neutrophils (Kwak et al., 2003) occurred. Respiratory burst (Misra et al., 
2006; Gopalakannan and Arul, 2010) and phagocytic activities (Kwak et al., 2003; 
Misra et al., 2006) as well as alternative complement pathway and bactericidal activity 
(Misra et al., 2006) were improved. Furthermore, serum lysozyme activities were 
augmented (Kwak et al., 2003; Misra et al., 2006; Gopalakannan and Arul, 2010). In 
one study however (Selvaraj et al., 2005), carp did not show increased survival upon an 
A. hydrophila challenge. Strikingly, the simultaneously observed unaffected cellular and 
humoral immune responses (total and differential blood leukocyte counts, respiratory 
burst, bactericidal, classical and alternative complement pathway activities) could 
explain the non-responsiveness in survival rates. 
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Table 1.4: Reported immunostimulating and disease resistance effects of β-glucans after oral delivery in cyprinid aquaculture species 
Species β-glucan type Feeding regime Effects Reference 
Cyprinus carpio S. cerevisiae        
β-glucan 
1, 2 and 4% → survival against A. hydrophila                                                                          
→ total and differential blood leukocytes                                                              
→ bactericidal activity and respiratory burst                                                        
→ classical and alternative complement pathway                                                  
↑ slight increase of the antibody titre against A. hydrophila 
Selvaraj et al. 
(2005) 
Cyprinus carpio S. uvarum             
β-glucan 
1% ↑ survival against A. hydrophila                                                                              
↑ total blood leukocytes and respiratory burst                                                          
↑ serum lysozyme activity 
Gopalakannan 
and Arul     
(2010) 
Labeo rohita Barley β-glucan 0.01, 0.25 and 
0.5% 
↑ survival against A. hydrophila and E. tarda                                                   
↑ respiratory burst, phagocytic activity, lymphokine production index                
↑ lysozyme, alternative complement & bactericidal activity                               
↑ total blood leukocytes, serum protein, globulin and albumin:globulin ratio        
↓ serum glucose                                                                                             
↑ antibody titre against E. tarda; → antibody titre against A. hydrophila 
Misra et al. 
(2006) 
Cyprinus carpio Schizophyllan 0.1% ↑ survival against A. hydrophila                                                                              
↑ proportion of blood macrophages and neutrophils                                               
↑ phagocytic activities and lysozyme 
Kwak et al. 
(2003) 
Tinca tinca S. cerevisiae         
β-glucan 
0.05, 0.1 and 0.2% ↑ survival against A. hydrophila                                                                              
↑ respiratory burst and phagocytic activity                                                              
↑ proliferative response of lymphocytes                                                                 
↑ serum lysozyme and Ig levels; → total serum protein, ceruloplasmin 
Siwicki et al. 
(2010) 
Cyprinus carpio 
koi 
S. cerevisiae        
β-glucan 
0.09% ↑ survival against A. veronii                                                                            
↑ total blood leukocytes, respiratory burst, phagocytic & SOD activity                 
↑ lysozyme; → alternative complement pathway 
Lin et al.     
(2011) 
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1.7.4. Effects of β-glucans on immunocompromised fish 
An interesting question is how β-glucans influence the immune response in immuno-
compromised organisms, that is, what effect does an immunostimulant have on an 
already challenged immune system? Only a few studies have been conducted with fish 
so far by “artificially” inducing a compromised immune system, using injections of 
cyclophosphamide (Kumari and Sahoo, 2006 a, b), mercuric chloride (El-Boshy et al., 
2010) or aflatoxin B1 (Sahoo and Mukherjee, 2001; 2002).  
Two studies of Kumari and Sahoo with immunocompromised Asian catfish (Clarias 
batrachus) reported enhancing β-glucan effects on cellular and humoral innate immune 
responses (2006a) as well as on the adaptive immune response and the survival rates of 
vaccinated and non-vaccinated fish after an A. hydrophila challenge (2006b). Similarly, 
El-Boshy et al. (2010) observed significant increases of cellular and humoral innate 
immune responses and survival rates upon an A. hydrophila challenge in Nile tilapia fed 
β-glucans. Dietary β-glucans also increased innate immune responses and survival rates 
upon an A. hydrophila challenge in immunocompromised rohu, but no effect on 
adaptive immune responses was observed (Sahoo and Mukherjee, 2001). A similar, 
subsequent study however demonstrated augmented adaptive immune responses and 
survival rates of vaccinated and non-vaccinated immunocompromised rohu upon an    
E. tarda challenge (Sahoo and Mukherjee, 2002). 
It therefore seems that dietary β-glucans are able to realize in immunocompromised fish 
the same positive effects regarding immune response and disease resistance as in 
healthy fish. But what are the effects of β-glucans on fish where naturally occurring 
diseases (being the reason for immunosuppression) are already manifest prior to the 
administration of the β-glucan? There is a lack of studies in this respect and there may 
be differences in immune responses and disease resistance compared to an artificially 
induced immunosuppression. 
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1.7.5 Use of β-glucans as adjuvants 
The word adjuvant originates from the Latin word adiuvare which means to aid. By 
definition, “an adjuvant is a substance that helps and enhances the pharmacological 
effect of a drug or increases the ability of an antigen to stimulate the immune system”. 
The aim is to increase efficacy and potency of the vaccine. They activate antigen-
presenting cells (e.g. macrophages) and stimulate those to generate more of the signal 
molecules (e.g. cytokines) which activate other immune cells (Raa, 2000). β-glucans 
have the potential to act as such without causing the problems like oil emulsion based 
adjuvants, e.g. tissue damage or skeletal deformities (Dalmo and Bøgwald, 2008). 
Early studies reported that injection of β-glucans together with A. salmonicida vaccines 
enhanced survival rates of coho salmon (Oncorhynchus kisutch) (Nikl et al., 1991)  and 
Atlantic salmon (Rørstad et al., 1993) upon challenges with A. salmonicida. In contrast, 
the mortality of turbot upon a V. anguillarum challenge did not differ when an orally 
administered anti-vibriosis vaccine was given alone or adjuvanted with β-glucan 
(deBaulny et al., 1996).  
In cyprinids, adjuvant effects of β-glucans on survival and immune responses have been 
reported in carp (Selvaraj et al., 2006) and catla (Kamilya et al., 2006b) upon challenges 
with A. hydrophila. Moreover, Selvaraj et al. (2006) observed that the adjuvanticity 
depends on the administration route. Survival and immune responses were highest with 
ip injection even at low dosages and oral delivery required medium to high dosages. 
Bathing however did not enhance any of the analysed parameters and survival rates. 
Also, some immune parameters (IL-1β mRNA expression, classical and alternative 
complement pathway) were not affected independent of the delivery route. 
Adjuvants are generally administered alongside the vaccine. Anderson et al. (1989) 
reported that the administration of levamisole prior to the vaccine suppressed the 
immune responses of rainbow trout against Y. ruckeri, mainly at high dosages. Time-
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dependent adjuvanticity was studied when a S. cerevisiae β-glucan was given to turbots 
before, simultaneously and after the V. damsela vaccine (Figueras et al., 1998). Immune 
responses including antibody titres were higher when the glucan was given afterwards.  
 
1.7.6. Administration strategies for use in aquaculture 
As mentioned beforehand, the ip injection seems to be most effective in administering 
β-glucans; immersion appears to be less successful as fish are probably not capable of 
absorbing particulate β-glucans (Dalmo and Bøgwald, 2008) which are insoluble in 
water. But the oral delivery would be the easy and more cost-efficient way, if they are 
incorporated in the diets and given in the daily feeding process. There are two 
recognized strategies of oral delivery of any immunostimulant (Fig. 1.10), the 
continuous feeding or the pulse feeding (Bricknell and Dalmo, 2005). By continuous 
feeding the immune response can be enhanced and maintained until the 
immunostimulant delivery is stopped or after initial enhancement adverse effects occur 
and the immune response drops (possibly to even lower levels compared to fish fed no 
immunostimulant). This can occur through an acquired tolerance induced by a 
desensitisation of the immune system and even lead to an immune-suppression. A 
pulsative administration in 4-6 week intervals could potentially avoid this and can be 
applied for stressful periods with higher disease risks like seasonal temperature changes, 
transportation, prior to the breeding season, sea-water transfer of smolts, fishing dry of 
ponds, etc. 
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Figure 1.10: Possible outcomes after immunostimulant administration to fish (from 
Bricknell and Dalmo, 2005) 
 
1.8 Recent advances in β-glucan research in cyprinids 
Several recent studies gave insights into new aspects of β-glucan research in cyprinids, 
e.g. comprehensive gene expression studies relating to immune responses, first-line-of-
defence-mechanisms and apoptosis, or the recently discovered neutrophil extracellular 
traps.  
Namely, it has been shown that β-glucans protect neutrophil extracellular traps (NETs) 
against bacterial degradation by A. hydrophila nuclease in common carp (Brogden et 
al., 2012). This could possibly contribute to the frequently observed enhancing effect of 
β-glucans on survival rates in A. hydrophila challenge studies described in the previous 
paragraphs. 
Miest et al. (2012) hypothesized that the known elevating effect of β-glucan on the 
production of reactive oxygen species may affect apoptosis. But the authors conclude 
from their studies that dietary β-glucan alone or combined with other pathogenic factors 
did not induce significant apoptosis in common carp immune organs. 
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Falco et al. (2012) proposed that the gene expression of pro-inflammatory cytokines 
may be down-regulated by dietary β-glucans in carp intestine. Similar results have been 
reported in rainbow trout spleen (Djordjevic et al., 2009). Furthermore, when carp were 
challenged with a non-lethal A. salmonicida infection, the gene expression of pro-
inflammatory cytokines shortly after infection was overall down-regulated in the 
intestine but up-regulated in the pronephros (Falco et al., 2012). The authors suggest 
prevention from acute, possibly detrimental responses in the gut and increase of 
inflammatory responses in the pronephros.     
β-glucans also influenced the mucosal systems of epithelial surfaces in carp (van der 
Marel et al., 2012). A significant increase of the gene expression of antimicrobial 
peptides, β-defensin 1 in skin and β-defensin 2 in skin and gills, occurred upon dietary 
β-glucan administration; yet, expression remained unaffected in the first and second 
intestinal segment. Furthermore, the β-glucans caused changes in the expression of 
mucins, the main components of the mucus covering the epithelial surfaces. The gene 
Muc5B was higher expressed in skin (significantly) and gills (non-significantly), 
respectively, whereas expression was unaffected in either intestinal region. Muc2 
however was slightly reduced in both intestinal segments and in gills and unchanged in 
skin. Overall, this suggests a contribution to improved first-line-of-defence-mechanisms 
by dietary β-glucans.  
Pionnier et al. (2013) observed enhancing effects of dietary β-glucans on C-reactive 
protein levels and alternative complement activity in serum of both healthy and A. 
salmonicida challenged carp. The expression pattern of the related genes displayed an 
organ and time dependent profile during infection stages: early on, an up-regulation of 
the gene expression was observed in pronephros followed by an up-regulation in the 
liver. Interestingly, in mid-gut the expression was up-regulated after 24 h but then 
down-regulated after 72 h. 
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1.9. Conclusions and aims of the study 
As described in this literature review, numerous studies have shown that β-glucans are 
able to enhance growth performance, elicit immune reactions and improve disease 
resistance in aquatic species. It is also obvious, that beneficial results are not always 
observed and issues of reproducibility and consistency exist. Common to the studies 
investigating the effects of a dietary β-glucan administration so far is that they used 
semi-purified diets or even industrial diets. Thus, it is likely that substances with 
immunostimulating properties other than the supplemented β-glucans, e.g. nucleotides 
in fish meal or β-(1,3)(1,4)-D-glucans in cereal products, are present through the 
ingredients used. Consequently, this effect is likely to vary considerably between 
studies and, furthermore, the possibly resulting immunostimulating effects could 
potentially influence or disguise the actual immunostimulating effects of the 
supplemented β-glucan. The key scientific approach of this study was the use of highly 
purified basal diets in order to ascertain to the highest possible degree that the observed 
effects are deducible from the supplemented β-glucans. These diets, consistently used in 
all experiments, were supplemented with MacroGard®, a commercially available                 
ß-(1,3)(1,6)-D-glucan derived from the yeast Saccharomyces cerevisiae.  
The overarching aim of the study was to determine the effects of the orally administered 
MacroGard® on growth and intestinal functionality in mirror carp (Cyprinus carpio L.) 
(Chapters 3&4), and if an enhanced disease resistance can be achieved in zebrafish 
(Danio rerio), also a cyprinid, through direct effects or indirect effects (Chapter 5).  
In summary of the above literature review, it is evident that there are still gaps in 
knowledge regarding β-glucan research in aquatic species. Even though there is 
information on effects of dietary β-glucan supplementation on growth performance, this 
information is, generally in teleosts, inconsistent and, specifically in carp, very scarce. 
The aim of the 1st experiment (Chapter 3) therefore was to evaluate the efficacy of 
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MacroGard® on growth performance and nutrient retention of mirror carp. In order to 
assess the fishes’ health status and physiological response towards the supplemented    
ß-glucan, general haemato-immunological indices were determined at the end of the 
experiment. In addition, as little is known about localized intestinal immune responses 
in teleosts upon contact of orally administered ß-glucans and the mucus-layer/mucosa, 
another objective was to examine whether intestinal morphology and intestinal immune 
response were affected by dietary provision of ß-glucans. 
Further important aspects increasingly having gained attention in aquaculture over the 
last decade are the intestinal microbiota and their interactions with the host, with dietary 
components and among each other. Surprisingly, to date almost no information however 
is available whether dietary β-glucans have an impact on these microbial communities 
(and/or vice versa) in aquatic species and, in consequence, possibly affect this network 
of interactions. The 2nd experiment (Chapter 4) therefore aimed at assessing the effects 
of dietary MacroGard® supplementation on the intestinal microbial communities in 
mirror carp. Moreover, little is known about β-glucan effects on the ultrastructure of the 
apical brush border of the enterocytes. Since possible alterations of the intestinal 
microbiota however may influence physiological processes in the mucosa, a further 
objective of the 2nd experiment was to also examine this aspect.  
A plethora of dietary β-glucan studies have reported augmented disease resistance of 
aquatic species against various pathogens. Understandably, challenges are generally 
applied during or at the end of β-glucan administration. But an interesting question is if 
β-glucans influence the progression of a naturally developed disease existent in the fish 
prior to ß-glucan administration. Since literature is scarce in this regard and challenge 
tests could not be performed with mirror carp, the 3rd experiment (Chapter 5) dealt with 
the effects of dietary MacroGard® on survival rates, histopathology and intestinal 
microbiota of zebrafish suffering from a pre-existing, chronic mycobacteriosis.  
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2.1. Overview 
The subsequently described general experimental conditions and analytical techniques 
were essential for the experiments conducted during this study. Further methods and 
techniques specific to individual experiments are described in their respective 
methodology sections. All experiments were carried out under the Home Office project 
licence number 30/2644 and personal licence number 30/9104 under the Animal 
Scientific Procedures Act of 1986. 
 
2.2. Rearing facilities and water quality 
All experiments with carp were undertaken in the freshwater recirculating system “B” 
within the aquarium facilities of the Aquatic Animal Health and Nutrition Research 
Group of Plymouth University. The total volume of this system accounts for 
approximately 3900 litres with each of the 18 polyethylene tanks having a capacity of 
71 litres each (Plate 2.1). The system has been fed with municipal freshwater, and 99% 
recirculated aerated freshwater was provided at a rate of 25 litres per hour. 
 
 
Plate 2.1: Outline of system “B” with technical data of the water holding capacity  
 
18 tanks à 71 l = 1278 l 
Side sumps      = 994 l 
Middle sumps  = 711 l 
Back sump       = 950 l 
Total          = 3933 l 
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Effluent water from the tanks was treated in three steps: a mechanical filtration using 
layers of different foam mattings and gauze, a biological filtration in which ammonia is 
oxidized over nitrite to nitrate, and a chemical filtration using UV-light. Mechanical 
filters were cleaned daily and a partial water exchange (about 10%) was done once a 
week in order to avoid accumulation of nitrogenous compounds. With the aid of a 
heating unit the average water temperature was maintained at 24 – 25°C. Water quality 
was monitored by daily measuring temperature, oxygen saturation and pH-value using 
an electronic meter (Hach HQ40d). Whenever necessary, pH-values were regulated by 
adding sodium bicarbonate (NaHCO3
-) to the water circulation. Ammonium, nitrate and 
nitrite were recorded once a week with Hach Lange GmbH vials (Ammonia 0.015-2.0 
mg/l, Nitrite 0.015-0.6 mg/l, and Nitrate 5-35mg/l) and a photo spectrometer (Hach 
Lange DR2800). Their content in the system was kept below the following limits: 0.1 
mg/l for ammonia; 1 mg/l for nitrite and 50 mg/l for nitrate. An automatically controlled 
photoperiod was set to a 12/12 h light/dark cycle using fluorescent tubes installed above 
the tanks. Plate 2.2 shows Senior Technician Ben Eynon feeding carp in tank 5 of 
system “B”. 
 
Plate 2.2: Feeding carp during the acclimatization period in tank 5 of system “B”. 
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2.3. Experimental fish and feeding 
All mirror carp were delivered from Hampshire Carp Hatcheries, Hampshire, UK. The 
fish, weighing about 7 g on average, were carefully acclimatized over approximately six 
weeks feeding the control diet at a level of 2% of their body weight (BW) spread across 
three meals a day. A preliminary pre-grading was undertaken after three weeks and the 
main grading prior to the experiment start took place after six weeks. During the 
experimental period the carp were fed by hand at a fixed rate of 4% of their BW over 
four meals (8:30, 11:00, 14:00 & 17:00) for five days a week. On the morning of the 
sixth day 1% of BW was given to allow a sufficient starving period of 24 hours prior to 
weighing on the seventh day. After weighing, carp were fed 2% of the BW in the 
afternoon. The body weight was determined weekly as whole tank body mass. 
Afterwards the feed amounts for the following week were calculated based on those 
measurements. 
 
2.4. Measurement of growth related parameters 
Important parameters for the measurement of growth of the fish are the mean body 
weight BW (g), the weight gain WG (g), the specific growth rate (%) and the feed 
conversion ratio FCR (g/g). The mean BW was determined by dividing the total body 
mass BM in each tank by the number of carp (n).  
	() =  ÷ 
 
 
The WG per fish was calculated by subtracting the initial weight Wi from the final 
weight Wf :  
	() =  − 
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The specific growth rate (SGR) describes the percentage weight gain per day within a 
certain period; it depends on the initial weight (Wi), the weight (Wt) after a certain 
period and the amount of days (t) in this period. Positive values stand for weight gain, 
negative values for weight loss (LN = natural logarithm): 
	(%) = () − () ÷  × 100  
 
The feed conversion ratio FCR (g/g) reflects to what extent the ingested feed (feed 
intake, FI) is converted into growth; it tells how much of this particular feed (in g) is 
needed to gain one g in weight: 
	(/) =  ÷ 
 
The protein efficiency ratio (PER [g/g]) reflects the ability of the ingested dietary 
protein (= protein intake PI) to sustain growth, i.e. it measures the conversion of this 
protein into growth by means of the body weight: 
	(/) =  ÷  
 
2.5. Composition of experimental diets 
A nutritionally balanced basal diet fulfilling the requirements of carp was prepared by 
TETRA GmbH (Melle, Germany). Main ingredients were fish protein concentrate 
(Soprapeche CPSP 90) containing at least 83% crude protein and at most 10% lipids, 
and wheat starch (not less than 84% starch). The aim was the production of a highly 
purified diet with minimal immunologically active substances to avoid any unwanted 
effects originating from other sources than the β-glucan (MacroGard®). Among other 
possible reasons contamination could occur through the used ingredients. Therefore the 
relevant ingredients were subjected to immunological in vitro tests with carp phagocytes 
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such as respiratory burst (NBT) and nitric oxide assay as well as a cell viability test. The 
tests confirmed on the one hand, that MacroGard® seems to be a good immune 
stimulator at a concentration of 10 µg/ml or more, on the other hand the fish protein did 
not cause any effects. Ascorbic acid showed moderate effects at a concentration of      
10 µg/ml. Four isonitrogenous and isocaloric extruded diets were produced with the 
basal diet by supplementing 0% (control diet), 0.1%, 1% and 2% w/w MacroGard®,       
a β-(1,3)(1,6)-D-glucan derived from the yeast S. cerevisiae. Table 2.1 shows the 
composition of the basal diet and the proximate analysis of the four experimental diets. 
Pellet size was 2.5 mm. Diets were stored in polythene bags and refrigerated at 4°C 
throughout the experiment.   
 
2.6. Proximate analysis of diets and fish carcasses 
Samples of the four diets as well as of fish were taken for a comprehensive chemical 
analysis in order to determine important parameters of nutrient metabolism at the end of 
the experiment. With regards to the fish 12 carp (pooled into four samples) from the 
stock were sampled for initial body composition at the experiment start. Similarly, at the 
end of the trial three carp per tank were sampled and pooled together for the final body 
composition. All samples were analysed according to AOAC protocols (2003). 
2.6.1. Moisture 
In order to examine the moisture content of the diets, ~ 6 g of the finely grounded 
material was placed into a crucible and put in a drying oven at 105°C until a constant 
weight was achieved (Gallenkamp Oven BS, OV-160; UK). The ratio of the sample 
weight after and prior to drying leads to the moisture content: 
 !"#$	(%) = %$	%$ℎ	() − '#(	%$ℎ	() ÷ %$	%$ℎ	() × 100 
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Table 2.2: Formulations (g per 1000g) and chemical composition (%) of the 
experimental diets; M = MacroGard® 
Ingredients Control 0.1% M 1% M 2% M 
Fish protein concentrate 450.0 450.0 450.0 450.0 
Wheat starch 410.0 409.0 400.0 390.0 
Fish oil 45.0 45.0 45.0 45.0 
Soybean oil 45.0 45.0 45.0 45.0 
Cellulose 25.65 25.65 25.65 25.65 
Min/trace element premix * 20.60 20.60 20.60 20.60 
Vitamin premix † 2.50 2.50 2.50 2.50 
Stabilized vitamin C ‡ 1.10 1.10 1.10 1.10 
Ethoxyquin 0.15 0.15 0.15 0.15 
MacroGard
®
 0 1 10 20 
Chemical composition (%DM)    
Dry matter § 92.9 ± 0.0 95.1 ± 0.0 94.8 ± 0.0 95.0 ± 0.1 
Crude protein ¶ 41.4 ± 0.1 42.4 ± 0.3 43.7 ± 0.3 42.8 ± 0.2 
Crude lipid § 14.2 ± 0.0 14.5 ± 0.1 15.0 ± 0.4 15.1 ± 0.3 
Ash § 4.6 ± 0.0 4.5 ± 0.0 4.6 ± 0.0 4.6 ± 0.0 
Energy (MJ/kg) ** 22.3 ± 0.1 22.4 ± 0.0 22.5 ± 0.2 22.2 ± 0.1 
Calcium (g/kg) 3.98 ± 0.04 3.98 ± 0.07 3.98 ± 0.05 3.98 ± 0.16 
Phosphorus (g/kg) 6.51 ± 0.05 6.49 ± 0.06 6.67 ± 0.09 6.87 ± 0.25 
* Mineral/trace element premix per kg feed meal (prior to extrusion):               
 20.0 g Mono-calcium-phosphate, 10.7 g Manganese-(II)-sulfate, 5.7 g Zinc sulfate,       
 4.1 g Ferreous-(II)-sulfate, 0.1 g Cobalt-(II)-acetate 
† Vitamin premix per kg feed meal (prior to extrusion):            
 64800 IU Vitamin A, 2700 IU Vitamin D3, 144 mg Vitamin E, 75.6 mg Vitamin B1,     
 57.6 mg Vitamin B2, 216 mg Calcium-D-pantothenate, 720 mg Niacin, 29 mg Vitamin B6,      
 126 µg Vitamin B12, 900 mg Inositol, 1134 mg Ascorbic acid; 
‡ min. 35 % Vitamin C activity                    
§ n = 3                                                                                                                                                         
¶ n = 5                                                                                                                                                        
** n = 2 
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The moisture content of the pooled initial and final fish samples took place in a very 
similar way. The fish were placed in a tray with the body cavity opened and the viscera 
exposed. Then the three pooled fish in each tray were proceeded in the same drying 
process as the diet samples. The dried samples were subsequently grounded in a blender 
for further analysis. 
2.6.2. Crude protein 
In order to determine the protein content, the nitrogen content of 100 mg of the sample 
was measured by the Kjeldahl method. After a digestion step, nitrogen was quantified 
by titration with concentrated sulfuric acid (H2SO4) in a distillation unit (Vapodest 40; 
Gerhardt Laboratory Instruments; Germany). The value was then multiplied by the 
factor 6.25 and divided by the efficiency factor (EF) of the process to calculate the 
protein content: 
#"'$	)# $
	(%) = 
# $
	(%) × 6.25 ÷  
2.6.3. Crude lipid 
Lipid contents were determined using the Soxhlet method. Thus, lipids were extracted 
from ~3 g of sample with petroleum ether in the Soxtherm apparatus (model 41x; 
Gerhardt Laboratory Instruments; Germany). 
#"'$	.)'	(%) = .)'	%$ℎ	() ÷ !/0).$	%$ℎ	() × 100 
2.6.4. Crude ash 
Ash contents were determined by incinerating ~ 500 mg of sample, placed in a ceramic 
crucible, at 550°C in a muffle furnace (Carbolite ESF3; UK) for 8 hours. 
#"'$	/!ℎ	(%) = /!ℎ	%$ℎ	() ÷ !/0).$%$ℎ	() × 100 
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2.6.5. Gross energy 
Gross energy was measured with a Parr Adiabatic Bomb Calorimeter 1356 (Parr 
Instrument Company, Illinois, US). Briefly, the sample (~1 g pressed into a pellet) was 
precisely weighed and placed into a nickel crucible inside the bomb with a fuse wire 
attached to the pellet. The bomb was then put in exactly 2 kg of water inside the 
instrument, which measured the amount of heat energy released from the bomb by the 
increase in water temperature after firing the bomb. 
2.6.6. Mineral analysis and net mineral retention 
Mineral contents of the diets and fish were analysed using an inductively coupled 
plasma optical emission spectrophotometer (ICP-OES) in triplicates. An acid digestion 
was conducted by placing approximately 150-200 mg of the dehydrated and 
homogenized samples into 10% nitric acid cleaned (24 hours) Kjeldahl boiling tubes. 
Subsequently, 10 ml of 70% nitric acid were added and the solution heated in a 
Gerhardt Kjeldatherm 40 tube digestion block (Gerhardt Laboratory Instruments, Bonn, 
Germany) according to the following protocol: 60°C for one hour, 90°C for one hour, 
110°C for 30 minutes, 135°C-140°C for 4 hours. A clear, pale yellow colour of the 
solution confirmed a successful digestion and the samples, once cooled down to room 
temperature, were diluted to 50 ml with deionised water. The mineral contents were 
then determined using a Varian 725-ES ICP-OES. In order to reduce dilution errors, all 
samples were standardised to indium which was included as internal standard (1 mg/l). 
Standard solutions containing 0, 0.5, 1, 5 and 10 mg/l of calcium, phosphorus, 
magnesium, potassium, sodium, sulphur and 0, 0.05, 0.1 0.5 and 1 mg/l of copper, zinc, 
iron and manganese were used to generate standard curves.   
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Net mineral retention (NMR) was then calculated with the known final (BMf) and initial 
(BMi) concentrations of the respective mineral in the body and the concentration of the 
mineral in the diet (DM) using the following formula:   
	(%) = 1( × 234 − × 5) ÷ ( × 6)7 × 100 
 
2.7. Light microscopy 
For histological appraisal of the intestine starved fish (n = 6 per treatment) were 
sampled and analysis was conducted using light microscopy. Intestinal samples of        
~1 cm length were taken from the anterior and posterior intestine. 
2.7.1. Sample preparation and paraffin wax embedding 
Intestinal samples were fixed in 10% neutral-buffered formalin immediately after 
dissection. After 48 hours the samples were transferred to 70% IMS (industrially 
methylated spirit). Subsequently, samples were dehydrated in a series of graded ethanol 
concentrations in an automated tissue processor (Leica TP1020) according to standard 
histological protocols and embedded in paraffin wax (Leica EG1150 H).  
2.7.2. Sectioning and Staining 
From each wax block multiple sets of 5 µm cross-sections were cut with a microtome 
(Leica) and mounted onto glass slides. Prior to staining the sections were cleared with 
histolene, re-hydrated in a series of graded ethanol concentrations (100% twice, 90%, 
70% and 50%) and rinsed in distilled water for 2 minutes. In each specimen, multiple 
sets of sections were stained with a standard haematoxylin and eosin (H&E) stain. 
Finally, sections were cleared in histolene and mounted with a cover slip and DPX. 
Slides were examined under an Olympus light microscope, photographed with an 
Olympus digital camera and processed using Corel Photo-Paint X5. 
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2.8. Culture-independent microbiology 
For evaluation of the microbial population allochthonous (digesta) and autochthonous 
(mucosal tissue) samples of the intestine were taken. Under aseptic conditions the body 
cavity was opened, the whole intestine excised and the digesta removed. The mucosal 
tissue samples were washed thoroughly three times with phosphate-buffered saline and 
homogenized in a macerator. All samples were stored at -20°C in sterile molecular 
grade 1.5 ml microcentrifuge tubes until further analysis. 
2.8.1. DNA extraction 
DNA was extracted from 200 mg of digesta and mucosal tissue samples using the 
QIAamp® Stool Mini Kit (Qiagen, Crawley, UK) with slight modifications of the 
manufacturer’s instructions. A pre-treatment was included  by incubating the samples 
with 500 µl of lysozyme (50 mg/ml in TE buffer) for 30 min at 37°C as described by 
Merrifield et al. (2009a) in order to enhance the lysis of the robust cell walls of gram 
positive bacteria. Four key steps characterize the extraction process: lysis, inhibitor 
removal, protein removal and purification. 
Firstly, 750 µl of buffer ASL was added to the sample incubated with lysozyme, 
vortexed for 1 min and incubated for 10 min at 90°C. Then the sample was vortexed 
again and centrifuged for 1 min at 20.000 x g. 700 µl of supernatant were transferred to 
a new, sterile microcentrifuge tube and half an Inhibitex tablet was added (removal of 
inhibitors). The sample was vortexed immediately for 1 min and then left to stand for 1 
min at room temperature. Subsequently, the sample was centrifuged at 20.000 x g for 6 
min, the supernatant transferred into a new, sterile microcentrifuge tube and centrifuged 
again for 4 min. Then 300 µl of supernatant were transferred into a new, sterile 
microcentrifuge tube and 17 µl of Proteinase K as well as 300 µl of buffer AL were 
added (protein removal). The sample was vortexed for 15 sec and incubated for 15 min 
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at 70°C. Afterwards 300 µl of molecular grade 100% ethanol were added and the 
sample vortexed. For the purification step 600 µl of the sample was applied to a 
QIAamp spin column in a 2 ml collection tube and centrifuged for 1 min. The spin 
column was then transferred to a new collection tube, 500 µl of Buffer AW1 were added 
and the sample centrifuged for 2 min. The spin column was again transferred to a new 
collection tube, 500 µl of Buffer AW2 were added and the sample centrifuged for 5 
min. Finally the spin column was again transferred to a new collection tube, 200 µl of 
Buffer AE were added and the sample was left to stand for 5 min. Then the sample was 
centrifuged for 3 min to elute the DNA into the collection tube. Subsequently, the 
sample was transferred to sterile microcentrifuge tubes and stored at 4°C until further 
analysis. 
 2.8.2. 16S rRNA amplification 
The extracted DNA templates were subjected to a Polymerase Chain Reaction (PCR) 
for amplification of the V3 region of the 16S rRNA gene. The forward primer P3       
(5'-CGCCCGCCGCGCGCGGCGGGCGGGGCGGGGGCACGGGGGGCCTACGGG 
AGGCAGCAG-3') which includes an additional 40 nucleotide-rich GC-sequence (GC-
clamp) on its 5’-end, and the reverse primer P2 (5'-ATTACCGCGGCTGCTGG-3') 
from Muyzer et al. (1993) were used. Each single PCR reaction consisted of 25 µl 
ReadyMixTM Taq PCR Reaction Mix with MgCl2 (Sigma-Aldrich Company Ltd., 
Gillingham, England), 1 µl each of primer P2 and P3 (50 pmol/µl Eurofins MWG 
Operon, Ebersberg, Germany), 1 µl of DNA template and sterile, molecular grade water 
to adjust the final volume of the reaction to 50 µl. This yielded in a final concentration 
of 1.5 U Taq DNA polymerase, 10mM Tris-HCl, 50mM KCl, 1.5 mM MgCl2, 0.001% 
gelatine and 0.2mM dNTPs. The samples including a negative (sterile, molecular grade 
water as template) and a positive control (cultured Arthrobacter globiformis as 
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template, Microbiology Laboratory culture collection, Plymouth University, UK) then 
were run through a PCR reaction using a GeneAmp® PCR system 9700 (Perkin-Elmer, 
CA, USA) with the following parameters: touchdown thermal cycling at 94°C for 5 min 
and then 20 cycles of 94°C for 1 min, 65°C for 1 min (decreasing 1°C every 2nd cycle) 
and 72°C for 1 min; this was followed by 15 cycles of 94°C for 1 min, 55°C for 1 min 
and 72°C for 1 min. A final extension for 5 min at 72°C was performed. In order to 
ascertain a successful PCR amplification  8 µl of the PCR product mixed with 3 µl 
loading buffer was subjected to electrophoresis at 80 V for approximately 40 min on a 
1.5% agarose gel containing 1 µl SYBR Safe DNA gel stain (Invitrogen, Carlsbad, US) 
per 10 ml of molten agarose. A Hyper ladder IV (Bioline, London, UK) and the 
negative/positive control (as described above) were run alongside the samples to 
identify the correct amplification of the V3 region (233 bp) or possible contaminations. 
2.8.3. Denaturing gradient gel electrophoresis 
A denaturing gradient gel electrophoresis (DGGE) was conducted with the PCR 
products (standardized to 40 ng/µl) using a DCode Universal Mutation Detection 
System (Bio-Rad laboratories, Italy). With the aid of a Bio-Rad mode 475 gradient 
delivery system (Bio-Rad laboratories, Italy) an 8% polyacrylamide gel (16 cm x 16 cm 
x 1 mm) was poured with a denaturing gradient of 40 – 60% (where 100% denaturant is 
7 M urea and 40% formamide) and left to set for 2 hours. Plate 2.3 (left image) depicts 
the pouring of such a DGGE-gel. 20 µl of PCR product were mixed with 5 µl of loading 
buffer (4 ml glycerol, 6 ml 1x TE buffer, 25 mg bromophenol blue), and 20 µl of this 
mixture were run on the gel for 16 hours at 60°C and 65 V in 1x TAE buffer (66 mM 
Tris, 5 mM Na acetate and 1 mM EDTA). DGGE bands were visualized by staining the 
gel with 200 µl of 1 µl/10 ml SYBR Gold Nucleic Acid Gel Stain (Invitrogen, Carlsbad, 
US) for 30 min. Finally, the gel was scanned in a Bio-Rad universal hood II (Bio-Rad 
  
laboratories, Italy) and negative images were taken with the software Quantity One, 
version 4.6.3 (Bio-Rad laboratories, Italy)
contrast and greyscale.
samples were taken with molecular grade pipette tips comparable to a biopsy punch
excised with a sterile scalpel
under UV light. The DNA was eluted in 30 
least 12 hours prior to re
Plate 2.3: Pouring of a DGGE
(left) and excising bands from a DGGE
 
 2.8.4. 16S rRNA amplification of excised DGGE bands
The DNA template of the excised bands
re-PCR using the same conditions as described under
amplification. The only exception was that primer P1 was used instead of primer P3; 
primer P1 is the same primer as P3
amplification was tested on a further agarose gel as described under
52 
 and optimized for analysis by enhancing 
 Bands of interest were selected for sequence analysis and 
. Plate 2.3 depicts the excision of bands from a DGGE
µl of molecular grade water at 4°C for at 
-PCR. 
-gel with the Bio-Rad mode 475 gradient delivery system 
-gel under UV light (right).
 
 gained from the DGGE was subjected to a     
 section
 but without the GC-clamp.
Chapter 2 
 or 
-gel 
 
 2.8.2 for further 
 Success of the PCR 
 section 2.8.2.  
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2.8.5. Purification of the PCR products and sequence analysis 
Subsequently, 25 µl of the PCR product was purified using Diffinity Rapid Tips (West 
Henrietta, US) and then sequenced by GATC laboratories (GATC Biotech, Konstanz, 
Germany). The determined nucleotide sequences were submitted to a BLAST search in 
GenBank (http://blast.ncbi.nlm.nih.gov/Blast.cgi) to obtain the closest known alignment 
identities for the partial 16S rRNA sequences, hence retrieving taxonomic groups for 
which the sequences showed the highest similarities. 
 
2.9. Statistical Analysis 
Unless otherwise stated, all presented data are means ± standard deviation (SD) and the 
data were checked for homogeneity of variance and then subjected to a one way 
analysis of variance (ANOVA). Significant differences between control and treatment 
groups were determined by a post-hoc LSD (least significant difference) test and were 
accepted at the P<0.05 level. Statistical analysis was performed using SPSS statistics, 
version 18 (SPSS Inc., Chicago, US).  
The images of the DGGE gels were subjected to a statistical analysis as described by 
Dimitroglou et al. (2009). The DGGE banding patterns were transformed into intensity 
matrices in order to evaluate similarities between treatments using the software Quantity 
one, version 4.6.3 (Bio-Rad Laboratories) after Schauer et al. (1992). Band intensities 
were measured and analysed using software Primer v6 (Clarke and Gorley, 2006) and 
similarity percentages (SIMPER) were performed. A 1-way analysis of similarity 
(ANOSIM) was used for pairwise comparison to determine differences between DGGE 
banding profiles (Abell and Bowman, 2005). Further tests were employed to investigate 
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changes in the intestinal microbiota and the results subjected to a one way analysis of 
variance (ANOVA) as described above:  
• total number of OTUs (S) 
• Margalef’s species richness: d = (S-1)/log(N) 
• Pielou’s evenness: J’ = H’/log(S) 
• Shannon’s diversity index: H’ = - ∑ (pi (ln pi) 
(N = total number of individuals (total intensity units), pi = the proportion of the total 
number of individuals in the ith species) 
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3.1. Abstract 
In recent years aquaculture research has focused on probiotics, prebiotics, and               
β-glucans, in order to improve health status and growth performance. Information 
regarding the effects of β-glucan on growth performance and intestinal immunity of 
mirror carp (Cyprinus carpio L.) is scarce. An experiment was therefore conducted to 
investigate the effects of a yeast β-glucan preparation (MacroGard®) on growth 
performance, intestinal morphology and haemato-immunological indices of mirror carp. 
Carp (initial weight 11.1 ± 0.0g) were fed highly purified diets supplemented with 0% 
(control), 0.1%, 1% or 2% MacroGard® for 8 weeks.   
Fish fed diets containing 1% and 2% MacroGard® exhibited significant improvements 
in weight gain, specific growth rate and feed conversion ratio compared to fish fed both 
the control and the 0.1% MacroGard® containing diet.  
Histological appraisal of the intestine revealed a significantly higher infiltration of 
leukocytes into the epithelial layer of fish fed diets supplemented with 1% and 2% 
MacroGard® in the anterior intestine compared to fish fed the control and 0.1% 
MacroGard® diet. This effect was not observed in the posterior intestine. There were no 
significant differences in the intestinal absorptive surface area and number of goblet 
cells in either intestinal region. 
At the end of the experiment the haematological status of the fish was examined. 
Compared to control fed fish, the haematocrit value was significantly elevated in fish 
fed the 2% MacroGard® diet. Furthermore, the blood monocyte fraction was 
significantly higher in fish fed the 1% and 2% MacroGard® diets. No significant 
changes were observed in the other blood parameters assessed.  
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The present study shows that high dietary β-glucan inclusion increases growth 
performance without detrimental effects on the health indicators assessed. Increased 
intraepithelial leukocytes in the anterior intestine may indicate a localized immune 
response; no detrimental effects on intestinal morphology were observed. 
 
3.2. Introduction 
Aquaculture remains the fastest growing agri-business sector with total global 
production (inland and marine, without aquatic plants) increasing to 63.6 million tonnes 
in 2011 from 47.3 million tonnes in 2006 (FAO, 2012). On a global scale cyprinid 
production is still the prominent sector of freshwater aquaculture (FAO, 2012), 
accounting for 71.9% (24.2 million tons) of freshwater production. The intensification 
of production can lead to increased incidences of stress and disease outbreaks. As a 
result a considerable effort has been made to find effective prophylactic measures to 
support and augment the immune response of fish reared under intensive conditions. 
Since the EU ratified a ban on non-medical use of antibiotics in animal nutrition in the 
Regulation (EC) No 1831/2003 (EU, 2003), effective from 2006 onwards, there has 
been a clear drive towards finding alternative dietary supplements to boost health and 
production. 
Among the most well studied dietary additives are β-glucans. They are ubiquitous in 
nature and can be found in the cell walls of yeasts, cereal grains, algae, bacteria and 
fungi (Zekovic et al., 2005). The most abundant source of natural β-glucans with highly 
immuno-modulating properties are fungi and yeasts, where research effort has focused 
in particular on β-(1,3)(1,6)-D-glucans. A plethora of information is available regarding 
their positive effects on growth performance, immune responses and disease resistance 
upon oral delivery to a number of farmed animals such as swine (Dritz et al., 1995; Li et 
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al., 2006), poultry (Guo et al., 2003; Chen et al., 2008), salmonids (Nikl et al., 1993; 
Siwicki et al., 1994; Jeney et al., 1997; Lauridsen and Buchmann, 2010) and shellfish 
(Van Hai and Fotedar; 2009). For cyprinids it is also well documented that β-glucans 
can enhance the innate immune response and disease resistance (Kwak et al., 2003; 
Misra et al., 2006; Gopalakannan and Arul, 2010; Siwicki et al., 2010) but to the 
authors’ knowledge the effects on growth performance are scarce.  
The aim of the present investigation therefore was to evaluate the efficacy of a 
commercially available β-(1,3)(1,6)-D-glucan preparation from the yeast 
Saccharomyces cerevisiae (MacroGard®) on growth performance, nutrient retention and 
general haematological indices of mirror carp. As little is known about localized 
intestinal immune responses in teleosts upon contact of orally administered β-glucans 
and the mucus-layer/mucosa, another objective was to examine whether intestinal 
morphology and intestinal immune response was affected by dietary provision of         
β-glucans. 
 
3.3. Material and Methods 
3.3.1. Rearing facilities and water quality 
The experiment was conducted as described under section 2.2 in system “B” within the 
rearing facilities of the University of Plymouth and water quality was monitored 
accordingly. Water temperature, oxygen saturation and pH were maintained at 25.0 ± 
0.2°C, 89.1 ± 3.1% and 6.33 ± 0.48, respectively. Ammonium, nitrite and nitrate were 
determined once a week and the levels ranged between 0 - 0.281 mg/l, 0.004 - 0.084 
mg/l and 8.15 - 52.92 mg/l, respectively. 
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3.3.2. Experimental fish and feeding 
Four hundred and fifty mirror carp were obtained from Hampshire Carp Hatcheries, 
Hampshire, UK and carefully acclimatized as described under section 2.3. Thereafter, 
25 carp were randomly allocated to each of the twelve 71L experimental tanks (n = 3 
tanks per treatment). The initial average body weight at the start of the experiment was 
11.14 ± 0.03g. Twelve of the remaining fish were sampled for analysis of the initial 
body composition.  Feeding scheme and bulk weighing was conducted as described 
under section 2.3. 
3.3.3. Measurement of growth related parameters 
Growth related parameters were determined as described under section 2.4. 
3.3.4. Proximate analysis of diets and fish carcasses 
Proximate analysis of diets and fish carcasses was determined as described under 
section 2.6. 
3.3.5. Net mineral retention 
Net mineral retention in whole body was determined as described under section 2.6.6. 
3.3.6. Blood sampling and general haemato-immunological parameters 
At the end of the trial, blood was sampled from five fish per tank (n=15 per treatment). 
The fish were euthanized with tricaine methanesulfonate (MS-222; Pharmaq Ltd., 
Fordingbridge, UK), buffered with sodium bicarbonate (NaHCO3-), followed by 
destruction of the brain (PIL № 30/9104 under PPL № 30/2644). Blood was withdrawn 
immediately from the caudal arch using a 1 ml syringe with a 25 gauge needle and 
transferred to 1.5 ml Eppendorf tubes.  
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3.3.6.1. Haematocrit 
Blood samples were drawn into heparinised capillary tubes and sealed. The samples 
were centrifuged at 3600 g in a microhaematocrit centrifuge (Brown, 1988). After, 
the % packed cell volume (PCV) was read with a Hawksley reader and recorded as 
percentage of the total blood volume. 
3.3.6.2. Haemoglobin 
Drabkin’s cyanide – ferricyanide solution was used to determine the haemoglobin levels 
in the blood (Drabkin, 1946). Four µl of blood sample was thoroughly mixed with 1 ml 
of Drabkin’s solution (Sigma-Aldrich Ltd, Dorset, UK) and samples were stored at 4°C 
until further analysis. The haemoglobin contents were then determined by measuring 
the absorbance at 540 nm in a spectrophotometer and reading the values against a 
standard curve (derived from a dilution series from 0 - 180 mg/l of a 
cyanmethemoglobin standard). 
3.3.6.3. Total blood cell counts 
Twenty µl of blood sample were thoroughly mixed with 980 µl of Dacies solution 
(equal to a 1:50 dilution) and stored at 4°C until further analysis. Total erythrocyte and 
leukocyte cells counts were determined using a Neubauer haemocytometer. 
3.3.6.4. Differential leukocyte counts 
Blood smears were prepared by using 5 µl of blood according to Rowley et al. (1988). 
The slides were then left to air-dry and fixed in 100% methanol for 1 minute. Smears 
were then stained with the May-Grünwald-Giemsa (MGG) stain (Biostain Ready 
Reagents Ltd., Cheshire, UK) and rinsed with distilled water. Slides were air-dried at 
room temperature and mounted with DPX and a cover slip. Two hundred leukocytes per 
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slide were counted and classified according to their morphological appearance into 
lymphocytes, granulocytes and monocytes. 
3.3.6.5. Serum glucose, total protein and albumin 
In order to obtain serum, whole blood was incubated at 4°C for 12 hours in order to 
allow clotting. After, the samples were centrifuged at 2500 g for 5 minutes, the 
supernatant serum was carefully removed and the serum samples were stored at -80°C 
until further analysis. The levels of glucose in the serum samples were determined using 
the glucose oxidase – peroxidase method after Trinder (1969). Total protein levels in 
serum samples were determined according to the method of Bradford (1976). Albumin 
levels in serum were determined using the bromocresol green assay by Doumas et al. 
(1971). The albumin/globulin ratio was also determined for each respective group. 
3.3.7. Intestinal histology 
Histological appraisal of H&E stained sections of anterior and posterior intestine 
(consistently sampled from the middle of the respective region) was undertaken using 
light microscopy as described under section 2.7.1 in order to examine the intestinal 
perimeter ratio after Dimitroglou et al. (2009). Briefly, the internal perimeter (IP) of the 
intestinal lumen and the external perimeter (EP) of the intestine were analysed using 
Image J version 1.42 (National Institutes of Health) and the perimeter ratio was 
calculated (PR = IP/EP, arbitrary units, AU). The number of leukocytes (histologically 
stained cells) infiltrated into the epithelial layer (i.e. intraepithelial leukocytes, IELs) 
across a standardized distance of 100 enterocytes was determined as described by 
Ferguson et al. (2010). In addition, sections were also stained with Alcian blue-PAS 
(Periodic acid Schiff) in order to differentiate between acid and neutral glycoconjugates 
and to determine the number of goblet cells in five random mucosal folds per specimen 
which were then standardized to 100 µm of mucosal fold length. Briefly, sections were 
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stained with 1% Alcian blue 8GX (pH 2.5) for 60 minutes, rinsed with distilled water, 
stained with 0.8% periodic acid for 10 minutes, rinsed with distilled water three times 
for 3 minutes, stained with Schiff’s reagent for 30 minutes, rinsed with distilled water 
and dehydrated in a series of graded ethanol concentrations (50%, 70%, 90% and twice 
100%). For both the leukocyte and the goblet cell counts the average of the cell numbers 
from all specimens was calculated. 
3.3.8. Statistical analysis 
Statistical analysis was conducted as described under section 2.9. 
 
3.4. Results 
3.4.1. Growth performance 
Carp displayed a high growth performance in all groups (Table 3.1) and no mortalities 
occurred during the experiment. After 8 weeks of feeding the final body weight 
increased by over 600%; the weight in groups fed with the 1% and 2% MacroGard® 
supplemented diet (69.0 ± 0.7g and 66.6 ± 1.9g, respectively) was significantly higher 
than the control (61.9 ± 2.4g; P ≤ 0.009) and the 0.1% MacroGard® group (63.0 ± 1.2g; 
P ≤ 0.030).  Consequently, the weight gain of fish fed the 1% and 2% MacroGard® 
supplemented diets was significantly higher. The same was observed for the specific 
growth rates (SGR) where fish fed the 1% (3.26 ± 0.02%) and 2% (3.19 ± 0.05%) 
MacroGard® supplemented diet displayed an increased SGR compared to fish fed the 
control (3.06 ± 0.07%) and the 0.1% MacroGard® (3.09 ± 0.03%) supplemented diet. 
This is also reflected in a better feed conversion with the 1% group showing the lowest 
FCR of 0.86 ± 0.01, which was significantly superior to all other groups (P < 0.029). 
Fish from the 2% group displayed significantly better FCR than the 0.1% group            
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(P = 0.012) and a trend towards a lower FCR compared to the control group                     
(P = 0.078). The protein utilisation was unaffected by dietary treatment. 
 
Table 3.1: Growth performance of carp after 8 weeks feeding experimental diets (n=3). 
 Control 0.1% M 1% M 2% M 
Initial BW (g) 11.13 ± 0.02 11.16 ± 0.00 11.13 ± 0.05 11.15 ± 0.02 
Final BW (g) 61.92 ± 2.44a 62.99 ± 1.23a 69.04 ± 0.70b 66.64 ± 1.89b 
Weight gain (g) 50.79 ± 2.46a 51.83 ± 1.23a 57.91 ± 0.68b 55.49 ± 1.87b 
SGR (%) 3.06 ± 0.07a 3.09 ± 0.03a 3.26 ± 0.02b 3.19 ± 0.05b 
FCR (g/g) 0.90± 0.02ab 0.92 ± 0.01a 0.86± 0.01c 0.88 ± 0.02b 
PER (g/g) 2.48 ± 0.05 2.45 ± 0.02 2.53 ± 0.02 2.51 ± 0.04 
   
abcdifferent superscripts indicate a significant difference (P<0.05) 
 
Figure 3.1: Mean body weight (g) of carp over the 8-week experimental period (n = 3). 
Week
0 2 4 6 8
B
o
d
y
 w
ei
g
h
t 
(g
)
0
10
20
30
40
50
60
70
Control 
0.1% glucan
1% glucan 
2% glucan 
Control 
0.1% M 
1% M 
2% M 
Chapter 3 
 
65 
 
3.4.2. Proximate analysis of diets and fish carcasses 
Table 3.2 shows the body composition of the carp at the beginning and at the end of the 
experiment. No significant differences were seen in any of the parameters between 
control and treatment groups at the end of the trial. The nutrient retention is displayed in 
Table 3.3. Dietary protein was retained at levels of 47% - 49% and energy at            
39% - 41%. There were no significant differences between treatments. 
 
Table 3.2: Initial (n=4) and final (n=3) body composition of the experimental carp.  
 Initial Control 0.1% M 1% M 2% M 
Moisture (%) 77.4 ± 0.4 72.7 ± 0.3 72.5 ± 0.4 73.0 ± 0.6 72.9 ± 0.3 
Protein (%) 14.8 ± 0.1 15.1 ± 0.4 15.3 ± 0.3 15.0 ± 0.5 15.3 ± 0.4 
Fat (%) 4.8 ± 0.5 9.3 ± 0.3 9.5 ± 0.3 8.9 ± 0.5 9.2 ± 0.3 
Ash (%) 3.3 ± 0.1 2.4 ± 0.1 2.4 ± 0.2 2.4 ± 0.1 2.4 ± 0.1 
Energy (MJ/kg) 5.2 ± 0.2 6.7 ± 0.1 6.6 ± 0.2 6.7 ± 0.2 6.7 ± 0.1 
 
 
Table 3.3: Protein and energy retention efficiency (%) over the 8-week period (n=3).  
 Control 0.1% M 1% M 2% M 
Protein retention 49.3 ± 0.7 47.8 ± 0.8 47.4 ± 1.9 48.6 ± 0.9 
Energy retention 40.4 ± 0.6 39.4 ± 0.9 41.1 ± 1.3 40.8 ± 0.3 
 
3.4.3. Net mineral retention 
The mean net mineral retention of carp over the course of the experiment is shown in 
table 3.4. Potassium was significantly higher retained (51.6 ± 0.9%) in fish fed the 1% 
MacroGard® supplemented diet compared to fish fed the control diet (48.6 ± 1.7%)     
(P = 0.007). All other elements assessed did not show any significant differences. 
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However, in several elements (except sulphur, iron and manganese) the mean retention 
showed a slight increase with 0.1% or 1% MacroGard® supplementation, whereas in 
fish fed the 2% MacroGard® supplemented diet the retention decreased to the values of 
the control group and in some cases even below that. Calcium showed retention of over 
100% in all treatments indicating that the fish absorbed calcium from the water. 
Calcium retention increased from 116.6 ± 13.6% in the control to 126.6 ± 14.2% and 
132.5 ± 11.3% in the 0.1% and 1% MacroGard® groups, respectively, whereas the 
retention in the 2% MacroGard® group was 122.3 ± 11.8%. Similarly, phosphorus 
retention improved from 55.3 ± 3.5% in the control to 58.8 ± 3.8% and 59.0 ± 3.6% in 
the 0.1% and 1% MacroGard® groups, respectively; fish fed the 2% MacroGard® 
supplemented diet only retained 54.7 ± 2.6% of the phosphorus. Also magnesium 
increased from 41.4 ± 2.7% (control) to 42.8 ± 1.8% and 42.0 ± 3.3% in the 0.1% and 
1% MacroGard® groups, respectively. In the 2% MacroGard® group however, 38.8 ± 
1.0% magnesium was retained. Also sodium retention increased from 21.4 ± 1.9% 
(control) to 22.5 ± 1.6% and 23.1 ± 0.7% (0.1% and 1% MacroGard®) and then 
decreased to 20.4 ± 0.5% (2% MacroGard®). Copper retention was 14.1 ± 2.4% in the 
control and was higher only in the 0.1% MacroGard® group (18.7 ± 4.3%); in the 1% 
MacroGard® group copper was retained at 14.7 ± 6.0%, whereas in the 2% MacroGard® 
group the level dropped to 11.9 ± 4.6%. Similarly, zinc retention increased from 70.2 ± 
3.3% in the control group to 73.6 ± 3.5% and 74.0 ± 12.3% in the 0.1% and 1% 
MacroGard® groups, respectively, and decreased to 67.1 ± 2.0% in the 2% MacroGard® 
group. 
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Table 3.4: Mean net mineral retention (%) of carp over the 8-week experimental period 
(n = 3) 
 Control 0.1% M 1% M 2% M 
Calcium 116.6 ± 13.6 126.6 ± 14.2 132.5 ± 11.3 122.3 ± 11.8 
Phosphorus 55.3 ± 3.5 58.8 ± 3.8 59.0 ± 3.6 54.7 ± 2.6 
Magnesium 41.4 ± 2.7 42.8 ± 1.8 42.0 ± 3.3 38.8 ± 1.0 
Potassium 48.6a ± 1.7 50.1ab ± 0.9 51.6b ± 0.9 50.0ab ± 0.2 
Sodium 21.4 ± 1.9 22.5 ± 1.6 23.1 ± 0.7 20.4 ± 0.5 
Sulphur 43.1 ± 1.6 44.6 ± 1.4 44.5 ± 0.8 43.2 ± 0.5 
Copper 14.1 ± 2.4 18.7 ± 4.3 14.7 ± 6.0 11.9 ± 4.6 
Zinc 70.2 ± 3.3 73.6 ± 3.5 74.0 ± 12.3 67.1 ± 2.0 
Iron 10.2 ± 2.7 11.0 ± 2.5 11.0 ± 2.0 9.2 ± 1.2 
Manganese 1.0 ± 0.2 1.1 ± 0.2 1.1 ± 0.1 1.0 ± 0.1 
  
ab
different superscripts indicate a significant difference (P<0.05) 
 
3.4.4. Haemato-immunological parameters 
The haemato-immunological parameters are presented in Table 3.5. Significant 
differences in haematocrit levels (%PCV) were observed between the groups. Fish fed 
the 2% MacroGard® diet displayed higher %PCV (47.5 ± 3.3%) when compared to fish 
fed the control and 0.1% MacroGard® diets. Haemoglobin levels remained unaffected 
by MacroGard® supplementation and therefore the mean corpuscular haemoglobin 
concentration (MCHC) was significantly lower in the 2% MacroGard® fed group (18.8 
± 1.4%). Furthermore, fish fed the 1% and 2% MacroGard® supplemented diets showed 
significantly elevated levels of monocytes (3.7 ± 1.8% and 3.0 ± 1.4%, respectively) in 
the peripheral blood compared to the control group (1.6 ± 0.8%; Table 3.6). Plate 3.1 A-
D illustrates micrographs of the different types of blood leukocytes (1000x 
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magnification). The other parameters were not significantly affected by dietary 
treatment. 
 
Table 3.5: Haemato-immunological parameters after the 8 week period (n=15). 
 Control 0.1% M 1% M 2% M 
Haematocrit (%) 42.8
 
± 4.0
a
 42.2 ± 2.6
a
 45.2 ± 5.9
ab
 47.5 ± 3.3
b
 
MCHC (%) 22.2 ± 3.3
a
 22.4 ± 2.0
a
 20.2 ± 4.5
ab
 18.8 ± 1.4
b
 
MCV (fL) 317.9 ± 60.9 309.8± 61.0 333.4 ± 53.1 332.7 ± 67.9 
Haemoglobin(g/dl) 9.4 ± 0.8 9.6 ± 0.8 9.3 ± 1.3 9.0 ± 0.6 
RBC (x 106 ml-1) 1.37 ± 0.19 1.44 ± 0.33 1.37 ± 0.17 1.47 ± 0.25 
WBC (x 104 ml-1) 2.97 ± 0.71 3.24 ± 1.10 3.39 ± 0.76 3.06 ± 0.58 
Glucose (mmol/l) 3.2 ± 0.7 2.7 ± 0.8 3.5 ± 1.1 3.2 ± 0.7 
Serum protein (g/dl) 2.91 ± 0.2 3.37 ± 0.47 3.15 ± 0.47 3.25 ± 0.32 
Serum albumin (g/dl) 1.08 ± 0.12 1.09 ± 0.07 1.12 ± 0.11 1.10 ± 0.09 
Serum globulin (g/dl) 1.84 ± 0.25 2.21 ± 0.48 2.08 ± 0.44 2.15 ± 0.31 
Albumin/Globulin 0.60 ± 0.14 0.52 ± 0.11 0.57 ± 0.14 0.52 ± 0.09 
 MCHC = mean corpuscular haemoglobin concentration; MCV = mean corpuscular 
volume; RBC = red blood cell count; WBC = white blood cell count. 
 
abdifferent superscripts indicate a significant difference (P<0.05) 
 
Table 3.6: Differential leukocyte cell counts (%) in the peripheral blood of carp after the 
8-week feeding period (n=15) 
 Control 0.1% M 1% M 2% M 
Lymphocytes 89.9 ± 4.8 88.7 ± 5.8 87.5 ± 4.9 89.1 ± 3.8 
Granulocytes 8.5 ± 4.6 8.8 ± 5.9 8.8 ± 4.7 7.9 ± 3.3 
Monocytes 1.6 ± 0.8a 2.5 ± 1.2ab 3.7 ± 1.8c 3.0 ± 1.4bc 
   
abcdifferent superscripts indicate a significant difference (P<0.05) 
 
Chapter 3 
 
69 
 
Plate 3.1: Micrographs of blood smears of carp after the 8-week period stained with        
May-Grünwald-Giemsa (MGG) depicting erythrocytes (e) and leukocytes (arrows):       
A = eosinophilic granulocyte, B = monocyte, C = neutrophilic granulocyte,                    
D = lymphocytes; scale bar represents 20 µm. 
 
3.4.5. Intestinal histology 
Light microscopy revealed a normal arrangement of columnar enterocyte cells, with an 
apical microvilli brush border, forming the epithelium of the mucosal folds. No 
pathological lesions or necrotic cells were observed in any of the fish sampled from 
each treatment group. Acidic mucosubstances were almost exclusively predominant in 
the goblet cells and in the mucus covering the brush border. There were no significant 
differences between treatment groups with regards to the absorptive surface area 
(Figures 3.2, Plate 3.2) or the number of goblet cells in the epithelium in either anterior 
or posterior intestinal sections (Figure 3.3). However, a trend towards elevated goblet 
cell levels was evident in the anterior intestine with MacroGard® supplementation                    
(P = 0.064). Plate 3.3 shows typical histology micrographs of transverse sections 
stained with Alcian blue – PAS (periodic acid Schiff) from each dietary treatment. 
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Plate 3.4: Transverse sections of the anterior (A-D) and posterior (E-H) intestine of carp 
after the 8-week period stained with H&E showing leukocytes (arrowheads) infiltrating 
from the lamina propria into the epithelial layer. (EC = enterocytes; GC = goblet cells; 
exemplary shown in B); A&E = control diet, B&F = 0.1% M, C&G = 1% M and    
D&H = 2% M. Scale bar represents 50 µm. 
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barley derived β-glucan at a rate of 3% of the body weight per day. Similarly, a             
S. cerevisiae derived β-(1,3)-glucan, fed to apparent satiation for 56 days to large 
yellow croaker (Pseudosciaena crocea) had positive effects on growth performance at 
0.09% dietary inclusion but not at 0.18% inclusion (Ai et al., 2007). Other studies have 
not observed growth enhancing properties when feeding β-glucans to Nile tilapia 
(Oreochromis niloticus) (Shelby et al., 2009), channel catfish (Ictalurus punctatus) 
(Welker et al., 2007), European sea bass (Dicentrarchus labrax) (Bagni et al., 2005) or 
hybrid striped bass (Morone chrysops x Morone saxatilis) (Li et al., 2009). In the 
present study, whole body chemical composition, protein retention and energy retention 
remained unaffected by dietary β-glucan inclusion indicating that the enhanced growth 
performance with 1% and 2% MacroGard® supplementation was not caused by a higher 
retention of these nutrients.  
At present, it is not clear what causes the improvements in growth observed with dietary 
β-glucans in previous studies and it is not evident why growth enhancing effects of          
β-glucans occur in some aquatic species and not in others. However, Dalmo and 
Bøgwald (2008) suggested that the effects may depend on the concentration of the           
β-glucan in the diet, its solubility, the fish species, the water temperature and length of 
the feeding period. They also hypothesize, when growth enhancing effects occur, that 
the β-glucans induce a localized intestinal immune response that in turn leads to 
resistance against pathogens which otherwise would cause reduced weight gain and 
possibly disease.  
However, histology derived data on the effects of β-glucans on the intestine and its 
associated lymphoid tissue (GALT) are scarce but data derived from the present study 
may help to support this hypothesis. High dietary inclusion levels (1% and 2%) of 
MacroGard® in the present study caused an increased infiltration of leukocytes from the 
lamina propria into the epithelial layer (i.e. IELs) in the anterior intestine whereas the 
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low inclusion of 0.1% MacroGard® had no such effect. Similar findings have been 
reported in mice; Tsukada et al. (2003) reported that mice receiving 25 mg of a            
β-(1,3)(1,6)-D-glucan per day displayed elevated intraepithelial lymphocytes in the 
small intestine. The lower β-glucan dosage (10 mg) decreased the number whereas 
doubling the dosage (50 mg) yielded a similar amount of intraepithelial lymphocytes.  
Shen et al. (2007) reported similar findings in their mice studies. In the present study 
dietary supplementation of 1 and 2% MacroGard® significantly elevated the monocyte 
proportion of the peripheral blood leukocytes. Monocytes are key components of the 
innate immune response and respond quickly to sites of inflammation to replenish 
macrophage and dendritic populations (Gordon and Taylor, 2005; Shi and Pamer, 
2011). The evaluation in the present study might be indicative of their transport to the 
anterior epithelium to bolster and replenish localized IEL levels. Further studies, such as 
the immunohistochemistry and the analysis of mucosal cytokines, are required to 
validate this hypothesis because it has recently been shown that orally administered     
β-glucans may down-regulate the gene expression of pro-inflammatory cytokines in 
carp intestine (Falco et al., 2012) and in rainbow trout spleen (Djordjevic et al., 2009). 
Even though absorption and pharmacokinetics of β-glucans in the teleost 
gastrointestinal tract are not known yet, it is possible that the different responses of the 
anterior and posterior intestinal regions might be due to differences in the β-glucan 
levels present in the intestinal regions. It is possible that β-glucans could be internalized 
by macrophages through phagocytic processes (Chan et al., 2009) as has been shown 
for soluble β-glucans in rats (Rice et al., 2005) and for particulate β-glucans in mice 
(Hong et al., 2004) or fermentative processes by the microbiota in the complex 
intestinal ecosystem (e.g. through β-glucanase activity (Chen and Seviour, 2007)) may 
reduce the level, or change the structure, of the β-glucans that reach the posterior 
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intestine. The experiment described in the subsequent chapter 4 investigated this 
hypothesis. 
Histological analysis also revealed that the mucus composition in the goblet cells 
consisted predominantly of acid mucus which is consistent with the findings of 
Ngamkala et al. (2010) who administered 1% dietary β-glucan to Nile tilapia for two 
weeks prior to a challenge with Aeromonas hydrophila. The total number of goblet cells 
in the anterior intestine with high β-glucan supplementation in the present study was not 
significantly different from the control group but a trend towards elevation was evident. 
Ngamkala et al. (2010) did not observe corresponding changes in anterior or posterior 
intestine in their study. This could be related to species-specific differences, the shorter 
administration of β-glucan over 2 weeks and/or the type of β-glucan they used 
(sonicated curdlan, a linear bacterial β-glucan). Zhu et al. (2012) however reported an 
increase of intestinal goblet cells in their study of channel catfish fed diets 
supplemented with a S. cerevisiae yeast polysaccharide mixture (containing                   
β-(1,3)(1,6)-D-glucan and mannan oligosaccharides (MOS)) for seven weeks. 
Unfortunately, the authors do not state exactly which intestinal region they sampled. 
The mucus produced and released by the goblet cells forms a layer covering the 
epidermal body surfaces (including the intestinal epithelium) and constitutes, among 
other functions, the first line of defence against external influences (Shephard, 1994). 
The mucus layer builds a trap for particles, bacteria and viruses, thereby hindering 
translocation to the internal environment, and subsequently the intestinal peristaltic 
processes expel those potentially pathogenic organisms (Mayer, 2003). It is likely 
therefore that an elevated number of goblet cells lead to a higher release of mucus in the 
intestine therefore improving first line of defence mechanisms. 
The absorptive surface area, as determined by the internal/external surface area ratio, 
was not affected by the dietary treatments in the present study. However, using scanning 
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electron microscopy, Van Hai and Fotedar (2009) found increased surface structures 
(larger upper folds) of the intestines of western king prawns after six and 12 weeks of 
dietary supplementation of β-glucan. Studies with broiler chickens showed that 
supplemented yeast cell wall fractions from S. cerevisiae, as well as its main structural 
components   β-glucan and mannoproteins, equally led to higher villus length in the 
jejunum (Moralez-Lopez et al., 2009). The same group found in a similar subsequent 
study that the same yeast cell wall fraction increased villus height, mucus thickness and 
number of goblet cells without changing the ileal content viscosity (Morales-Lopez et 
al., 2010).  A number of studies focusing on MOS derived from S. cerevisiae showed 
enhancing effects on gut morphology (absorptive surface area) and ultrastructure 
(microvilli length and density) in rainbow trout (Dimitroglou et al., 2009) and sea 
bream (Dimitroglou et al., 2010), whereas effects on gut histology were absent in 
European sea bass (Torrecillas et al., 2007).  
As haematological and biochemical indices are recognized as a useful means to assess 
health status and physiological response of an organism towards nutritional and 
environmental changes (Cnaani et al., 2004, Jawad et al., 2004, Schütt et al., 1997) the 
present study investigated a number of haemato-immunological parameters. Fish fed 
MacroGard® supplemented diets did not show significantly altered circulatory leukocyte 
cell counts, erythrocyte cell counts, serum glucose concentration, serum total protein, 
serum albumin or globulin levels or albumin/globulin ratio after 8 weeks. These 
findings are broadly in accordance with the study by Misra et al. (2006), who observed 
no effect on rohu serum total protein, serum albumin or globulin levels or 
albumin/globulin ratio after 8 weeks of feeding. However, some differences in these 
parameters were observed at earlier time points and glucose levels were reduced and 
peripheral leukocyte levels were elevated at 8 weeks. Peripheral leukocyte levels were 
also reported to be elevated in koi carp after 8 weeks feeding of 0.09% of a S. cerevisiae 
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β-glucan (Lin et al., 2011). Feeding tench (Tinca tinca) with MacroGard® (0.1% and 
0.2%) led to higher serum globulin levels after 4 weeks but serum total protein was not 
affected (Siwicki et al., 2010). A previous study reported that MacroGard® and other 
immunostimulants enhanced both parameters in rainbow trout after 1 week of feeding 
(Siwicki et al., 1994). 
In the present study haematocrit levels were significantly elevated in carp fed the 2% 
MacroGard® supplemented diet. The haemoglobin levels were unaffected by dietary      
β-glucan and thus, the MCHC levels were correspondingly lower in the same group. 
Increased haematocrit levels have been observed in channel catfish fed diets 
supplemented with 0.1% dietary MacroGard® for 4 weeks with no effect on 
haemoglobin concentration (Welker et al., 2007). Babicek et al. (2007) found increased 
haematocrit levels in rats fed a β-(1,3)(1,6)-D-glucan from S. cerevisiae. Higher 
haematocrit and haemoglobin levels were reported in Nile tilapia upon administration of 
high levels (0.1% to 0.5%) of baker’s yeast from S. cerevisiae (Abdel-Tawwab et al., 
2008). Other studies did not observe any changes in haematocrit levels, e.g. in spotted 
rose snapper (Lutjanus guttatus) (Del Rio-Zaragoza et al., 2011) or rainbow trout 
(Siwicki et al., 1994).  
 
3.6. Conclusions 
The current study demonstrates that high dietary inclusion levels of β-glucan can 
enhance growth performance and localized intestinal leukocyte infiltration in the 
anterior intestine of mirror carp without detrimental effects on carcass composition, 
intestinal morphology or the haemato-immunological parameters investigated. 
However, future research is needed in order to further investigate the underlying reasons 
for the growth promoting effects. Furthermore, detailed studies (e.g. using 
immunohistochemistry, gene expression and proteomics) of the localized immunity at 
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the mucosal level are required to explore the mechanisms and reasons for the increased 
IELs found in the present study. Future studies are also recommended to assess the 
gastrointestinal microbiota which could either be affected directly by selective 
utilisation of β-glucans by certain bacterial groups, or secondarily by changes in the 
host’s localised immune status. Possible changes could alter the microbial balance 
which in turn might influence the host immunity or β-glucan availability. 
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Effects of a dietary β-(1,3)(1,6)-D-glucan supplementation 
on intestinal microbial communities and intestinal 
ultrastructure of mirror carp (Cyprinus carpio L.) 
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4.1 Abstract 
The aim of this experiment was to assess the effects of a dietary Saccharomyces 
cerevisiae β-(1,3)(1,6)-D-glucan supplementation (MacroGard®) on mirror carp 
(Cyprinus carpio L.) intestinal microbiota and ultrastructure of the enterocyte apical 
brush border. The carp were fed either a control diet or diets supplemented with 0.1%, 
1% or 2% w/w MacroGard®. Culture-dependent microbiology revealed that aerobic 
heterotrophic bacterial levels were unaffected by dietary MacroGard® after two and four 
weeks. No effects were observed on the allochthonous lactic acid bacteria (LAB) 
populations at either time point, however, reduced autochthonous LAB populations 
were observed at week four. PCR-DGGE confirmed these findings through a reduction 
of the abundance of autochthonous LAB observed taxonomical units (OTUs) in 
MacroGard® fed fish compared to the control fed fish. DGGE analyses also revealed 
that dietary MacroGard® reduced the number of OTUs and the species richness of the 
allochthonous microbiota after two weeks, but not after four weeks. In contrast, dietary 
MacroGard® reduced the number of OTUs, the species richness and diversity of the 
autochthonous microbiota after two weeks, and those parameters remained reduced after 
four weeks. Transmission electron microscopy revealed that intestinal microvilli length 
and density were significantly increased after four weeks in fish fed diets supplemented 
with 1% MacroGard®. This study indicates that dietary MacroGard® supplementation 
modulates intestinal microbial communities of mirror carp and influences the 
morphology of the apical brush border. To the author’s knowledge this is the first study 
to investigate the effects of β-(1,3)(1,6)-D-glucans on fish gut microbial communities, 
using culture-independent methods, and the ultrastructure of the apical brush border of 
the enterocytes in fish. 
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4.2 Introduction 
The intestinal microbial communities and their metabolites play an integral role in the 
ontogeny of teleosts. They influence the host’s metabolic and nutritional balance, the 
immunological balance and physiological processes (Cerf-Bensussan and Gaboriau-
Routhiau, 2010; Merrifield et al., 2010; Sekirov et al., 2010). Intestinal microbial 
communities consist of allochthonous (digesta-associated, transient) and autochthonous 
(mucosa-associated, indigenous) microbiota (Ringø and Birkbeck, 1999; Ringø et al., 
2003). The piscine intestine itself is known to be one of the main portals for disease. 
Environmental changes, e.g. in the diet, can lead to imbalances in the intestinal 
microbial populations and disruption of the mucosal barrier, thus allowing for 
pathogenic invasion (Lødemel et al., 2001; Ringø et al., 2003; Vine et al., 2004; 
Birkbeck and Ringø, 2005; Ringø et al., 2007). 
As a result efforts have been directed towards strengthening the intestinal health of fish 
reared under intensive aquaculture conditions, especially since the EU ratified the ban 
on non-medical use of antibiotics in animal nutrition from 2006 onwards (EU, 2003). 
Functional dietary supplements such as β-glucans are frequently employed as 
immunomodulators in animal husbandry. β-glucans have been shown to trigger innate 
immune responses, increase disease resistance and enhance growth performance of fish 
(Dalmo and Bøgwald, 2008; Soltanian et al., 2009). Although a number of studies have 
examined the effect of prebiotics on the teleost intestinal microbial communities, the 
effects of β-glucans on the intestinal microbial communities have received little 
attention. β-glucans, like prebiotics, are non-digestible β-glycosidicly linked monomeric 
units. Prebiotics selectively stimulate the growth and/or activity of intestinal bacteria 
associated with health and well-being (Gibson et al., 2004). Recent studies have shown 
that prebiotics can modulate the gut microbiota of fish; for example, inulin in Atlantic 
salmon (Salmo salar L.) (Bakke-McKellep et al., 2007) and Arctic charr (Salvelinus 
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alpinus L.) (Ringø et al., 2006a), and mannan oligosaccharides (MOS) in rainbow trout 
(Oncorhynchus mykiss) (Dimitroglou et al., 2009) and gilthead sea bream (Sparus 
aurata) (Dimitroglou et al., 2010). However, the effects of β-glucans, which are often 
utilized for their immunostimulatory properties, on the gut microbiota of fish have 
seldom been investigated. To the authors knowledge only one study has reported the 
effect of dietary β-(1,3)(1,6)-D-glucans (chrysolaminaran, found in phytoplankton, and 
MacroGard®) on gut microbial populations of fish (Skjermo et al., 2006). This study 
revealed some evidence of the potential for β-glucans to modulate or disrupt the gut 
microbiota of fish; however, due to the limited number of replicates and the culture – 
dependent methods used, no comprehensive conclusions can be drawn.  
Recent investigations using culture – independent techniques have provided quantitative 
information on the vast diversity of bacterial species which inhabit the gastrointestinal 
(GI) tract of teleosts (Merrifield et al., 2010; Nayak, 2010). Using massively paralleled 
sequencing van Kessel et al. (2011) reported that the allochthonous microbiota of 
common carp (Cyprinus carpio L.) was highly diverse and composed of Fusobacteria 
(46%), Bacteroidetes (21%), Planctomycetes (12%), Gammaproteobacteria (7%), 
Firmicutes (ca. 4%) and Verrucomicrobiae (1%). Several studies have reported that 
members of the Firmicutes and Bacteroides produce β-glucanases [e.g. Bacillus 
circulans (Rombouts and Phaff, 1976a,b), Arthrobacter spp. (Kitamura et al., 1974; 
Vršanská et al., 1977; Doi and Doi, 1986), Flavobacterium dormitator (Mori et al., 
1977)].  
Therefore we hypothesize that the GI microbiota of fish maybe influenced by inclusion 
of dietary β-glucans. As β-glucans are becoming more commonly utilized in aquafeeds 
the potential impact on the gut microbiota warrants further investigation.  
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The aim of the present study was therefore to investigate the effects of a dietary 
administration of a Saccharomyces cerevisiae β-(1,3)(1,6)-D-glucan (MacroGard®) on 
the intestinal microbiota of mirror carp (Cyprinus carpio L.). Since possible changes in 
the composition of the intestinal microbiota may have implications for physiological 
processes in the mucosa, a further aim was to examine the ultrastructure of the apical 
brush border of the enterocytes. 
 
4.3 Material and Methods 
4.3.1 Rearing facilities and water quality 
The experiment was conducted as described under section 2.2 in system “B” within the 
rearing facilities of the University of Plymouth and water quality was monitored 
accordingly. Water temperature, oxygen saturation and pH were maintained at 23.7 ± 
0.4 °C, 94.1% ± 0.7 and 6.57 ± 0.50, respectively. Ammonium, nitrite and nitrate were 
determined once a week and the levels ranged between 0 - 0.039 mg/l, 0 - 0.004 mg/l 
and 16.11 - 31.02 mg/l, respectively. 
 
4.3.2. Experimental fish and feeding 
One hundred and fifty mirror carp were obtained from Hampshire Carp Hatcheries, 
Hampshire, UK and carefully acclimatized as described under section 2.3. Thereafter, 
15 carp were randomly allocated to each of the eight 71L experimental tanks (n = 2 
tanks per treatment). The initial average body weight at the start of the experiment was 
11.3 ± 0.1g. The fish were fed the experimental diets as described under section 2.5 
over a period of four weeks and bulk weighing and feeding regime was conducted as 
described under 2.3 with the exception that the body weight was determined after two 
weeks and the feeding rates were adjusted accordingly. 
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4.3.3. Microbiology sampling procedures 
For evaluation of the intestinal microbial communities, mucosa and digesta samples 
from the posterior intestine were taken after week two (n = 4) and week four (n = 3). 
Fish were euthanized with an overdose of tricaine methanesulfonate (MS-222; Pharmaq 
Ltd., Fordingbridge, UK), buffered with sodium bicarbonate (NaHCO3-), followed by 
destruction of the brain (PIL № 30/9104 under PPL № 30/2644). The body surface was 
cleaned with 70% ethanol, the body cavity was opened under aseptic conditions, the 
entire intestine excised and the digesta was removed by gentle squeezing (Merrifield et 
al., 2009a). The mucosal tissue samples were taken from the posterior end of the 
intestine and washed thoroughly three times with sterile phosphate-buffered saline 
(PBS) in order to remove adherent digesta. At this point, mucosa and digesta 
subsamples were used for culture-dependent analysis or stored at -20°C in sterile 
molecular grade 1.5 ml microcentrifuge tubes for later culture-independent analysis.  
 
4.3.4. Culture – dependent analysis of the intestinal microbiota 
One hundred mg of each sample (mucosa and digesta) was 10-fold diluted with sterile 
PBS and homogenized in a macerator (MSE, London, UK). Samples were serially 
diluted 10-fold with sterile PBS. One hundred µl were spread onto TSA (trypton soy 
agar, Oxoid, Basingstoke, UK) plates to determine aerobic heterotrophic bacterial levels 
and MRS (de Man, Rogosa, Sharpe agar, Oxoid, UK) plates to determine lactic acid 
bacteria (LAB) levels. Samples were plated in duplicate and incubated for 7 days at 
25°C before enumeration of colony forming units (CFUs) from statistically viable plates 
(i.e. plates containing 30-300 colonies)  (Merrifield et al., 2009b). 
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4.3.5. Culture – independent analysis of the intestinal microbiota 
DNA extraction and PCR amplification of the 16S rRNA V3 region were performed as 
described under sections 2.8.1 and 2.8.2, respectively. Subsequently, the V3 PCR 
amplicons were subjected to a 40% - 60% Denaturing Gradient Gel Electrophoresis 
(DGGE) as described under section 2.8.3. Finally, the excised bands were re-amplified, 
then purified and sequenced as described under sections 2.8.4 and 2.8.5, respectively. 
 
4.3.6. Transmission Electron Microscopy (TEM) 
Samples from the posterior intestine of 5 fish per treatment (n = 5) were obtained from 
fish fed the control, the 0.1% and the 1% MacroGard® supplemented diets for TEM 
analysis. Rectangular samples of circa 2 mm3 were taken both at week two and week 
four.  
4.3.6.1. Sample preparation and resin embedding 
Samples were fixed immediately after excision in 2.5% glutaraldehyde with 0.1 M 
cacodylate acid sodium salt solution (1:1 vol/vol), pH 7.2 and refrigerated at 4°C for 
later analysis (Merrifield et al., 2009b). Samples were then rinsed twice with 0.1 M 
sodium cacodylate buffer for 15 min each and post-fixed in buffered OsO4 for 1 h. 
Afterwards, samples were rinsed again twice with 0.1 M sodium cacodylate buffer and 
dehydrated with graded alcohol solutions of 30%, 50%, 70%, 90% and 100 % (twice) 
for at least 15 min each. Alcohol was removed by gradual replacement with low 
viscosity resin of 30%, 50%, 70% and 100% for at least 12 h in each solution. A second 
incubation step in 100% resin for 24 h followed. Samples were placed in Beem® 
embedding capsules (Beem® Inc., West Chester, US) and the resin was polymerised at 
60 °C (overnight).  
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4.3.6.2. Sectioning, staining and screening 
Resin blocks were trimmed using a glass knife and then blocks were sectioned using a 
diamond knife (~80nm). Ultrathin sections from each sample were placed on copper 
grids and stained with saturated uranyl acetate for 15 min, rinsed with distilled water 
and post-stained with Reynolds lead citrate for 15 min (Reynolds, 1963). Sections were 
screened with a JSM 1200EX transmission electron microscope at 120 kV (Jeol; Tokyo, 
Japan).  
TEM images were analysed using Image J version 1.42 (National Institutes of Health, 
USA) to measure the microvilli length as described by (Hu et al., 2007) with slight 
modifications. Briefly, the length of 10 well-orientated longitudinal microvilli was 
evaluated in 5 ultrathin sections per sample (50 measurements per sample, in total 250 
measurements per treatment). Furthermore, the microvilli density was assessed after 
Daniels et al. (2010) with a slight modification. Briefly, the number of microvilli 
present on the enterocyte surface was evaluated and then standardized to 1 µm in 5 
ultrathin sections per sample (5 measurements per sample, in total 25 measurements per 
treatment). 
 
4.3.7. Statistical Analysis 
Statistical analysis was performed as described under section 2.9. 
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4.4 Results 
4.4.1. Culture – dependent analysis of the intestinal microbiota 
The effects of a dietary MacroGard® supplementation on viable counts of aerobic 
heterotrophic bacteria and LAB in the carp intestine were determined by a culture-based 
approach using TSA and MRS agar plates, respectively. Figure 4.1 displays the 
allochthonous and autochthonous viable cell counts after week two and week four. After 
two weeks of feeding the levels of both allochthonous and autochthonous aerobic 
heterotrophic bacteria fluctuated at around log 6.5 CFU g-1 across treatments (Figure 
4.1A). Figure 4.1B shows that the allochthonous LAB reached levels of approximately 
log 5 CFU g-1 (present in all replicates) whereas the respective autochthonous levels 
were lower at levels of log 3 CFU g-1 (detectable in three of the four replicates of the 
0.1% MacroGard® group). After four weeks of feeding the allochthonous aerobic 
heterotrophic bacteria mirrored the results from week two with levels of around log 6.5 
CFU g-1 (Figure 4.1C); the levels of the respective aerobic heterotrophic autochthonous 
bacteria however decreased from log 6 CFU g-1 in the control group to log 3 CFU g-1 in 
the 2% MacroGard® group (detectable in two of the replicates). A clear reduction in the 
abundance of autochthonous LAB was observed in fish fed β-glucans (Figure 4.1D). 
Indeed, levels were too low to be statistically viable (i.e. below 30 CFU on the lowest 
dilution plate) in two fish from the 1% MacroGard® group and one fish from the 2% 
MacroGard® group. The levels decreased from log 3.9 CFU g-1 in the control group to 
log 1 CFU g-1 in the 1% MacroGard® group and log 1.4 CFU g-1 in the 2% MacroGard® 
group.   
 
  
Figure 4.1A-D: Viable counts (CFU g
heterotrophic bacteria and lactic acid bacteria in the carp intestine after 
4) and four weeks (n
supplemented diets. Statistically viable levels of b
replicates unless indicated by the number
 
4.4.2. Culture – independent analysis of the intestinal microbiota
The influences of dietary MacroGard
diversity of carp were investigated using culture
4.5 display the 16S rRNA V3 PCR
autochthonous microbiota after two and four weeks of feeding together with the 
respective dendrograms and
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Tables 4.1 and 4.2 show the microbial ecological parameters derived from those PCR-
DGGE fingerprints at week two and four, respectively.  
Week two 
Figure 4.2 illustrates low similarities between treatments (ca. 47% - 61%) of the 
allochthonous samples taken after two weeks. This is confirmed by the microbial 
ecological parameters displayed in Table 4.1 which show that dietary MacroGard® 
reduced the number of OTUs from 28.00 ± 3.27 in the control group to 23.00 ± 3.37    
(P = 0.033) and 21.25 ± 2.22 (P = 0.007) in the 0.1% and 2% MacroGard® group, 
respectively; the reduced numbers of OTUs in the 1% MacroGard® group (24.00 ± 
2.71) was approaching significance (P = 0.077). Similarly, the species richness was 
significantly reduced in all MacroGard® groups to 2.17 ± 0.28 (P = 0.020), 2.23 ± 0.24 
(P = 0.038) and 1.99 ± 0.16 (P = 0.003) from 2.63 ± 0.28 in the control treatment. 
Species diversity, evenness and SIMPER remained unaffected.  
Similarly, Figure 4.3 illustrates low similarities between treatments (ca. 54% - 78%) of 
the autochthonous microbiota after two weeks. This is confirmed by the microbial 
ecological parameters displayed in Table 4.1 which show that dietary MacroGard® 
reduced the number of OTUs from 34.00 ± 4.55 in the control group to 29.33 ± 2.08    
(P = 0.088), 28.75 ± 2.06 (P = 0.044) and 25.00 ± 3.37 (P = 0.002) in fish fed the 0.1%, 
1% and 2% MacroGard® supplemented diets, respectively. Additionally, the species 
richness decreased from 3.00 ± 0.36 in the control group to 2.63 ± 0.17 (P = 0.098), 
2.60 ± 0.18 (P = 0.055) and 2.31 ± 0.27 (P = 0.003) and Shannon’s diversity index 
decreased from 3.47 ± 0.13 in the control group to 3.31 ± 0.07 (P = 0.073), 3.30 ± 0.06 
(P = 0.044) and 3.15 ± 0.17 (P = 0.001) in the 0.1%, 1% and 2% MacroGard® groups, 
respectively. Species evenness and SIMPER remained unaffected by dietary 
MacroGard®. 
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Table 4.1: Microbial community analysis of the allochthonous and autochthonous microbial communities of carp from DGGE fingerprints after               
2 weeks of feeding control (0%) or MacroGard® (0.1%, 1%, 2% M) supplemented diets.  
Week 2 
allochthonous 
Microbial ecological parameters Similarity 
 N Richness Evenness Diversity SIMPER (%) Control 0.1% M 1% M 2% M 
Control 28.00 ± 3.27
a
 2.63 ± 0.28
a
 0.95 ±0.01 3.16 ± 0.12 57.5 ± 17.9 100 50.16 ± 12.62 56.11 ± 6.25 46.99 ± 11.18 
0.1% M 23.00 ± 3.37
b
 2.17 ± 0.28
b
 0.96 ± 0.02 3.00 ± 0.12 54.7 ± 18.3  100 60.66 ± 10.82 50.56 ±15.03 
1% M 24.00 ± 2.71
ab
 2.23 ± 0.24
b
 0.95 ± 0.01 3.02 ± 0.11 67.5 ± 3.0   100 54.81 ± 8.06 
2% M 21.25 ± 2.22
b
 1.99 ± 0.16
b
 0.96 ± 0.02 2.92 ± 0.11 42.0 ± 18.0    100 
 
Week 2 
autochthonous 
Microbial ecological parameters Similarity 
 N Richness Evenness Diversity SIMPER (%) Control 0.1% M 1% M 2% M 
Control 34.00 ± 4.55
a
 3.00 ± 0.36
a 0.99 ± 0.00 3.47 ± 0.13
a
 75.5 ± 8.1 100 73.10 ±4.75 67.48 ± 7.34 53.81 ± 8.78 
0.1% M 29.33 ± 2.08
ab
 2.63 ± 0.17
ab 0.98 ± 0.00 3.31 ± 0.07
ab
 80.6 ± 1.5  100 77.72 ± 8.89 62.07 ± 9.64 
1% M 28.75 ± 2.06
b
 2.60 ± 0.18
ab 0.98 ± 0.00 3.30 ± 0.06
b
 73.2 ± 9.2   100 64.62 ± 8.53 
2% M 25.00 ± 3.37
b
 2.31 ± 0.27
b 0.98 ± 0.00 3.15 ± 0.13
b
 67.8 ± 7.9    100 
N = number of operational taxonomical units, Richness = Margalef species richness, Diversity = Shannon’s diversity index, SIMPER = similarity percentage within 
group replicates. Similarity = pairwise comparison of weighted Bray – Curtis similarity. ab Different superscripts indicate a significant difference (P<0.05)  
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Week four 
At week four the allochthonous microbial profiles from each treatment group were 
highly similar (of ca. 82% - 90%) (Figure 4.4). The microbial ecological parameters 
revealed the total number of OTUs (28.67 - 32.00), the species richness (2.60 - 2.87), 
the species evenness (0.98), the species diversity (3.28 - 3.40) and the SIMPER 
similarity (85.81 - 95.17%) remained unaffected by dietary MacroGard® (Table 4.2).  
However, Figure 4.5 illustrates that the similarity of the autochthonous microbiota 
remained low between treatments at week four (ca. 56% - 84%). Dietary MacroGard® 
supplementation reduced the number of OTUs from 28.00 ± 3.27 in the control group to 
23.00 ± 3.37 (P = 0.045), 24.00 ± 2.71 (P = 0.131) and 21.25 ± 2.22 (P = 0.004) in fish 
fed the 0.1%, 1% and 2% MacroGard® supplemented diets (Table 4.2). Similarly, the 
species richness was reduced from 2.31 ± 0.32 in the control group to 1.83 ± 0.31 (P = 
0.052), 1.99 ± 0.22 (P = 0.163) and 1.53 ± 0.09 (P = 0.006) and the Shannon diversity 
index from 3.14 ± 0.16 in the control group to 2.87 ± 0.19 (P = 0.052), 2.98 ± 0.14 (P = 
0.211) and 2.69 ± 0.01 (P = 0.005) in the 0.1%, 1% and 2% MacroGard® groups, 
respectively. Species evenness was unaffected. A significant increase in SIMPER 
similarity in all MacroGard® groups was observed from 70.81 ± 1.85% in the control 
group to 82.48 ± 6.08% (P = 0.006), 87.36 ± 2.48% (P = 0.001) and 84.61 ± 3.78% (P = 
0.003) in the 0.1%, 1% and 2% MacroGard® groups, respectively. 
 
  
Figure 4.4: A: Denaturing gradient gel electrophoresis (DGGE) profiles of PCR 
amplified products of the V3 region of the 16S rRNA gene from week 4 allochthonous 
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multidimensional scaling analysis plots showing clusters at different similarity levels 
(%). Carp were fed control (0%) or MacroGard
for 4 weeks. 
 
97 
Curtis dendrogram demonstrating the similarity. C: nonmetric 
® (0.1%, 1%, 2% M) supplemented diets 
Chapter 4 
 
– 
  
Figure 4.5: A: Denaturing
amplified products of the V3 region of the 16S rRNA gene from week 4 autochthonous 
samples. B: Bray – 
multidimensional scaling analysis plot
(%). Carp were fed control (0%) or MacroGard
for 4 weeks.  
98 
 gradient gel electrophoresis (DGGE) profiles of PCR 
Curtis dendrogram demonstrating the similarity
s showing clusters at different similarity levels 
® (0.1%, 1%, 2% M) supplemented diets 
Chapter 4 
 
– 
. C: nonmetric 
Chapter 4 
 
99 
 
Table 4.2: Microbial community analysis of the allochthonous and autochthonous microbial communities of carp from DGGE fingerprints after 
4 weeks of feeding control (0%) or MacroGard® (0.1%, 1%, 2% M) supplemented diets.  
Week 4 
allochthonous 
Microbial ecological parameters Similarity 
 N Richness Evenness Diversity SIMPER (%) Control 0.1% M 1% M 2% M 
Control 30.67 ± 1.15 2.76 ± 0.09 0.98 ± 0.00 3.36 ± 0.04 92.75 ± 3.34 100 89.62 ± 2.08 86.37 ± 1.87 81.91 ± 1.28 
0.1% M 32.00 ± 0.00 2.87 ± 0.02 0.98 ± 0.00 3.40 ± 0.01 95.17 ± 2.47  100.00 87.67 ± 3.92 84.51 ± 4.96 
1% M 28.67 ± 1.15 2.60 ± 0.08 0.98 ± 0.00 3.28 ± 0.04 90.53 ± 3.02   100.00 83.12 ± 3.50 
2% M 31.67 ± 2.31 2.83 ± 0.17 0.98 ± 0.00 3.39 ± 0.08 85.81 ± 9.42    100 
 
Week 4 
autochthonous 
Microbial ecological parameters Similarity 
 N Richness Evenness Diversity SIMPER (%) Control 0.1% M 1% M 2% M 
Control 28.00 ± 3.27
a
 2.31 ± 0.32
a 0.97 ± 0.01 3.14 ± 0.16
a
 70.81 ± 1.85
a
 100 70.00 ± 7.67 71.22 ± 5.82 55.77 ± 5.32 
0.1% M 23.00 ± 3.37
b
 1.83 ± 0.31
ab 0.97 ± 0.01 2.87 ± 0.19
ab
 82.48 ± 6.08
b
  100 83.67 ± 3.80 69.58 ± 7.06 
1% M 24.00 ± 2.71
ab
 1.99 ± 0.22
ab 0.98 ± 0.01 2.98 ± 0.14
a
 87.36 ± 2.48
b
   100 71.94 ± 6.46 
2% M 21.25 ± 2.22
b
 1.53 ± 0.09
b 0.97 ± 0.02 2.69 ± 0.01
b
 84.61 ± 3.78
b
    100 
N = number of operational taxonomical units, Richness = Margalef species richness, Diversity = Shannon’s diversity index, SIMPER = similarity percentage 
within group replicates. Similarity = pairwise comparison of weighted Bray – Curtis similarity. ab Different superscripts indicate a significant difference 
(P<0.05). 
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4.4.3. Sequence Analysis 
A number of OTUs were excised for sequence analysis from the PCR-DGGE gels 
(Tables 4.3 and 4.4). These OTUs belonged to the phyla Proteobacteria, Firmicutes, 
Fusobacteria or were unidentified uncultured bacteria. Potentially pathogenic (e.g. 
Aeromonas spp., Lactococcus garvieae), probiotic (e.g. Vagococcus spp., Weissella 
spp., Lactococcus spp.) and beneficial (e.g. Cetobacterium) microbiota were found.   
Week two 
In the allochthonous microbiota after two weeks of feeding the relative abundance of 
Lc. garvieae (OTU 1) increased in fish fed the 1% and 2% MacroGard® supplemented 
diet (130.5% and 149.0% relative to the control abundance, respectively). Reductions in 
relative abundance were seen in an uncultured Propionigenium sp. (OTU 3) and an 
uncultured bacterium (OTU 6) with all MacroGard® concentrations. Minor changes in 
relative abundance were observed for Aeromonas hydrophila strains (OTU 8-10) and 
uncultured Aeromonas sp. (OTU 11) and Aeromonas sp. (OTU 2). 
In the autochthonous microbiota after two weeks of feeding the abundance of LAB 
OTUs (Weissella cibaria, uncultured Lactococcus sp., Vagococcus sp.; OTUs 12-14) 
and Aeromonads (Aeromonas sp., Aeromonas hydrophila; OTUs 15 and 16) decreased 
with increasing dietary MacroGard® supplementation. The presence of Vagococcus sp. 
(OTU 14) was clearly reduced in all MacroGard® groups (0.1%M = 62.1%, 1%M = 
45.0% and 2%M = 50.3%). The uncultured Lactococcus sp. (OTU 13) was less 
prominent only at the 1% and 2% MacroGard® concentrations (81.5% and 61.7%, 
respectively). The relative abundance of Weissella cibaria (OTU 12) was marginally 
decreased with all dietary MacroGard® concentrations (83.0%, 93.3% and 73.7%). 
Aeromonas sp. (OTU 15) decreased to 81.5% and 67.5% and Aeromonas hydrophila 
(OTU 16) decreased to 80.8% and 65.7% in the 1% and 2% MacroGard® groups.  
 
Chapter 4 
 
101 
 
Week four 
In the allochthonous microbiota after four weeks of feeding the sequences retrieved 
from the excised bands were present in all samples and identified as Lactobacillus sakei 
(OTU 17), Vagococcus sp. (OTU 18), Streptococcus sp. (OTU 19), Clostridium tetani 
(OTU 20) and an uncultured bacterium (OTU 21). 0.1% MacroGard® supplementation 
had no effect on abundances but marginal reductions were observed at 1% and 2% 
MacroGard® supplementation.  
In the autochthonous microbiota after four weeks of feeding OTUs identified as 
uncultured Lactococcus sp. (OTU 24) and Vagococcus sp. (OTU 25) were present in all 
samples, but the abundances were reduced in fish fed the MacroGard® supplemented 
diets. The uncultured Lactococcus sp. decreased to 83.0% and 85.2% with the 0.1% and 
1% MacroGard® supplemented diets and further decreased to 69.9% with the 2% 
MacroGard® supplemented diet. Similarly, the Vagococcus sp. was reduced to 86.9% 
and 93.3% in fish fed the 0.1% and 1% MacroGard® supplemented diets and further 
reduced to 78.5% in fish fed the 2% MacroGard® supplemented diet. An uncultured 
Cetobacterium sp. (OTU 26) was marginally reduced in the 0.1% and 1% MacroGard® 
groups (79.9% and 80.0%, respectively) and clearly reduced in the 2% MacroGard® 
group (40.1%; absent in one replicate). Lc. garvieae (OTU 23) was absent in one 
control replicate and in 2 replicates of fish fed the 0.1% MacroGard® supplemented diet 
(38.9% abundance); the abundance was increased to 145.4% and 112.7% in the 1% and 
2% MacroGard® groups, respectively. OTU 27, identified as A. hydrophila, was present 
in two of the three control replicates, but was not detectable in any of the replicates of 
the MacroGard® treatments. 
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Table 4.3: Closest relatives with similarity (%) to the respective relatives and mean relative abundance for the sequences obtained from the PCR-DGGE of the 
allochthonous and autochthonous microbial communities from carp after 2 weeks of feeding control (0%) or MacroGard
®
 (0.1%, 1%, 2% M) supplemented diets.  
Band № Closest Relative Identity (%) 
Mean Relative Abundance (%) 
Control 0.1% M 1% M 2% M 
Week 2 allochthonous 
1 Lactococcus garvieae 100% 100% 89.8% 130.5% 149.0% 
2 Aeromonas sp. 99% - + - - 
3 Uncultured Propionigenium sp. 100% 100% 0.0% 75.9% 36.5% 
4 Vagococcus sp. 100% 100% 79.9% 136.2% 60.4% 
5 Uncultured bacterium 99% 100% 120.1% 120.3% 58.0% 
6 Uncultured bacterium 100% 100% 57.9% 83.9% 57.4% 
7 Uncultured Propionigenium sp. 100% 100% 43.3% 133.5% 65.4% 
8 Aeromonas hydrophila 99% - + + + 
9 Aeromonas hydrophila 98% 100% 116.8% 116.8% 111.3% 
10 Aeromonas hydrophila 100% 100% 98.3% 123.7% 99.0% 
11 Uncultured Aeromonas sp. 100% - - + + 
Week 2 autochthonous 
12 Weissella cibaria 100% 100% 83.0% 93.3% 73.7% 
13 Uncultured Lactococcus sp. 100% 100% 108.2% 81.5% 61.7% 
14 Vagococcus sp. 100% 100% 62.1% 45.0% 50.3% 
15 Aeromonas sp. 100% 100% 96.0% 81.5% 67.5% 
16 Aeromonas hydrophila 100% 100% 89.0% 80.8% 65.7% 
" − " = species absent; " + " = species present at least in one replicate. 
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Table 4.4: Closest relatives with similarity (%) to the respective relatives and mean relative abundance for the sequences obtained from the PCR-DGGE of the 
allochthonous and autochthonous microbial communities from carp after 4 weeks of feeding control (0%) or MacroGard
®
 (0.1%, 1%, 2% M) supplemented diets. 
Band № Closest Relative Identity (%) 
Mean Relative Abundance (%) 
Control 0.1% M 1% M 2% M 
Week 4 allochthonous 
17 Lactobacillus sakei 94% 100% 105.3% 86.5% 87.8% 
18 Vagococcus sp. 100% 100% 104.9% 93.1% 93.9% 
19 Uncultured Streptococcus sp. 99% 100% 100.0% 92.5% 87.0% 
20 Chlostridium tetani 93% 100% 104.9% 74.6% 95.8% 
21 Uncultured bacterium 100% 100% 103.4% 93.2% 104.2% 
Week 4 autochthonous 
22 Uncultured bacterium 97% 100% 0.0% 0.0% 0.0% 
23 Lactococcus garvieae 100% 100% 38.9% 145.4% 112.7% 
24 Uncultured Lactococcus sp. 100% 100% 83.0% 85.2% 69.9% 
25 Vagococcus sp. 99% 100% 86.9% 93.3% 78.5% 
26 Uncultured Cetobacterium sp. 99% 100% 79.9% 80.0% 40.1% 
27 Aeromonas hydrophila 100% 100% 0.0% 0.0% 0.0% 
Chapter 4 
 
104 
 
4.4.4. Epithelial ultrastructure 
The apical brush border of the enterocytes in the posterior intestinal region from fish fed 
either the control, the 0.1% or the 1% MacroGard® supplemented diets were examined 
using transmission electron microscopy. Overall, the epithelial architecture appeared 
healthy with integrated, columnar shaped enterocytes. Numerous, well-developed 
microvilli with the presence of associated terminal webs and no damage to tight 
junctional complexes, desmosomes or intercellular spaces was observed (Plate 4.1). The 
microvilli length and density of intestinal enterocytes was analysed (Table 4.5). Dietary 
MacroGard® supplementation did not affect microvilli length or density after two weeks 
of feeding. After four weeks of feeding however, the administration of 1% MacroGard® 
led to a significant increase of the microvilli length (P < 0.025) and density (P < 0.038) 
compared to fish fed the control and the 0.1% MacroGard® supplemented diet.  
 
Table 4.5: Transmission electron microscopy analysis of the microvilli length (in µm) 
and the microvilli density (microvilli µm-1) of posterior intestinal enterocytes of carp 
after 2 and 4 weeks of feeding control (0%) or MacroGard® (0.1%, 1% M) 
supplemented diets (n = 5).  
  Control 0.1% M 1% M 
Microvilli length 
Week 2 1.38 ± 0.20 1.22 ± 0.14 1.42 ± 0.19 
Week 4 1.32 ± 0.15a 1.46 ± 0.15a 1.68 ± 0.12b 
Microvilli density 
Week 2 7.06 ± 0.25 7.28 ± 0.21 7.37 ± 0.40 
Week 4 7.21 ± 0.42a 7.36 ± 0.22a 7.85 ± 0.33b 
ab different superscripts indicate a significant difference (P<0.05) 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Plate 4.1: Comparative TEM micrographs displaying posterior intestinal microvilli of 
enterocytes of carp fed: (A) the control diet, (B
MacroGard® supplemented diet
D = desmosome, Mi = mitochondria
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Plate 4.2: Comparative TEM micrographs
enterocytes of carp fed: (A) the control diet, (B) the 0.1% MacroGard
MacroGard® supplemented diet
density in (C). MV = microvilli, TJ = ti
Mi = mitochondria, AF = actin filaments
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4.5 Discussion 
The present study indicates for the first time that dietary β-(1,3)(1,6)-D-glucans may 
affect the intestinal microbial communities in teleosts. Carp intestinal microbial 
communities have been assessed using culture-dependent methods in the past and 
consisted mainly of aerobes and facultative anaerobes (Sugita et al., 1985) with 
Aeromonas species being highly abundant (Sugita et al., 1990; Namba et al., 2007). 
Enterobacteriaceae, Pseudomonas, Moraxella, Acinetobacter and Micrococcus (Sugita 
et al., 1990; Namba et al., 2007), Bacteriodetes (Sugita et al., 1990; Tsuchiya et al., 
2008), Plesiomonas, Flavobacterium, Staphylococcus, Streptococcus, Bacillus and 
Chlostridium (Sugita et al., 1990), Vibrio (Namba et al., 2007) and Cetobacterium 
(Tsuchiya et al., 2008) have also been detected. It is however generally accepted that 
evaluation of intestinal microbial communities by using culture-based techniques alone 
is inaccurate and restricted to culturable bacteria (Cahill, 1990; Ringø et al., 2006b; He 
et al., 2011a). To the author’s knowledge, there is no published information about the 
effects of β-glucans on teleost intestinal microbiota using culture-independent methods. 
The present study therefore applied culture-dependent and culture-independent PCR-
DGGE methods to assess effects of a dietary β-(1,3)(1,6)-D-glucan (MacroGard®) 
supplementation on allochthonous and autochthonous microbial communities in mirror 
carp (Cyprinus carpio L.).  
In the present study, cultivable allochthonous LAB levels were not affected by dietary 
MacroGard® at either sampling time point. Similarly, Smith et al. (2011) reported that 
laminarin,  a low molecular weight (7.7 kDa), soluble β-1,3-1,6-D-glucan found in 
brown algae, had no effect on allochthonous lactobacilli and bifidobacteria levels in the 
pig colon. Contradictory results have been reported in rats, where elevated 
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allochthonous intestinal lactobacilli levels have been observed after dietary β-glucan 
supplementation (Dongowski et al., 2002; Snart et al., 2006). 
In the present study, the autochthonous LAB levels were not affected after two weeks 
by dietary MacroGard® supplementation. After four weeks however, autochthonous 
LAB levels decreased with increasing MacroGard® supplementation. Sequence analyses 
from DGGE profiles identified a number of LAB and, confirming the culture based 
results, the abundance of the autochthonous LAB were reduced in the MacroGard® fed 
fish. After two weeks of feeding the abundance of Weissella cibaria, uncultured 
Lactococcus sp. and Vagococcus sp. (OTUs 12-14) decreased with increasing dietary 
MacroGard® supplementation. Similarly, after four weeks of feeding the abundance of 
uncultured Lactococcus sp. (OTU 24) and Vagococcus sp. (OTU 25) were reduced in 
fish fed the MacroGard® supplemented diets. To the authors’ knowledge there is no 
information available on the effects of dietary β-glucan supplementation on 
autochthonous LAB in fish or mammals. In the present study, the total number of 
cultivable aerobic heterotrophic bacteria levels were not affected by MacroGard® 
supplementation which is in accordance with the preliminary results observed in 
Atlantic cod (Gadus morhua) Skjermo et al. (2006). Culture-independent analyses 
revealed that dietary MacroGard® reduced the number of phylotypes and the species 
richness of the allochthonous microbiota in the carp intestine after two weeks, but not 
after four weeks of feeding. For the autochthonous microbiota, dietary MacroGard® 
reduced the number of phylotypes, the species richness and diversity after two weeks, 
and those parameters remained reduced after four weeks of feeding. Sequence analysis 
identified that the abundance of autochthonous A. hydrophila was reduced with dietary 
MacroGard® whereas the effect on the abundance of allochthonous Aeromonad OTUs 
was more variable. These results demonstrate that the effect of MacroGard® on the 
bacterial communities in the intestine of carp is different, with a more pronounced effect 
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on the autochthonous microbiota which may be reflective of a different community 
composition on the mucosal surface, than in the lumen, or potentially the observed 
changes may be a result of structural or immunological changes in the host’s epithelial 
brush border or mucus biochemistry. 
After four weeks of feeding the posterior intestinal microvilli length and density were 
significantly increased in fish fed diets supplemented with 1% MacroGard® whereas 
after two weeks no differences were observed. To the authors’ knowledge no report on 
the effects of β-glucans on the apical brush border morphology of teleost enterocytes 
has been published to date. However, a number of studies have reported similar effects 
with dietary mannanoligosaccharides (MOS) isolated from Saccharomyces cerevisiae 
yeast cell walls. Increased microvilli length was observed in red drum (Sciaenops 
ocellatus) when MOS and other prebiotic oligosaccharides were included in the diet at 
1% (Zhou et al., 2010) and in Pacific white shrimp (Litopenaeus vannamei) with MOS 
supplementations from 0.2-0.8% but not with 0.1% (Zhang et al., 2012). In addition, 
increased microvilli length and density were reported in European lobsters (Homarus 
gammarus L.) (Daniels et al., 2010) and rainbow trout (Oncorhynchus mykiss) 
(Dimitroglou et al., 2009) fed MOS supplemented diets. The authors suggest that a 
well-developed, healthy mucosal epithelium may be advantageous in the defence of 
opportunistic indigenous bacterial infections in addition to a likely improved feed 
utilization.  
 
4.6 Conclusions 
The present study was the first to comprehensively investigate the time-dependent 
effects of a dietary immunostimulating β-(1,3)(1,6)-D-glucan (MacroGard®) on both 
allochthonous and autochthonous microbial communities in the teleost intestine. The 
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results indicated that dietary MacroGard® may affect the composition of the carp 
intestinal microbial communities. Furthermore, positive effects on intestinal microvilli 
length and density were also observed. Future research is required to validate whether 
the present observations occur under different environmental conditions, e.g. in 
commercial husbandry, or in fish species with different digestive systems, e.g. in 
carnivorous species in contrast to omnivorous, stomachless carp used in the present 
study. In addition, studies are required to elucidate the differences in the intestinal 
microbial activities and the impact of such changes on the host immune response and 
digestive activity. 
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Chapter 5:  
Effects of a dietary β-(1,3)(1,6)-D-glucan supplementation 
on a chronic progressive  Mycobacterium haemophilum 
mycobacteriosis in zebrafish (Danio rerio)  
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5.1 Abstract 
Mycobacteriosis infections can cause economic losses in aquaculture and pose a threat 
to research facilities. Prophylactic dietary ß-glucan administration has been proven to 
increase resistance against bacterial pathogens in various fish species. Knowledge 
however about their possible therapeutic effects on chronic diseases such as 
mycobacteriosis is very limited. Two experiments were therefore conducted to examine 
the effects of a dietary Saccharomyces cerevisiae ß-glucan (MacroGard®) on chronic 
mycobacteriosis in adult zebrafish. Sequencing of PCR-amplified liver DNA extracts 
using Mycobacterium genus-specific primers identified Mycobacterium haemophilum as 
the causative pathogen. In the long-term study, experiment I (200 days), zebrafish 
were fed highly purified diets supplemented with 0% (control, C) or 0.1% MacroGard® 
(B), and survival rates were recorded. In the short-term study, experiment II (63 days), 
zebrafish were fed diet C or diet B continuously or both diets intermittently (CB) in 
weekly intervals. Survival rates, histopathological status and intestinal microbial 
communities were analysed. Dead and moribund fish displayed the typical clinical signs 
of mycobacteriosis. Dietary MacroGard® failed to improve survival rates (values           
± SEM) in experiment I (C = 36.2 ± 4.2% vs. B = 20.0 ± 7.3%) and in experiment II    
(C = 72.5 ± 1.0% vs. B = 78.3 ± 0.3% vs. CB = 78.3 ± 1.6%). Histopathological analysis 
revealed absent (normal appearance), moderate and severe manifestations of 
granulomas, the hallmarks of mycobacteriosis. Ecological microbial community 
analysis of intestinal samples collected at day 63 showed significantly higher number of 
OTUs, species richness and diversity in treatments B and CB compared to the control 
treatment. In conclusion, MacroGard® failed to improve zebrafish resistance against 
mycobacteriosis irrespective of length or sequence of administration. Yet, since gaps in 
knowledge still exist, further research is required to eliminate the current ambiguities. 
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5.2 Introduction 
The importance of zebrafish (Danio rerio) in research has risen over the last decade as 
many laboratories have utilised this species to develop protocols modelling cancer and 
infection studies for both teleosts and humans (van der Sar et al., 2004; Mione and 
Trede, 2010). For example, mycobacteriosis in zebrafish serves as a model for human 
tuberculosis due to the pathological similarities (Davis et al., 2002; Prouty et al., 2003; 
van der Sar et al., 2004). In addition, the zebrafish has also been established as a model 
for investigations of the intestinal microbiota, especially when gnotobiotic zebrafish 
models are used (Rawls et al., 2004; Bates et al., 2006). Mycobacterial infections 
frequently pose a threat to zebrafish facilities when mycobacteriosis is not the intended 
focus of research. Mycobacteria are widespread in aquatic environments making control 
of these pathogens by avoidance difficult; currently there are no effective treatments for 
mycobacteriosis in zebrafish available (Ramsay et al., 2009).  
Piscine mycobacteriosis is a systemic, predominantly chronic, progressive disease 
where clinical signs may not even occur (Gauthier and Rhodes, 2009). Seldom, acute 
forms however have been reported leading to substantial mortalities in aquaculture 
(Hedrick et al., 1987; Bruno et al., 1998). Studies with M. marinum and Mycobacterium 
peregrinum indicated that the natural route of infection in zebrafish is primarily through 
the gastrointestinal tract (Hariff et al., 2007). All tissues and organs may be affected and 
non-specific external clinical signs may include lethargy, loss of equilibrium, anorexia, 
skin, fin and scale alterations, exophthalmia, emaciation, ascites and skeletal deformities 
(Talaat et al., 1998; Decostere et al., 2004; Swaim et al., 2006; Watral and Kent, 2007; 
Whipps et al., 2007; Gauthier and Rhodes, 2009). Granulomatous inflammation is the 
typical histopathological manifestation in teleosts suffering from mycobacteriosis 
(Gauthier and Rhodes, 2009). A granuloma is defined as “a compact (organized) 
collection of mature mononuclear phagocytes (macrophages and/or epithelioid cells) 
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which may or may not be accompanied by accessory features such as necrosis or the 
infiltration of other inflammatory leukocytes" (Adams, 1976). Size and structural 
organization of granulomas can vary considerably (Gauthier and Rhodes, 2009). The 
chronic proliferative form of the disease is characterized by granulomas; sub-acute and 
acute forms are associated with necrosis and acid-fast bacilli scattered diffusely among 
affected tissues including the kidney, liver and spleen, and often all visceral organs 
(Ferguson 2006).  
As described in previous chapters, dietary ß-glucans have been reported to improve the 
immune response and disease resistance against bacterial pathogens in fish including 
cyprinids (Kwak et al., 2003; Misra et al., 2006; Gopalakannan and Arul, 2010). In 
zebrafish specifically, one study also reported increased survival rates upon an 
Aeromonas hydrophila challenge when ß-glucans were injected intraperitoneally 
(Rodriguez et al., 2009). Dietary ß-glucans also enhanced survival rates in artificially 
immune-suppressed fish (Sahoo and Mukherjee, 2001, 2002; Kumari and Sahoo, 2006b; 
El-Boshy et al., 2010) upon bacterial challenges. Literature however about the effects of 
dietary immunostimulants on mycobacteriosis is scarce. One study by Li and Gatlin 
(2005) indicated positive effects of partially autolyzed brewer’s yeast (Brewtech®) and 
GroBiotic®-A, a mixture of partially autolyzed brewer’s yeast, dairy ingredient 
components and dried fermentation products on survival rates of hybrid striped bass 
(Morone chrysops x M. saxatilis). Immunostimulants, such as ß-glucans, therefore 
could potentially have beneficial effects on the progression of chronic mycobacteriosis 
in teleosts. 
Since Chapter 4 demonstrates comprehensively for the first time that dietary                   
ß-(1,3)(1,6)-D-glucans modulate the intestinal microbiota in carp, such an effect could 
also occur in zebrafish. As already mentioned, the intestinal microbial communities and 
their metabolites are highly important by influencing, among other factors, the 
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immunological balance and physiological processes of teleosts (Cerf-Bensussan and 
Gaboriau-Routhiau, 2010; Merrifield et al., 2010; Sekirov et al., 2010).  
Thus, two experiments were conducted to assess the efficacy of dietary β-glucan 
applications on zebrafish resistance to mycobacteriosis and to determine if the dietary 
provision of β-glucans influences the zebrafish gut microbiome. The aim of experiment 
I was to investigate the effects of a dietary β-(1,3)(1,6)-D-glucan (MacroGard®) on 
survival rates of zebrafish suffering from a chronic, pre-existing mycobacteriosis over a 
period of 200 days. The subsequent experiment II aimed at identifying the exact 
Mycobacterium spp. causing the mycobacteriosis in the facilities and examining the 
effects of MacroGard® on survival rates and severity of infection of zebrafish over 63 
days. In order to avoid potential immunosuppression previous studies have suggested a 
pulse/intermittent feeding regime (Bricknell and Dalmo, 2005; Ringø et al., 2011) and 
therefore an intermittent diet was also included in experiment II. 
 
5.3 Material and Methods 
5.3.1 Rearing facilities and water quality 
The experiments were conducted in the Zebrafish Research Facility at the University of 
Plymouth, UK and water quality was monitored as described under section 2.2. The 
water temperature and the pH were maintained at 28 ± 0.2 °C and between 6.8 and 7.2, 
respectively, with the water being partially re-circulated (30% water change per day). 
The photoperiod was maintained at a 12/12 h light/dark cycle.    
 
5.3.2 Experimental fish and feeding 
For both experiments, adult (approximately one year old) wild type zebrafish (Danio 
rerio) were obtained from the Zebrafish Research Facility at Plymouth University, UK.  
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For experiment I, 210 zebrafish (478 ± 91 mg) were randomly allocated in groups of 35 
to each of the six 40L experimental tanks (n = 3 tanks per treatment). For experiment II, 
360 zebrafish (503 ± 117 mg) were randomly allocated in groups of 40 to each of the 
nine 40L experimental tanks (n = 3 tanks per treatment). After allocation the fish were 
carefully acclimatized over three weeks prior to the experimental period whilst being 
manually fed the control diet. The basal diet consisted of the same ingredients as 
described under section 2.5 and was supplemented with 0% w/w MacroGard® (control 
diet) or 0.1% w/w MacroGard® and produced in flake form (Tetra GmbH, Melle, 
Germany). In experiment I fish were fed diet C or the experimental diet B. In 
experiment II fish were fed either 1] the control diet (C), 2] the experimental diet 
continuously (B) or 3] the control and experimental diet fed intermittently in weekly 
intervals (CB). At all times fish were manually fed twice per day to apparent satiation. 
 
5.3.3 Cumulative mortality 
Cumulative mortality was recorded over a period of 200 days and 63 days in experiment 
I and experiment II, respectively. Dead and/or moribund fish showing extensive signs of 
fish tuberculosis just prior to death (skin haemorrhages, abdominal distension, lethargy, 
emaciation, raised scales) were removed from the tanks and euthanized in 0.1 ppm 
buffered tricaine methanesulfonate (MS-222; Pharmaq Ltd., Fordingbridge, UK). Fish 
were stored at -20°C. 
 
5.3.4 Sampling procedures 
At the end of experiment II samples for histopathology, intestinal microbiology and 
confirmation and identification of mycobacteria were taken. Fish were euthanized in 0.1 
ppm buffered tricaine methanesulfonate (MS-222).  
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5.3.4.1 Histopathology 
On day 56 and day 63 six fish (2 per tank) were randomly sampled (n = 6 per time 
point) for histopathological examination and fixed in 10% neutral buffered formalin. 
Midsagittal sections (4-7 µm) were taken from the mid-trunk region to obtain a portion 
of multiple organ systems including the liver, kidney and spleen. Sections were 
decalcified for 30 min and processed for routine paraffin embedding and microtome 
sectioning. Sections were stained with haematoxylin and eosin (H&E). Sections were 
also stained for acid-fast bacilli with a modified Ziehl-Neelsen staining protocol (Luna, 
1968). Briefly, sections were stained in carbol fuchsin for 60 minutes at room 
temperature, rinsed with tap water and then differentiated in 1% acid alcohol. After a 
further rinse with tap water, sections were counterstained with methylene blue (diluted 
1:9 in distilled water) for 2 seconds, followed by a rinse with distilled water and then 
tap water. All preparing working steps (e.g. clearing, re- and de-hydration and mounting 
with a coverslip) were conducted as described under section 2.7.2. Slides were 
examined under an Olympus light microscope, photographed with an Olympus digital 
camera and processed using Corel Photo-Paint X5. Kidney, liver, spleen, 
gastrointestinal tract, swim bladder, reproductive organs, and muscle tissue were both 
quantitatively and qualitatively examined for granulomas. To evaluate the extent of 
zebrafish organ and tissue inflammation, a severity of infection index, using an arbitrary 
scoring scale of the liver, spleen and kidney, was adapted and modified from Talaat et 
al. (1998). The index was defined as: score 1 = normal, 2 = moderate and 3 = severe.      
A score of normal indicates no granulomas. A score of moderate indicates that 
granulomas were focal or multifocal in an organ but not diffuse. A score of severe 
indicates where granulomas were multifocal or diffuse to an extent that normal tissue is 
almost unrecognizable.  
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5.3.4.2 Assessment of intestinal microbiota 
For the evaluation of the intestinal microbial communities, intestinal samples from         
5 fish per tank were isolated, pooled and homogenized after Merrifield et al. (2013) at 
day 56 and day 63, thus leading to 3 replicates per treatment, each representing 5 fish. 
Fish from the intermittent treatment CB were fed the control diet (day 56) and the 
MacroGard® supplemented diet (day 63) the week preceding the sampling, respectively. 
DNA extraction and PCR amplification of the 16S rRNA V3 region were performed as 
described under sections 2.8.1 and 2.8.2, respectively. Subsequently, the V3 PCR 
amplicons were subjected to a 40% - 60% Denaturing Gradient Gel Electrophoresis 
(DGGE) as described under section 2.8.3. 
 
5.3.4.3 Confirmation and identification of mycobacteria 
Liver tissue samples were taken from the initial pool of fish of each treatment in order 
to confirm mycobacteria presence and to verify that all fish had an equal probability of 
infection. Four random samples per treatment were collected from live fish which did 
not exhibit clinical signs of mycobacteriosis. Genomic DNA was extracted using the 
DNeasy Blood and Tissue Kit (QIAGEN, Crawley, UK). A conserved region of the 16S 
rRNA gene of mycobacteria (924 bp product) was amplified by PCR using genus-
specific primers after Talaat et al. (1997). Subsequently, 8 µl of the PCR product mixed 
with 2 µl loading buffer were subjected to electrophoresis on a 2% agarose gel 
containing 2.5 µl ethidium bromide (10mg/ml). Hyper ladder IV (Bioline, London, UK) 
as well as a negative and positive control (cultured Mycobacterium phlei, Microbiology 
Laboratory culture collection, Plymouth University, UK) were run alongside the 
samples to identify the correct amplification of the product. All samples displayed a 
band in the same position indicating that Mycobacterium DNA was present (Plate 5.1).  
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Two PCR samples of each treatment were purified, sequenced and submitted to a 
BLAST search in GenBank as described under section 2.8.5. The closest relatives 
obtained were identical for all six samples which identified Mycobacterium 
haemophilum as the causative pathogen (Table 5.1). 
 
 
Table 5.1: Closest relatives, identity (%) and accession numbers with the respective 
treatments and nucleotide length (Nt. length) obtained from the PCR amplification of 
the liver DNA extracts using Mycobacterium-specific primers 
Treatment Nt. length Closest relative Identity (%) Accession № 
C 887 nt Mycobacterium haemophilum 99% DQ851570 
C 885 nt Mycobacterium haemophilum 99% DQ851570 
B 884 nt Mycobacterium haemophilum 99% DQ851570 
B 891 nt Mycobacterium haemophilum 98% DQ851570 
CB 886 nt Mycobacterium haemophilum 99% DQ851570 
CB 810 nt Mycobacterium haemophilum 99% DQ851570 
 
L
nC 
cMy 
C 
L 
C 
C 
C 
cMy 
CB 
CB 
CB 
 CB 
B 
B 
B 
B 
nC 
Plate 5.1: Presence/absence of Mycobacterium spp. within samples after DNA extraction 
from liver and subsequent PCR amplification of 16S rRNA using genus specific primers:   
L = ladder (1000 bp); nC = no template control; cMy = cultured Mycobacterium phlei;       
C = control treatment; CB = MacroGard® intermittent treatment; B = MacroGard® 
continuous treatment 
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5.3.5 Statistical Analysis 
Kaplan-Meier analysis was used to generate survival curves, and a log-rank test was 
performed to compare the survival of fish in each experimental group. Histopathological 
data assuming sphericity (Mauchly’s Sphericity test) or violating sphericity 
(Greenhouse-Geisser) was subjected to a repeated-measures ANOVA and significant 
differences revealed with a Bonferroni correction. The images of the DGGE-gels were 
statistically analysed as described under section 2.9. A significance level of P < 0.05 
was used for all statistical tests. Statistical analysis was performed using SPSS statistics, 
version 18 (SPSS Inc., Chicago, US). 
 
5.4 Results 
5.4.1 Clinical signs and survival rates Experiment I and II 
In the present study infected fish showed external clinical signs of mycobacteriosis as 
described elsewhere (Swaim et al., 2006; Whipps et al., 2007). Death was preceded by 
reduced feed intake, weakened mobility and loss of buoyancy for approximately one 
week. The fish either were often lethargic at the bottom of the tank or showed listless 
piping, remaining at the surface, constantly opening and closing their mouths in an 
attempt to increase gas exchange. Infected fish in both experiments presented clinical 
signs including severe haemorrhages on the trunk ventral to the lateral line and in close 
proximity to internal organs, localized granulomatous nodules, abdominal distension, 
raised scales, clamped fins, exophthalmia, ascites, emaciation and scoliosis (Plate 5.2).
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B 
A 
C 
D 
Plate 5.2: Examples of zebrafish from experiment II displaying clinical signs of 
mycobacteriosis. A = abdominal distension & granulomatous nodule; B = scoliosis & 
exophthalmia; C = raised scales and haemorrhages; D = emaciation.  
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After 200 days (experiment I) mean survival rates of fish fed the 0.1% MacroGard® 
supplemented diet were lower, at 20.0 ± 7.3%, but differences were not significantly   
(P = 0.21) different compared to fish fed the control diet, where 36.2 ± 4.2% of the 
individuals survived (Figure 5.1).  
 
Figure 5.1: Mean survival (%) ± SEM of zebrafish suffering from Mycobacterium 
haemophilum mycobacteriosis fed either the diet C (  ) or the diet B supplemented with 
0.1% MacroGard® (  ) over the 200 days experimental period. 
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As Figure 5.2 illustrates, after 63 days (experiment II) mean survival rates of fish fed 
the diet C (control) were marginally lower (72.5 ± 1.0%) compared to fish fed the 0.1% 
MacroGard® supplemented diets B (78.3 ± 0.3%) or CB (78.3 ± 1.6%) but differences 
were not statistically different (P = 0.76). 
 
Figure 5.2: Mean survival (%) ± SEM of zebrafish suffering from Mycobacterium 
haemophilum mycobacteriosis fed either diet C (  ) or the 0.1% MacroGard® 
supplemented diets B (   ) or CB (   ) over the 63 days experimental period. 
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5.4.2 Histopathology 
H & E staining revealed granuloma formation in the organs examined including kidney 
(Plate 5.3 C), liver (Plate 5.3 D, F) and spleen (Plate 5.3 E, G, H), gastrointestinal tract 
(Plate 5.3 B), swim bladder, ovaries and muscle tissue (Plate 5.3 E). Ziehl-Neelsen 
staining showed numerous rod-shaped acid-fast bacilli located in the granulomas (Plate 
5.3 H and I). Foci of inflammation had a round pinkish amorphous area approximately 
0.1 to 1.0 mm in diameter and included well-distinguished granulomas.  
The majority of granulomas had necrotic centres and granular debris including 
numerous intracellular and extracellular acid fast-bacilli (Plate 5.3 H and I); but also 
necrotizing centres lacking and non-necrotizing centres displaying acid-fast bacilli 
under Ziehl-Neelsen stain were detected. Plate 5.3.G shows necrotizing and non-
necrotizing centres of granulomas. Central necrosis often developed into caseous 
necrosis (e.g. Plate 5.3 C). Granulomas occasionally collected and grew into larger 
loosely organized groups, i.e. multicentric granulomas (Plate 5.3 F). These groups 
included granulomas with central necrosis with or without visible bacteria. Infrequently, 
accumulations were detected at the sites of inflammation which most likely comprised 
of melanomacrophages within the granulomas (Plate 5.3 E).  
Normal, moderate and severe infections were found in each experimental group (Figure 
5.6). Although, there was a trend for severe infection within the β-glucan supplemented 
diets, it was not statistically different to the control (P = 0.07). 
  
a b 
* 
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Plate 5.3:                                              
(A) Normal zebrafish liver (a), spleen 
(b) with no signs of inflammation.  
(B) Overview of a severe infection.  
(C) Granuloma in kidney with central, 
caseous necrosis (asterisk).      
(D) Liver with scattered granulomas 
(arrows). Areas of the liver are brighter 
in colour than those in (A). 
(E) Granulomas in spleen with 
melanomacrophages (black arrows) 
and a granuloma in muscle tissue (blue 
arrow).         
 (F) Multicentric necrotizing 
granulomas (arrows) in liver.                
(G) Granuloma in spleen with central 
necrosis (blue arrow), granuloma with 
caseous necrosis (black arrow), and a 
non-necrotizing granuloma in early 
stages of development (red arrow) just 
above a blood vessel (asterisk). 
(H) Multicentric granuloma (dotted 
line) in spleen containing 3 granulomas 
(arrows) with high amount of acid fast 
bacilli stained red.                                    
(I) Granuloma with caseous necrosis 
and rod shaped acid-fast bacilli 
(arrowheads).  
Scale bars: B = 500 µm; A, C, D, E, F,                                          
G and H = 200 µm; I = 20 µm.  
Staining: H&E (A-G) and modified 
 Ziehl-Neelsen (H&I). 
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Figure 5.3: Frequency of severity of infection score after Talaat et al. (1998) for fish fed 
either the diet C (black bar), diet B (dark-grey, dashed bar) or CB (light-grey bar). 
 
5.4.3 Assessment of intestinal microbiota 
The influence of a dietary MacroGard® supplementation (0.1%) on the intestinal 
microbial diversity under a chronic mycobacteriosis condition in wild-type zebrafish 
(Danio rerio) was assessed using PCR-DGGE. Figures 5.4 and 5.5 display the 16S 
rRNA V3 PCR-DGGE fingerprints and the respective dendrograms of the intestinal 
microbiota after 8 weeks (day 56) and 9 weeks (day 63) of feeding, respectively. The 
respective microbial ecological parameters derived from PCR-DGGE fingerprints are 
presented in Table 5.2.  
Figure 5.4 illustrates low similarities between treatments (ca. 68% - 72%) of the 
samples taken at day 56. Furthermore, the similarities within the replicates of each 
individual treatment (SIMPER) were low (ca. 62% - 79%), but CB (78.74 ± 7.43%) was 
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approaching significance towards a higher value than B (62.33 ± 2.88%, P = 0.059). 
There were no significant differences between treatments with regards to the number of 
OTUs, the species richness, evenness or diversity. 
Figure 5.5 displays the equivalent after 63 days weeks of feeding when fish from the 
intermittent treatment CB were fed the 0.1% MacroGard® supplemented diet the week 
prior to sampling. It is evident that the three replicates from fish fed the control diet 
cluster together and display low similarity compared to fish fed both MacroGard® 
supplemented diets (C vs. B 73.83 ± 8.15% similarity, C vs. CB 74.72 ± 5.51% 
similarity). The similarity between treatment B and CB however was higher (89.92 ± 
4.49%). Furthermore, the similarity within the group replicates was equally high for all 
treatments (approx. 88 - 90%). Irrespective of continuous or intermittent feeding 
regime, dietary MacroGard® also significantly (P < 0.001) increased the total number of 
OTUs from 21.33 ± 0.58% in the control group to 28.67 ± 1.53% in treatment B and 
28.67 ± 0.58% in treatment CB. The species richness was also significantly (P < 0.001) 
higher with 2.70 ± 0.12% and 2.71 ± 0.06% in treatments B and CB, respectively, 
compared to the control (2.09 ± 0.03%). In addition, diversity was significantly higher 
(P < 0.001) in treatments B (3.31 ± 0.05%) and CB (3.31 ± 0.03%) compared to the 
control (3.05 ± 0.02%). The evenness remained unaffected. 
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Figure 5.4: Denaturing gradient gel electrophoresis (DGGE) profiles of PCR –
amplified products of the V3 region of the 16S rRNA gene from day 56 intestinal 
samples with the respective Bray – Curtis dendrogram demonstrating the similarity.
Treatments: C 1-3 = control replicates, B 1-3 = replicates treatment B, and CB1-3 = 
replicates treatment B. 
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Figure 5.5: Denaturing gradient gel electrophoresis (DGGE) profiles of PCR –
amplified products of the V3 region of the 16S rRNA gene from day 63 intestinal 
samples with the respective Bray – Curtis dendrogram demonstrating the similarity.
Treatments: C 1-3 = control replicates, B 1-3 = replicates treatment B, and CB1-3 = 
replicates treatment B. 
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Table 5.2: Analysis of the intestinal microbial communities of zebrafish (n = 3) from PCR-DGGE fingerprints after 56 and 63 days of feeding control 
(C) or MacroGard® (0.1%) supplemented diets continuously (B) or intermittently (CB). On day 56 fish from treatment CB were fed the control diet, 
and on day 63 they were fed the MacroGard® (0.1%) supplemented diet the preceding week.  
Day 56 Microbial ecological parameters                     Similarity 
 N Richness Evenness Diversity SIMPER (%) C B CB 
C 23.33 ± 3.21 2.16 ± 0.29 0.98 ± 0.01 3.09 ± 0.13 69.69 ± 8.08 100 72.25 ± 11.28 67.68 ± 7.71 
B 22.67 ± 2.52 2.10 ± 0.25 0.98 ± 0.00 3.06 ± 0.11 62.33 ± 2.88  100 71.47 ± 10.49 
CB 21.67 ± 3.21 2.01 ± 0.30 0.98 ± 0.00 3.01 ± 0.16 78.74 ± 7.43   100 
 
Day 63 Microbial ecological parameters                     Similarity 
 N Richness Evenness Diversity SIMPER (%) C B CB 
C 21.33 ± 0.58
a
 2.09 ± 0.03
a
 1.00 ± 0.00 3.05 ± 0.02
a
 90.15 ± 5.50 100 73.83 ± 8.15 74.72 ± 5.51 
B 28.67 ± 1.53
b
 2.70 ± 0.12
b
 0.99 ± 0.01 3.31 ± 0.05
b
 88.58 ± 3.93  100 89.92 ± 4.49 
CB 28.67 ± 0.58
b
 2.71 ± 0.06
b
 0.99 ± 0.00 3.31 ± 0.03
b
 88.36 ± 5.02   100 
N = number of operational taxonomical units, richness = Margalef species richness, diversity = Shannon’s diversity index, SIMPER = similarity percentage within 
group replicates. Similarity = pairwise comparison of weighted Bray – Curtis similarity. ab Different superscripts indicate a significant difference (P < 0.05). 
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5.5 Discussion 
Piscine mycobacteriosis constitutes a threat to zebrafish research facilities, and 
pathogenic Mycobacterium spp. causing this disease in zebrafish include M. marinum 
(Prouty et al., 2003; Watral and Kent, 2007), Mycobacterium fortuitum, M. chelonae, 
Mycobacterium abscessus (Astrofsky et al., 2000) and Mycobacterium peregrinum 
(Kent et al., 2004). Also, the pathogenic Mycobacterium haemophilum (accession 
number DQ851570) identified as the causative agent for the severe mycobacteriosis in 
the present study has previously been described (Kent et al., 2004; Whipps et al., 2007) 
and considered as highly virulent species associated with severe disease (Whipps et al., 
2012). Injecting 8 month old zebrafish with M. haemophilum at 1.2 x 105 CFU fish-1 
resulted in approx. 35% mortalities after 8 weeks (Whipps et al., 2007). Comparable 
mortality rates were observed in the present study: approx. 26% in the control group and 
35% in the MacroGard® group in experiment I after 60 days (64% and 80%, 
respectively, after 200 days). In experiment II approx. 28% in the control group and 
approx. 22% in both the continuous and intermittent MacroGard® group deceased at day 
63. It must be noted however that the fish in the present study were not injected with the 
pathogen but suffered from a mycobacteriosis caused by the ubiquitous presence of    
M. haemophilum within the facilities. The detection of M. haemophilum in biofilms 
from zebrafish research facilities has been reported elsewhere, indicating that biofilms 
constitute a reservoir and continuous source of infection in recirculating water systems 
(Whipps et al., 2007). This fact supports the observation that the zebrafish in the 
facilities used in the present study become infected in early life stages, suffering from a 
chronic form of mycobacteriosis which slowly develops into sub-acute and acute forms 
over time, possibly triggered by stressors, as described for other mycobacteriosis 
infections in fish (Ramsay et al., 2009). 
Chapter 5 
 
133 
 
As apparent from Figures 5.1 and 5.2, dietary β-glucan supplementation in the form 
0.1% MacroGard® could not increase the survival rates of zebrafish suffering from 
severe M. haemophilum mycobacteriosis. Moreover, it was of no difference whether 
MacroGard® was administered over long- or short-term periods (experiment I, 200 days 
vs. experiment II, 63 days) or if administered in weekly intervals (experiment II). In 
contrast to the findings of the present study, Li and Gatlin (2005) observed a marginal, 
but significant, increase in survival rates of hybrid striped bass fed diets supplemented 
with partially autolyzed brewer’s yeast (Brewtech®) and GroBiotic®-A, a mixture of 
partially autolyzed brewer’s yeast, dairy ingredient components and dried fermentation 
products, under a progressing in situ infection with M. marinum which became well 
established at week 16. It is difficult however to compare these data to the data from the 
present study where a highly purified ß-glucan was used. 
In general, pathogenic mycobacteria mainly infect macrophages (or other macrophage-
like phagocytic cells) and are able to escape killing by the cell-intrinsic immune 
responses of macrophages and subsequently proliferate within the macrophages 
(Hagedorn and Soldati, 2009). In doing so, mycobacteria ironically exploit the host’s 
defence mechanism of phagocytosis which acts to protect the host from infection. 
Literature on M. haemophilum mycobacteriosis in teleosts and literature on the effects 
of ß-glucans on mycobacteriosis is limited. A recent in vitro study however using 
human macrophages was able to illustrate the interaction between mycobacteria and      
ß-glucans (Betz et al., 2011). Treating the macrophages with a particulate S. cerevisiae 
ß-glucan prior to, or after infection, was able to decrease cell association and 
intracellular survival of the M. tuberculosis vaccine Bacillus Culmette Guerin (BCG; an 
attenuated strain of Mycobacterium bovis). In contrast, no effect was observed when a 
virulent Mycobacterium tuberculosis (Erdman strain, ATCC #25618) was used despite 
the fact that the ß-glucan increased oxidative burst and pro-inflammatory cytokines, 
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mediated through Dectin-1. The authors hypothesize that M. tuberculosis is equipped 
with a unique mechanism to inhibit downstream-signalling of Dectin-1 (potentially by 
preventing induction of NF-κB and pro-inflammatory responses), thus evading the 
macrophage’s killing machinery. Indeed, M. tuberculosis has been shown to prevent 
phagosome maturation in macrophages and survive inside these vesicles; M. marinum 
can survive inside phagosomes but furthermore escape into the cytosol and spread to 
neighbour cells (van der Vaart et al., 2012). It is conceivable that the virulent                
M. haemophilum is equipped with similar mechanisms which could be one reason why 
the ß-glucan administration did not impact survival rates in the present study.  
In contradiction to the findings of Betz et al. (2011), a study by Hetland and Sandven 
(2002) reported that particulate MacroGard®, as used in the present study, successfully 
reduced the number of intracellular M. tuberculosis cells in mouse macrophages when 
incubated together with the bacteria; however, the authors used a different strain           
M. tuberculosis (strain H37Rv). The interesting finding however in this study was that 
this effect was not observed when the MacroGard was added after M. tuberculosis. This 
could also be indicative for the findings of the present study where the mycobacteriosis 
was well established and already existing prior to the start of the ß-glucan 
administration. One could hypothesize that the zebrafish were in an immuno-
compromised state to such an extent that the immunostimulating effects of β-glucans 
described frequently in healthy fish (Dalmo and Bøgwald, 2008; Soltanian et al., 2009) 
do not occur and provide protection against mycobacteriosis post infection. Immuno-
suppressive effects of mycobacteriosis have indeed been demonstrated in human 
tuberculosis caused by M. tuberculosis (Fenton and Vermeulen, 1996) and by 
Mycobacterium leprae cell wall lipids in mice (Moura and Mariano, 1997). 
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A further possible explanation could be that the recognition of the pathogen associated 
molecular patterns (PAMPs) of both the β-glucan and the mycobacteria by the immune 
system occurs partially via the same pattern recognition receptors (PRRs). β-glucan 
recognition by the mammalian innate immune system occurs via several receptors 
including scavenger receptors, complement receptor 3 and lactosylceramide (Dalmo and 
Bøgwald, 2008), but Dectin-1 either alone, or in interaction with Toll-like receptor 
(TLR) 2, is considered the main receptor (Brown et al., 2003; Gantner et al., 2003; 
Dennehy and Brown, 2007; Dostert and Tschopp, 2007). In contrast, β-glucan receptor 
identification in teleosts is limited so far, but the assumption that teleost and 
mammalian cells share many similar receptors may lead to a prediction of the effects of 
immunostimulants in fish (Ringø et al., 2011). The presence of zTLR2 however, the 
homologue of human TLR2, in zebrafish has been reported by Meijer et al. (2004); 
furthermore, gene expression of zTLR 2 (and other TLRs) was up-regulated when adult 
zebrafish were infected with  M. marinum and showed clinical signs of mycobacteriosis. 
A pro-inflammatory immune response of mouse macrophages against various 
Mycobacterium spp. was mediated by TLR2 in vivo (Underhill et al., 1999) and by 
Dectin-1 along with TLR2 in vitro (Yadav and Schorey, 2006). If the zebrafish, and 
indeed the macrophages, are already infected by the mycobacteria, then the 
macrophages are stimulated to a high degree (and possibly already compromised). In 
consequence, it might be questionable whether the macrophages can be stimulated any 
further beyond its current level by ß-glucan if the signalling pathways are mediated 
through the same receptors. And even if the macrophages can yet be stimulated, it may 
be too late if the mycobacteria have already compromised too many of the 
macrophages. In two cases in Yadav and Schorey’s study (2006) however the immune 
response was independent of dectin-1 indicating that the mediation of the immune 
response could also depend on the Mycobacterium strain.  
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Determining the effects of dietary ß-glucan supplementation on the intestinal microbiota 
under the chronic progressive zebrafish mycobacteriosis was an important aspect of this 
experiment. To the author’s knowledge no information is available in this respect in 
teleosts. In the present study the microbial ecological parameters were altered. The 
numbers of OTUs and the species richness and diversity were elevated at day 63 (but 
not at day 56) in fish fed MacroGard® supplemented diets compared to the control 
group. As with survival rates and histopathology, the outcome regarding the microbial 
ecological parameters was irrespective of the method of ß-glucan administration 
(continuous or intermittent). Surprisingly, no change was seen in the continuously fed 
ß-glucan group at day 56; one would expect a similar increase as that observed at day 
63. Similarly, in the intermittent group the increase at day 63 occurred when the fish 
were fed the control diet in the preceding week; a time-delayed effect could explain this 
phenomenon. In contrast to these findings, the 2nd experiment (Chapter 4) demonstrated 
reductions of the numbers of OTUs and the species richness and diversity in apparently 
healthy mirror carp fed ß-glucan supplemented diets, and sequence analysis revealed 
that mainly the abundance of LABs, but also of some Aeromonads decreased, while the 
abundance of a few species increased. Hence, it would be interesting to identify which 
intestinal bacteria species are present under mycobacterial infection to detect in 
consequence of which species the abundance is increased. Of utmost interest would be 
if the causative pathogen M. haemophilum is present and if its abundance changes with 
dietary ß-glucan administration. Furthermore, identifying the bacteria species could help 
in elucidating why changes of the intestinal microbial communities occurred at day 63, 
but not at day 56. Therefore further studies are required to identify the bacteria species 
by sequencing. 
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5.6 Conclusions 
The present study clearly demonstrates that both continuous and intermittent dietary 
administration of MacroGard fails to improve histopathological findings or reduce the 
severe mortalities of zebrafish suffering from chronic, pre-existing mycobacteriosis 
caused by M. haemophilum. Further research is required to characterize the 
immunological processes under such circumstances in fish. Whether an improvement of 
resistance can be attained by ß-glucan supplementation prior to Mycobacterium 
infection remains to be seen and future studies should address this topic. Furthermore, 
the determination of the microbiota present in the intestine under this chronic disease, 
both with and without ß-glucan influence, by quantitative analyses and sequencing 
should be conducted.  
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Each of the three experiments conducted during this research programme investigated 
aspects which have not, or only marginally, been in the focus of research related to the 
dietary administration of ß-glucans in humans and/or animals including fish. Emphasis 
shall be put on the overarching scientific approach of using highly purified basal diets 
of the same composition in each experiment. The aim was to minimize the presence of 
immunostimulating substances other than the supplemented MacroGard® originating 
from the various ingredients of the diets. From literature it is evident that all studies 
related to dietary ß-glucan supplementation in teleosts have been conducted using 
commercial or, at best, semi-purified diets. Important ingredients of fish feed however 
are known to contain immunostimulating substances. For example, standard fish meal 
contains significant amounts of nucleotides (Mateo et al., 2004) and cereals like wheat, 
barley, oat and rye contain ß-(1,3)(1,4)-D-glucans (Sealey et al., 2008). Dietary 
nucleotides (Li and Gatlin, 2006; Ringø et al., 2011) are potent immunostimulants in 
teleosts; the knowledge about cereal ß-glucans in this respect is still restricted, but 
Ringø et al. (2010) state that barley ß-glucans are highly likely to be able to induce 
immune responses. Such substances, undesired in the present studies, would most likely 
induce “background” immune responses themselves as a side-effect thereby possibly 
masking the true immunostimulating effect of the supplemented MacroGard®.  
It was particularly striking to note that in the experiments with mirror carp (Cyprinus 
carpio L.) (Chapters 3 and 4) the diets supplemented with 0.1% MacroGard®, the actual 
dosage recommended by the supplier for industrial applications, had no effects on the 
parameters assessed (except on the intestinal microbial communities). Only high dietary 
MacroGard® levels of 1% and 2% exerted enhancing effects on parameters like growth 
performance, some haematological indices (e.g. blood monocyte fraction), 
intraepithelial leukocytes in the anterior gut mucosa and the enterocytes’ microvilli 
length and density (not assessed for 2% MacroGard® supplementation). This 
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phenomenon may underpin the importance of the just described lack of background 
immunostimulation through the use of highly purified diets. Consequently, a most 
interesting question would be to conduct ceteris paribus experiments with a typical 
industrial basal diet and to compare the results with the results gained in Chapters 3 and 
4 and, in addition, whether such results could be achieved under commercial husbandry 
conditions.  
 
The first experiment described in Chapter 3 was concerned with the effects of 
MacroGard® on growth performance, haemato-immunological profile and intestinal 
morphology in mirror carp. Some information has been available about growth and 
haematology from literature (as described in Chapter 1), information about ß-glucan 
effects on intestinal morphology however has been very limited. High dietary 
MacroGard® supplementation significantly increased growth performance. As discussed 
in Chapter 3, the reasons for growth performance enhancing effects observed with 
dietary ß-glucans still remain unclear. Future research is required to elucidate these 
mysteries and novel technology should be able to achieve this. Tacchi et al. (2011) 
analysed the transcriptomic responses in liver and muscle tissue of Atlantic salmon 
(Salmo salar L.) fed diets supplemented with a “functional feed” premix containing 
nucleotides, mannan oligosaccharides, fructooligosaccharides, vitamin C and vitamin E. 
The fish displayed a decreased expression of protein turnover genes, reduced circulating 
plasma proteins and a down-regulation of immune response genes suggesting a decrease 
in whole body metabolic demands. The changes appear to result in reduced energy 
expenditure in fish and enhanced growth and performance; the feed conversion of fish 
fed the “functional feed” diet was improved by 4.1%. Unfortunately, the authors do not 
state whether the difference was significant compared to the control group, and no 
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detailed information is given about other growth performance parameters like weight 
gain or specific growth rate. However, such an approach could be applied to a ß-glucan 
study like the present one. Dalmo and Bøgwald (2008) suggest that ß-glucans induce a 
localized intestinal immune response that in turn leads to resistance against pathogens 
which otherwise would cause reduced weight gain and possibly disease. The present 
study indicated that a localized intestinal immune response may occur through an 
enhanced infiltration of intraepithelial leukocytes (IELs). Using transcriptomic 
technology, the expression patterns of a plethora of genes could be analysed 
simultaneously in intestinal tissue and the influence of dietary ß-glucan supplementation 
on immune modulation and intestinal health could be assessed. This could possibly help 
linking the enhanced growth performance to the enhanced infiltration of intraepithelial 
leukocytes observed in the present study. 
Future studies should also aim at exactly identifying the types of IELs in order to assess 
whether or not the increased infiltration of IELs in the anterior intestine in the present 
study is caused by an increased infiltration of one certain type of leukocyte. Animal 
studies indicate that dietary ß-glucans entering the proximal small intestine are captured 
by macrophages (Chan et al., 2009). It is therefore conceivable that a higher number of 
macrophages migrates to the epithelium to respond to a high delivery of ß-glucans (such 
as the 1% and 2% MacroGard® in the present study) during intestinal passage. 
Immunohistochemistry would be a useful means for the identification of leukocytes. 
Inami et al. (2008) used myeloperoxidase and acid phosphatase staining to identify 
granulocytes and macrophage-like cells, respectively, in cod (Gadus morhua L.) 
intestine and rectum. Monoclonal antibodies used in carp studies in order to identify 
leukocytes are WCI-12 for B-cells, WCL-15 for monocytes and macrophages in tissue 
sections (Forlenza et al., 2008) and WCL38 for mucosal T-cells (Rombout et al., 2011). 
TCL-BE8 binds to carp neutrophilic granulocytes (strong affinity), monocytes (low 
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affinity), and basophilic granulocytes (intermediate affinity) (Forlenza et al., 2008). 
Using these available tools future studies should be able to shed light on the increased 
intestinal IEL presence observed in the present study. 
 
No research has been conducted previously on the effects of ß-glucans on intestinal 
microbial communities using advanced methods and ultrastructure of the apical brush 
border of enterocytes in teleosts which were investigated using mirror carp in the 
second experiment in Chapter 4. Dietary MacroGard® clearly altered intestinal 
microbial communities in a time- and tissue dependent manner as assessed by culture-
based and culture-independent methods. The limitations of culture-based methods 
however are known (Cahill, 1990; Ringø et al., 2006b; He et al., 2011a). It should 
furthermore be noted that PCR-DGGE, the culture-independent method used here, is a 
semi-quantitative method (Merrifield et al., 2013), and future studies should ideally 
apply next generation sequencing methods to investigate the effects of dietary ß-glucans 
on intestinal microbial communities, e.g. full-length sequencing or 454 pyrosequencing, 
allowing for a much higher taxonomic resolution (Sekirov et al., 2010). Several recent 
studies employed such sequencing methods in teleosts and demonstrated, how vastly 
diverse in general the intestinal microbial communities are in salmonids, e.g. rainbow 
trout (Oncorhynchus mykiss) (Desai et al., 2012) and cyprinids like common carp (van 
Kessel et al., 2011), zebrafish (Danio rerio) (Roeseler et al., 2011) and grass carp 
(Ctenopharyngodon idellus) (Wu et al., 2012). Even though next generation sequencing 
methods will advance current knowledge about the entirety of microbiomes in different 
teleosts and under different conditions (like dietary pre- and probiotic administration), 
they cannot give insights into the microbiome’s contribution towards functionality and 
metabolic processes in health and disease (Sekirov et al., 2010). Looking even further 
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ahead, future studies should therefore try to use meta’omic approaches (metagenomics, 
metaproteomics, metabolomics and metatranscriptomics) which will enable researchers 
to study complex ecosystems and their interactions (Figure 6.1; Segata et al., 2013). 
DNA-based metagenomics will not only allow to likely detect all members of the 
microbial communities present in the sample but also to predict their biological 
functions, e.g. by environmental shotgun sequencing (Venter et al., 2004) which can be 
also applied for a parallel, comparative analysis of different samples (Eisen, 2007). 
Metagenomics however only allow insights into the functional and metabolic diversity 
of microbial communities but cannot give information about their actual metabolic 
activity (Simon and Daniel, 2011) or microbial abundance. This can be achieved by 
RNA-based metatranscriptomic studies giving insights into gene expression of 
microbial communities, but this method is currently still subjected to limitations. Such 
methods however would significantly increase current knowledge about possible 
influences of orally administered ß-glucans on the complex network of the intestinal 
microbiome and the host, and the interactions herein. 
 
 
 
Figure 6.1: “Open biological questions in microbial community biology, and emerging 
technologies and models for their exploration. Microbial communities are complex 
biological entities interacting with the environment, host organisms, and transient microbes. 
Predictive models for most of the interactions within these ecosystems are currently rare, 
but several studies have begun to provide key insights.” (from Segata et al., 2013) 
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The importance of the relationship between the intestinal microbiome and the host has 
been highlighted by two recent, pioneering studies in zebrafish (Rawls et al., 2004; 
Bates et al., 2006). Using germ-free zebrafish models, Rawls et al. (2004) observed that 
the microbiota stimulated intestinal epithelial proliferation and influenced enterocyte 
morphology, and Bates et al. (2006) demonstrated that the intestinal gut mucosa failed 
to differentiate fully in germ-free larvae. Reintroduction of the microbiota however 
caused a reversion of this deficiency in the study of Bates et al. (2006). These studies 
demonstrate the significance of the microbiota regarding gut development, possibly 
connecting the observed shifts in both autochthonous and allochthonous microbial 
populations with the observed increased microvilli length and density in the present 
study under the influence of the dietary supplementation of 1% MacroGard®. It can 
however not be determined whether the enhancing effects on microvilli length and 
density in the present study have been resulting from direct effects of the ß-glucan on 
the enterocytes or from secondary effects through the observed shifts in the microbial 
communities possibly caused by ß-glucans. Therefore, most interesting for future 
research would be to study the direct effects of dietary ß-glucans and other prebiotics in 
germ-free fish models to exclude influences of the microbiota. 
 
The third experiment described in Chapter 5 examined the effects of dietary 
MacroGard® on disease resistance and intestinal microbial communities of zebrafish 
(Danio rerio) during a chronic progressive, pre-existing mycobacteriosis. This 
mycobacteriosis was caused by Mycobacterium haemophilum about which information 
is eminently limited in teleosts. As described, MacroGard® failed to improve mortality 
rates and histopathological findings caused by the mycobacteriosis. Even though much 
is known about the pathology of mycobacterial infections in general, the fundamental 
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immunological processes are not well defined (Li and Gatlin, 2005). Understanding the 
host-pathogen interactions is highly important in order to be able to develop effective 
prophylactic or therapeutic measures. Recent studies however have advanced 
knowledge using zebrafish Mycobacterium marinum models. Transcriptomic studies 
gained new knowledge into immune gene expression with M. marinum infected 
zebrafish larvae (van der Vaart et al., 2012) and adult zebrafish (van der Sar et al., 
2009) in early stages of infection, in adult zebrafish and larvae during acute and chronic 
disease (Rotman et al., 2011) and in reactivation of dormant mycobacteria in adult 
zebrafish (Parikka et al., 2012). In future however, researchers need to examine the 
degree of translation of these transcribed genes into proteins using proteomic 
technology as already suggested above in the context of microbiota (metaproteomics), 
and in succession, what the effects of these proteins on the disease are. For example, it 
seems evident so far that tumor necrosis factor α (TNFα) plays a significant role in 
controlling M. marinum infections since TNFα receptor knockdown zebrafish exhibited 
enhanced intracellular mycobacterial growth, granuloma formation, necrotic death of 
macrophages and granuloma breakdown eventually leading to higher mortality (Clay et 
al., 2008). Furthermore, the balance between the pro-inflammatory TNFα and anti-
inflammatory lipoxins is important in the control of the disease (Tobin et al., 2010). 
And finally, referring back to the present study, all of these aspects are required to be 
equally researched for M. haemophilum infections in zebrafish, of course. 
Further research also needs to identify the pathogen responses and the associated 
mechanisms towards the host immune response. For example, it should be clarified 
whether M. haemophilum is equipped with similar mechanisms to evade macrophage 
immune response as Mycobacterium tuberculosis (Betz et al., 2011) and M. marinum 
(van der Vaart et al., 2012). The present findings may be indicative for that. But future 
studies should also address whether or not dietary ß-glucan administration prior to       
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M. haemophilum mycobacteriosis disease can counteract the disease or, at least, 
alleviate the symptoms, following the philosophy of a prophylactic approach. Growth 
inhibiting effects on M. tuberculosis have indeed been successfully demonstrated in 
vitro when MacroGard® was simultaneously administered to mouse macrophages 
(Hetland and Sandven, 2002). Whether this effect can be observed in vivo and against 
M. haemophilum remains to be illustrated. 
The importance of the microbiome has been already mentioned and in recent years a lot 
of research effort has been put into investigating reasons and effects of dysbiosis 
(meaning imbalances) of the microbiome. In humans, dysbiosis has been connected to 
inflammatory bowel disease, diabetes mellitus, obesity, cardiovascular disease and 
cancer (Pflughoeft and Versalovic, 2012; Brown et al., 2012). The only link so far 
between mycobacteria and intestinal microbiota with regards to chronic disease is 
present in inflammatory bowel disease in humans and the Johne’s disease in cattle. 
Among others factors, Mycobacterium avium ssp. paratuberculosis (MAP) has been 
suggested to be involved in the pathogenesis of Crohn’s Disease and Ulcerative colitis 
(Sekirov et al., 2010; Friswell et al., 2010). A general dysbiosis of the microbiota has 
been described in patients, it is still not clarified however whether the dysbiosis is cause 
or consequence of the disease. Several studies reported decreased numbers of members 
of Firmicutes and the Clostridium cluster IV with a simultaneous increase in the number 
of Bacteroides. Remarkable is that several studies detected a lower abundance of the 
commensal, anti-inflammatory bacterium Faecalibacterium prausnitzii (Firmicutes) in 
both digesta and mucosa samples (Sokol et al., 2008; Joossens et al., 2011). Alterations 
of the intestinal microbial communities were observed in the present zebrafish study 
induced by dietary MacroGard®. Future studies however need to identify the microbiota 
by sequencing to discover which species are present in zebrafish infected with                        
M. haemophilum with or without dietary ß-glucan influence. Furthermore, studies need 
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to include a negative control (fish uninfected with M. haemophilum) which was a 
drawback of this study due to the unavailability of healthy zebrafish. Ideally, those 
studies should employ the already discussed meta’omic approaches to further illustrate 
the influence of the microbiome on the host under this chronic progressive disease. 
Another interesting aspect is to assess possible changes of the microbial communities 
under mycobacterial infection when the ß-glucan was administered prior to infection 
since the gastrointestinal tract has been reported as the primary route of infection for           
M. marinum and Mycobacterium peregrinum (Harriff et al., 2007) likely indicating the 
same route for M. haemophilum. 
 
Reflecting from the two carp experiments, future research is required to narrow down 
the supplementation range between 0.1% and 1% MacroGard® in order to detect at 
which minimum dosage level similar alterations of the parameters assessed occur as 
they did with 1% and 2% dietary MacroGard®. Namely, it is important to be aware that 
such high supplementation levels of 1% or even 2% of MacroGard® or comparable 
products are critical from an economic point of view. The prices for products like 
MacroGard® are currently considerable with approximately 35 €/kg due to the complex 
and cost-intensive processing. Increasing the dosage from 0.1% to 1% MacroGard® by 
ten-fold means that the portion of costs per ton of feed mixture would amount to 
approximately 350 €. This is economically not feasible considering current main 
commodities prices of approximately 1400 €/t for standard fish meal, 1800 €/t for fish 
oil, 830 €/t soya oil or 233 €/t for wheat (Source: The World Bank; as of April 2013). In 
contrast however, reflecting from the zebrafish experiment, future research should 
investigate if supplementation levels higher than the 0.1% MacroGard® used could 
possibly have a positive impact on the progression of a chronic, pre-existing 
mycobacteriosis. 
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As a final note, the results of the current study with its overarching approach of using 
highly purified diets also provide manifold incentives for further investigations. In the 
here presented carp experiments the ß-glucan effects were only examined in juvenile 
specimen over comparatively short periods of four and eight weeks, respectively. A 
topic of high interest is whether the here observed enhancing effects on growth, 
haematological and intestinal morphological parameters as well as the changes in the 
intestinal microbial communities can be observed in common carp of different life 
stages, e.g. in fry from first feeding onwards or in adult fish. In addition, the potential of 
dietary ß-glucans with regards to spawning should be given attention to determine, if 
positive effects on brood stock and the problems related to spawning occur, and if in 
consequence improvements in egg quality and quantity, and beyond that, in larval 
survival could also be achieved. Furthermore, long-term experiments should be 
conducted to examine whether these effects can persist over several months or possibly 
over the whole growth phase up to marketable size or whether suppressing effects occur 
since immunosuppression through long-term application of immunostimulants has been 
proposed (Bricknell and Dalmo, 2005; Ringø et al., 2011). Consequently, trials with 
various pulsative administration strategies of dietary ß-glucans should be included. 
Since traditional carp production is subject to changing weather conditions during the 
course of the year, the aspect of temperature is of high importance and should be given 
serious consideration. The present study examined the ß-glucan effects on a chronic, 
pre-existing zebrafish mycobacteriosis; tests on other cyprinid diseases of chronic and 
non-chronic nature are required. The use of ß-glucans from different commercial 
suppliers might results in differing outcomes of studies since the product properties will 
likely vary due to distinctions in the product’s origin (e.g. baker’s yeast vs. brewer’s 
yeast vs. yeast from bioethanol production) and extraction technique. For example, the 
degree of purification is higher for some products, and for brewer’s yeasts it is known 
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that they contain humolones (α-acids) and lupolones (ß-acids), bitter principles from 
hops exhibiting bacteriostatic effects. Therefore, comparison experiments will be of 
interest to determine the product efficacies under the plethora of approaches described. 
Innovative combinations of various yeast cell wall components/yeast autolysates among 
each other or combinations with other pre- and probiotics might further advance product 
development in this important sector. In conclusion, all these mentioned aspects shall 
also be investigated in other aquatic species relevant to aquaculture production, like in 
different fish species and in the various crustaceans to overall warrant efficient and 
sustainable production in the future. In 2050, it is highly likely that at least 9 billion 
people on planet earth will need food, and aquaculture plays an increasingly important 
role in the system! 
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